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Chapter 110
During the first 9 months of our life more significant changes happen to man than in 
the 70 years that follow — Samuel Taylor Coleridge 
RATIONALE
The complex architecture of our brain has baffled scientists for centuries. Development of the human 
brain is an extremely complex process which begins with the differentiation of neural progenitor 
cells resulting in the formation of a simple tube. The neural tube differentiates further into an organ 
that distinguishes man from all the other species on our planet (Figure 1). Neurodevelopmental 
processes follow a strictly orchestrated sequence driven by an complex interplay between genetic 
and environmental input [1]. Individual brain regions develop asynchronously. Therefore, disruption 
of early brain development caused by harmful environmental exposures and altered gene expression 
results in disorders specific for the time window during which they occur [2]. In addition, the type and 
severity of the harmful exposure also contributes to specific alterations and the range of subsequent 
neurodevelopmental consequences [4,5].
Neurodevelopmental disorders carry a heavy economic and emotional burden for societies. One in six 
children in the industrialized world is affected and prevalence rates are rising [6-8]. Subtle deviations in 
size of the brain and individual brain structures (cerebellum, cerebral ventricular system, white matter) 
serve as markers of brain development and predispose to neurodevelopmental impairment and 
psychiatric disorders [9-11]. Therefore, there is a need to increase knowledge on disruptive conditions 
and to unravel underlying mechanisms causing alterations in early brain development in order to 
early diagnose and predict neurodevelopmental disorders. Ultimately, this allows the development of 
neuroprotective strategies and interventions to improve neurodevelopmental outcome in fetuses at 
risk for abnormal brain development.
The paradigm of the developmental origins of health and disease (DOHaD) postulates that an adverse 
intra-uterine environment leads to developmental adaptations that permanently program the 
structure, physiology and metabolism of fetal organs [14-16]. Mal programming can result in fetal growth 
deviations and increased susceptibility for adult diseases. The Dutch Famine birth cohort study has 
substantiated this hypothesis demonstrating the impact of famine during pregnancy on the occurrence 
of diseases in adult life [18]. Other large cohort studies (ALSPAC, the Barwon infant study, Generation 
R, Norwegian mother and Child study) have been conducted worldwide and investigated the impact of 
maternal environmental exposures on outcomes in offspring from the second trimester of pregnancy 
until early adulthood [19-22]. Evidence is rising however that in particular the periconceptional 
period (14 weeks before until 10 weeks after conception) is essential for programming, growth and 
development of the embryo as well as fetal and postnatal health [23]. Therefore, most developmental 
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Figure 1 — Early human brain 
development
From an ectodermal neural plate 
the neural tube forms and closes in 
the third week after conception [1]. 
During the following week this tube is 
organized n three major subdivisions; 
prosencephalon, mesencephalon, 
rhombencephalon (A: embryonic brain 
at 7 weeks GA) [1]. After 5 weeks, 
division of the rhombencephalon 
into the metencephalon and 
myelencephalon becomes evident 
when the cerebellum and the pons 
develop [2]. The cerebellum precedes 
most rapidly developing brain regions 
and can already be visualized by 
ultrasound from 7 weeks gestational 
age (GA) [3]. After gestational week 
12, most fundamental structures of 
the brain are already formed (B: early 
fetal brain at 12 weeks GA). From this 
point on the amount of brain tissue 
is expanding rapidly. Outgrowth of 
the cerebral cortex starts in caudal 
direction bending ventrally and then 
rostrally giving shape to the temporal 
lobe and thereby the insula and 
Sylvian fissure (C: fetal brain at 26 
weeks GA) [2]. From mid-gestation 
onwards neurogenesis peaks and 
new neuronal cells migrate to their 
target destination where they acquire 
characteristics specific to that area of 
the brain. Connectivity between the 
two cerebral hemispheres is assured 
when the corpus callosum has been 
formed around 24 weeks of gestation. 
The perinatal period, from 24 weeks 
until delivery, is characterized by 
neuronal maturation, synaptogenesis, 
cortical folding and volume expansion 
of the cerebrum [12,13]. At the end of 
gestation the 300-400 grams weighing 
newborn brain has been formed (D: 
neonatal brain at term age) [17].
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disorders and deviations in growth occurring later in pregnancy are likely to originate in this period 
[14-16]. Although the DOHaD paradigm includes all windows of sensitivity to environmental stressors 
across the life span, only few cohort studies have included the periconceptional window [24,25]. 
The DOHaD paradigm is also most relevant to early human brain development and its consequences 
for neurodevelopmental functioning in later life. As the brain starts developing rapidly during very 
early gestation, its complex architecture is particularly susceptible to the intra-uterine environment. 
Environmental factors can influence early brain development directly and indirectly by impacting other 
organ systems or fetal growth as a whole. In this regard, particularly fetuses with a congenital heart 
defect (CHD), fetal growth restriction (FGR) and preterm born infants are at risk for abnormal brain 
development and postnatal neurodevelopmental impairment during later life [26-28]. So far, only a few 
studies have investigated the impact of prenatal exposures on early prenatal brain development. Ekblad 
et al. has reviewed the literature on the impact of maternal smoking during pregnancy and reported 
reduced brain growth and regional brain volumes as well as altered microstructure in offspring with 
consequences for functional outcome in the child [29]. Moreover, maternal intoxications such as the 
use of cocaine during pregnancy are associated with decreased grey matter volume in the offspring 
which was most profound in the prefrontal and frontal regions [30]. Social alcohol consumption is 
widely tolerated in women of reproductive age. This is particularly alarming because prenatal alcohol 
exposure has been associated with decreased total brain volumes and grey and white matter volumes 
in children [31,32]. In contrast to these harmful impacts, are the reported positive associations between 
maternal folate levels and fetal head size and growth [33].
NEUROSONOGRAPHY
Although most of our knowledge of prenatal brain development is still based on post-mortem studies, 
improvements in sophisticated imaging techniques have changed the scope to in vivo evaluation of 
human brain development. Ultrasound is an unique imaging technique as it is non-invasive, easily 
accessible and safe for the small embryo [34]. Therefore, it is very suitable for longitudinal use and 
follow-up. The greatest challenge of ultrasound is that the image quality is mostly influenced by the 
sonographers’ skills and the quality of the equipment [34]. Nevertheless ultrasound has been the 
first choice diagnostic during pregnancy ever since it made its debut in obstetrics in 1958 [34]. The 
widespread use of two-dimensional ultrasound (2D-US) for prenatal diagnosis came with the invention 
of real time scanning during the early 1970s. In the Netherlands however, structural 2D-US evaluation 
of fetal anatomy as standard second trimester obstetrical care was not implemented until 2006. Three-
dimensional ultrasound (3D-US) has been introduced during the 1980s. This technique largely has two 
modules: the multiplanar mode and volume rendering which enables the reconstruction of precise 
orthogonal planes and a rendered surface image. Both modules have shown to be practical tools for 
prenatal neuro-sonography; a detailed ultrasound evaluation of the prenatal central nervous system.
Processed on: 7-4-2017
509071-L-bw-Koning
Introduction 13
1
Figure 2
Sectional planes with images of the 
fetal brain extracted from a 3D-US 
volume; A: coronal, B: mid-sagittal, C: 
transventricular and D: transcerebellar 
planes. Images with permission.
3D-US is useful in addition to conventional 2D-US as it ensures precise measurements and can 
improve diagnostic accuracy for a number of structural malformations. The use of high-resolution 
transvaginal transducers allows detailed imaging during the early first trimester of pregnancy [35]. As 
a result reference charts of several embryonic brain structures have been created to study normal and 
abnormal brain development [36,37]. Moreover, display of 3D-US images requires desktop applications 
which offer interactive visualization tools (Figure 2). In addition, virtual reality technologies such as 
the Barco I-Space (Barco N.V., Kortrijk, Belgium) offer depth perception with a volume-rendered 3D 
dataset. It enables visualization and quantification of morphology as well as biometric and volumetric 
measurements of an embryo in vivo [38,39]. However, a virtual reality system is less suitable for analysis 
of 3D-US volumes of the fetal brain later in pregnancy. These commonly used desktop applications can 
be used more easily to analyse these volumes.
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HYPOTHESIS
The development of reliable markers of early brain development is essential to detect early deviations 
in human brain development. Such measures also provide the opportunity to study associations 
between periconceptional maternal and fetal factors and the sizes and growth patterns of several brain 
structures. Identifying potential disruptors and protective agents of brain development will give rise to 
improvement of preconception counselling and antenatal strategies to prevent neurodevelopmental 
impairments in early and later life. 
AIMS OF THE THESIS
In this thesis we aim to investigate the impact of periconceptional maternal and fetal factors on early 
human brain development (Figure 3). The main objectives of this thesis are:
1. To develop protocols and establish reliability of embryonic, fetal and neonatal brain measurements 
using ultrasound techniques.
2. To investigate the impact of periconceptional maternal factors on early development of the human 
brain
3. To study the association between early human brain development and fetal characteristics such as 
congenital heart defects, fetal growth restriction and gender. 
 
Processed on: 7-4-2017
509071-L-bw-Koning
Introduction 15
1
Fi
gu
re
 3
 —
 A
im
s o
f t
he
 th
es
is
A
re
 p
er
ic
on
ce
pti
on
al
 m
at
er
na
l 
be
ha
vi
or
s 
(f
ol
ic
 a
ci
d 
su
pp
le
m
en
t 
us
e,
 a
lc
oh
ol
 c
on
su
m
pti
on
, 
sm
ok
in
g,
 o
be
si
ty
) 
an
d 
ch
ar
ac
te
ri
sti
cs
 (
ag
e,
 e
th
ni
ci
ty
, 
pa
ri
ty
 a
nd
 m
od
e 
of
 c
on
ce
pti
on
) 
an
d 
fe
ta
l f
ac
to
rs
 (
co
ng
en
it
al
 h
ea
rt
 d
ef
ec
t,
 f
et
al
 g
ro
w
th
 r
es
tr
ic
ti
on
 a
nd
 g
en
de
r)
 a
ss
oc
ia
te
d 
w
it
h 
br
ai
n 
de
ve
lo
pm
en
t?
 B
ra
in
 s
tr
uc
tu
re
s 
of
 in
te
re
st
 a
re
 d
ep
ic
te
d 
in
 b
lu
e:
 h
ea
d 
vo
lu
m
e,
 
ce
re
be
llu
m
, c
or
pu
s 
ca
llo
su
m
 a
nd
 c
or
ti
ca
l f
ol
di
ng
.
Processed on: 7-4-2017
509071-L-bw-Koning
Chapter 116
SETTING
The studies described in this thesis were performed in the Dream study and the Submarine study.
The Dream study is a longitudinal ultrasound cohort embedded in the ongoing Rotterdam 
Periconception Cohort (Predict study >2009), a hospital-based cohort from the preconceptional period 
with follow up after birth, conducted at the Erasmus MC University Medical Center in Rotterdam [24]. 
Pregnant women are enrolled during the first trimester and received 3D-US examinations at 7, 9, 11, 
22, 26 and 32 weeks GA. Ultrasound scans were performed using a 1-7 MHz transabdominal transducer 
and a 6-12 MHz transvaginal transducer of the Voluson E8 system (General Electrics Medical Systems, 
Zipf, Australia). Standard biometric measurements were performed online and measurements of 
various brain structures were performed offline on 3D-US volumes using 4D View software (General 
Electrics Medical Systems, Zipf, Australia) and the Barco I-Space virtual reality system. After delivery, 
at approximately 42 weeks post-menstrual age all newborns were invited for one last visit to collect 
anthropometric data and perform a cranial ultrasound scan (CUS) using a MyLab 70 scanner (Esaote, 
Genoa, Italy), with a convex neonatal probe (7.5 MHz). Repeated measurements of embryonic, fetal 
and neonatal brain structures were combined to create growth trajectories. At study entry data on 
maternal characteristics, medical obstetrical history and lifestyle were obtained from self-reported 
questionnaires and verified by a researcher. Data on pregnancy course and neonatal outcomes were 
obtained from self-reported questionnaires and validated by ultrasound reports and medical records. 
The Submarine study is a prospective observational cohort conducted at the Neonatal Intensive 
Care Unit of the Sophia Children’s Hospital, Erasmus MC in Rotterdam. Preterm born infants were 
included between 2010 and 2012 and CUS were performed according to the standard local protocol 
using a MyLab 70 scanner (Esaote, Genoa, Italy), with a convex neonatal probe (7.5 MHz). Scans 
were performed on the day of birth; on days 1, 2, 3, and 7 of life; and then weekly until discharge. 
Measurements were performed off-line by using the Mylab software (Esaote).
OUTLINE OF THE THESIS
In PART I we study the early development of the human cerebellum. In Chapter 2 we present the results 
from a systematic review of literature on the impact of parental environmental exposures and intrinsic 
factors on prenatal growth and development of the human cerebellum. The associations between 
periconceptional maternal folate status and cerebellar growth in the first trimester of pregnancy are 
described in Chapter 3. In Chapter 4 cerebellar growth trajectories from 9 weeks to 32 weeks GA were 
created for the investigation of associations with periconceptional maternal and fetal factors.
In PART II we investigate the feasibility of other markers of early human head and brain development. 
In Chapter 5, we introduce embryonic head volume as a new marker for head size during the first 
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1
trimester and demonstrate associations with periconceptional maternal and fetal factors. In Chapter 6, 
the impact of fetal congenital heart defects (CHD) on brain fissure depth measurements is addressed. 
We present a new ultrasound marker for monitoring of preterm brain growth; corpus callosum – 
fastigium length in Chapter 7. The use of this marker for the evaluation of fetal brain growth of fetuses 
with CHD, fetal growth restriction and controls is investigated in Chapter 8.
 
PART III includes the general discussion and summary.
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Impacts on prenatal development of the 
human cerebellum: A systematic review
Irene V. Koning, Myrte J. Tielemans, Freek E. Hoebeek, 
Ginette M. Ecury – Goossen, Irwin K.M. Reiss, 
Régine P.M. Steegers-Theunissen, Jeroen Dudink
J Matern Fetal Neonatal Med. 2016 Nov 2:1-2.
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ABSTRACT
Background — The cerebellum is essential for normal neurodevelopment and is particularly susceptible 
for intra-uterine disruptions. Although some causal prenatal exposures have been identified, the origin 
of neurodevelopmental disorders remains mostly unclear. Therefore, a systematic literature search 
was conducted to provide an overview of parental environmental exposures and intrinsic factors 
influencing prenatal cerebellar growth and development in humans.
Methods — The literature search was limited to human studies in the English language and was 
conducted in Embase, Medline, Cochrane, Web of Science, Pubmed and GoogleScholar. Eligible studies 
were selected by three independent reviewers and study quality was scored by two independent 
reviewers.
Results — The search yielded 3872 articles. We found 15 eligible studies reporting associations 
between cerebellar development and maternal smoking (4), use of alcohol (3), in vitro fertilization 
mediums (1), mercury (1), mifepristone (2), aminopropionitriles (1), ethnicity (2) and cortisol levels (1). 
No studies reported on paternal factors.
Conclusions — Current literature on associations between parental environmental exposures, intrinsic 
factors and human cerebellar development is scarce. Yet, this systematic review provided an essential 
overview of human studies demonstrating the vulnerability of the cerebellum to the intra-uterine 
environment.
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INTRODUCTION
One in six children in industrialized countries are affected by neurodevelopmental problems, including 
cognitive defects, motor disabilities and psychiatric diseases [6]. Most of these aberrations cause 
lifelong problems with severe societal and economic impact [40]. Harmful prenatal environmental 
exposures can alter epigenetic programming and structural development, potentially inducing 
neurodevelopmental short-comings [23,41,42]. The exact contribution of environmental exposures 
to neurodevelopmental problems is poorly understood. Since individual brain regions develop 
asynchronously, the exact alterations are not only determined by the type or severity of harmful 
exposure but also the critical time windows [4,5].
Of the rapidly developing brain regions, the cerebellum precedes most brain structures and shows 
very early connectivity. It also shows a steep growth curve during fetal life, increasing up to 500% in 
cerebellar volume between 24-40 weeks of gestation [43-45]. Harmful environmental exposures during 
pregnancy may therefore pose a risk to disrupt prenatal cerebellar development [46]. Postnatally, 
the cerebellum is involved in a wide variety of sensorimotor tasks as well as cognitive, emotional 
and language behaviour [47-49]. This may explain why an altered prenatal cerebellar development 
or injury may be associated with an increased risk for neurodevelopmental impairment and mental 
health issues [46,47,50-52].
Overwhelming evidence from animal studies have established the impact of an adverse intra-uterine 
environment compromised by toxic agents, environmental exposures, infection, inflammation, 
hypoxia, imbalances in vitamin or hormonal status on cerebellar development [5,46,53]. Human 
studies on this issue are scarce, predominantly focusing on postnatal cerebellar functions disregarding 
prenatal deviances in growth and development.
We believe that studying the impact of the intra-uterine environment on human prenatal cerebellar 
growth and development may provide more insight for better understanding consequences for 
neurodevelopmental functioning. Therefore, we provide an overview of the literature on parental 
environmental exposures and intrinsic factors influencing prenatal growth and development of the 
human cerebellum. The ultimate aim is to identify risk factors for impaired prenatal cerebellar growth 
and development with potential consequences for neurodevelopmental outcome.
MATERIALS AND METHODS
Search Strategy and Selection Criteria
A literature search according to a predefined protocol was generated by an experienced medical 
information specialist from the Medical Library of the Erasmus MC University Medical Center. All 
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relevant literature up to September 4th 2015 was searched in Embase, Medline, Cochrane central, 
WebofScience, Pubmed and GoogleScholar. The complete search strategy (Appendix A) combined 
controlled vocabulary terms (in Medline and Embase) and free text words in title and/or abstract 
related to the exposure (e.g. alcohol, nutrition, ethnicity), the outcome (prenatal cerebellum in context 
of growth, development and abnormalities), and the studied population (e.g. pregnancy, pregnant 
women, maternal, paternal). The search was limited to human studies in the English language.
All randomized controlled trials, intervention studies, cohort studies, case-control studies and case 
reports were eligible for inclusion when they reported the human cerebellum as prenatal outcome 
measure, in terms of size, histology, morphology or any other measurement of the cerebellum during 
pregnancy. Eligible studies should report on any environmental or intrinsic factor as exposure, including 
maternal conditions or characteristics, environmental toxicities, occupational and lifestyle exposures. 
Exclusion criteria were (1) no or irrelevant exposure defined as an exposure that is not environmental 
or intrinsic; (2) postnatal cerebellar outcome only; (3) results obtained from animal or in vitro studies; 
(4) articles with no full text available; (5) book chapters and reviews lacking unique data analysis.
Working in pairs, three independent reviewers (IVK, MJT, GMEG) screened the titles and abstracts on 
the selection criteria. All differences in the study selection were resolved through discussion with the 
first reviewer (IVK) who read all abstracts. For all selected articles, full text was retrieved and evaluated 
to decide whether the study met the inclusion criteria. Reference lists of all included studies were 
checked for potential eligible articles. 
Quality assessment
Two reviewers (IVK, MJT) independently scored the quality of the included studies according to a 
predefined quality score (Appendix B) based on five items namely the study design, population size, 
exposure and outcome measurements and confounder handling. Each item could score zero, one or 
two points, resulting in a maximum of ten points representing the highest quality. Case reports were 
not assessed on quality. Discrepancies in assigned quality scores were discussed until the reviewers 
agreed. As the quality score was not used as an exclusion criterion we did not define a cut-off score.
RESULTS
The literature search resulted in 3872 unique articles. During title and abstract screening we excluded 
3817 articles. Full texts of 55 studies were reviewed for relevance. We excluded studies because of 
irrelevant outcome (7), irrelevant study population (10), no or irrelevant exposure (9), irrelevant study 
type or no available full text (7), animal or in vitro models (6), duplicate data (1) or the manuscript 
was not written in the English language (1). Additionally, we included one study through hand search 
of reference lists of the included studies. In total, 15 studies were included in this systematic review.
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Table I, presents details of the included articles and quality scores. In the selected literature we 
found eligible case reports, cross-sectional, intervention and cohort studies on maternal smoking (4), 
maternal use of alcohol (3), endemic mercury exposure (1), the influence of in vitro fertilization (IVF) 
mediums (1), mifepristone (1) ethnicity (2) and maternal cortisol levels (1). Two case reports described 
fetuses with cerebellar anomalies after exposure to mifepristone and aminopropionitriles. No 
studies reported on paternal exposures or factors influencing cerebellar development. We identified 
environmental exposures defined as environmental toxicities, occupational and lifestyle exposures 
and intrinsic factors defined as factors that characterize the origin of a person including ethnicity and 
stress levels (Figure 1). Findings are presented per documented exposure.
Figure 1 — Impact of maternal environmental exposures and intrinsic factors on prenatal development of 
the human cerebellum
Smoking
Gestaonal age
Alcohol
 Corsol
 Ethnicity
Mifepristone
Aminopropriotriles
IVF medium
Mercury
0  4  8  12  16  20  24  28  32  36  40
Expansion of volume and foliaon
Development of the main fissures
Joining of cerebellar primordia and development of the vermis
Growth and reshaping into a transversely oriented structure
Migraon of  neurons
Formaon rhombic lips
Cerebeller neurogenesis
5 mm
A schematic display of the evidence found in this systematic review of the impact of maternal factors, divided in environmental 
exposures (green) and intrinsic factors (blue) on prenatal development of the human cerebellum with respect to gestational 
age and the most essential developmental stages of the cerebellum. Adjusted from Rakic et al. 1970 [54].
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Environmental exposures and intrinsic factors
Maternal smoking
Four studies evaluated the association between maternal smoking and fetal cerebellar development 
[55-58]. A prospective cohort described a significantly smaller fetal transcerebellar diameter (TCD) 
in addition to smaller head parameters in fetuses of mothers who continued smoking throughout 
pregnancy compared to non-smoking mothers (-0.08mm, 95%CI= -0.15;-0.00) when adjusting for 
known confounders [58]. Cerebellar growth did not differ significantly [58]. In addition, morphological 
associations between tobacco and cerebellar development have been studied by Lavezzi et al., 
suggesting defective maturation and migration of Purkinje cells in histology specimen of fetuses with 
sudden intra-uterine death [56]. In 91% of these cases at least one developmental alteration was 
shown, suggesting a strong correlation between tobacco exposure and prenatal cerebellar insults. 
Moreover, in a similar study, 92% of fetuses had bio-pathological alterations in the cerebellar cortex 
(p<0.05) [57]. A fourth study showed that maternal smoking during pregnancy, compared to non-
smoking, significantly increased the expression of nicotinic and muscarinic acetylcholine receptors in 
human cerebellum, pons and medulla oblongata tissue of fetuses between 5 and 12 weeks gestation 
obtained after routine abortion procedures [55].
Maternal use of alcohol
Three studies evaluating the association between maternal alcohol consumption and fetal cerebellar 
growth measured by TCD, showed inconsistent results [59-61]. The study with the highest quality 
investigated the influence of maternal alcohol consumption measured in average ounces of absolute 
alcohol consumption per day and fetal brain measurements in 167 women. Maternal alcohol 
consumption was reported to be associated with a reduction of the frontal cortex and not to cerebellar 
size (Pearson= -0.040, p≥0.10) [61]. This finding is supported by a prospective cohort which compared 
mothers using alcohol with mother not using alcohol in the second (mean difference TCD= 0.7mm, 
p>0.05) and third trimester (mean difference TCD= 0.2mm, p>0.05) [60]. In this study alcohol 
consumption was recorded by validated self-administered questionnaires [62,63]. In contrast, using 
the same questionnaires another study reported smaller cerebellar size (p= 0.087) and significantly 
decreased cerebellar growth (p= 0.008) in heavy drinking women who continued drinking compared 
to early abstainers and non-drinkers [59].
Environmental toxicities
Five studies reported on the impact of maternal exposure to environmental toxicities on prenatal 
cerebellar development [64-68]. An intervention study reported differences in fetal TCD (mean 
difference= 0.4mm, p= 0.008) in fetuses exposed as an embryo to different commercially available 
culture media (Vitrolife G1.3, Göteborg, Sweden vs. Cook K-SICM, Brisbane, Australia), establishing the 
culture medium as a direct environment for the growing embryo outside of the uterus [67]. In fetal 
brain tissue from the Seychelles endemically exposed to mercury demonstrated a correlation of dietary 
mercury exposure and levels in the brain. These levels were highest in posterior fossa structures and 
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subcortical nuclei [66]. Although this study identified no structural pathological alterations, histological 
alterations were found in cerebellar white matter of which clinical significance remains unclear 
[66]. Two cases of cerebellar anomalies after failed induction of abortion with mifepristone and 
prostaglandins have been reported, including cerebellar atrophy and half-sided cerebellar agenesis 
[64,68]. Teratogenic effects of aminopropionitriles have been suggested in a case report of an exposed 
fetus with multiple congenital anomalies including cerebellar malformations [65].
Intrinsic maternal factors
Li et al. conducted a cross-sectional study in relatively low risk singleton pregnancies to evaluate 
associations of maternal stress levels measured by serum cortisol before delivery and fetal growth 
measures. A negative correlation between maternal serum cortisol and mid-gestation TCD (R2= 0.76, 
p= 0.014) not late TCD was demonstrated, adjusting for maternal body mass index, age and body weight 
at delivery, moment of the ultrasound, infant gender, moment of cortisol measurement and maternal 
uterine contraction states [69]. Two studies reported ethnicity in relation to cerebellar size [70,71]. TCD 
measurements were dependent of ethnicity when comparing measurements from Moroccan, Turkish 
and Belgian fetuses [71]. Additionally, cerebellar volume of Taiwanese fetuses compared Brazilian 
fetuses showed a significantly increased cerebellar growth curve (mean difference= 0.366mm, 
p<0.001) [70].
DISCUSSION
This review provides a complete overview of the current published literature of the effects of parental 
environmental exposures and intrinsic factors on prenatal human cerebellar growth and development. 
Notable, we did not find any evidence of paternal factors affecting cerebellar development. Although 
the available data were collected from heterogenic study populations with various outcomes, they 
provide ample evidence to support the particular susceptibility of the human cerebellum to maternal 
environmental exposures and intrinsic factors [47]. We found associations between maternal smoking, 
use of alcohol, type of IVF culture medium, mercury, mifepristone, aminopropionitriles, ethnicity, 
maternal cortisol levels and cerebellar growth or development. We discuss these findings in detail and 
aim to guide future studies investigating impacts on prenatal development on the human cerebellum.
Main findings
Maternal smoking
We found evidence in histological and ultrasound studies that maternal smoking has a harmful effect 
on prenatal cerebellar development, complementing previously documented reduced cerebellar 
volumes in prematurely born infants of smoking mothers [72]. So far, direct influences of maternal 
smoking have only been demonstrated in animal studies reporting alterations in various receptors 
and cellular processes [73,74]. Human studies have only reported indirect evidence for harmful 
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influences of nicotine on behavioural and cognitive outcome in the offspring [75]. Previous imaging 
studies also showed that maternal smoking was associated with reduced head growth and total brain 
volume measured in the second half of pregnancy [29,58,76]. However, whether the relationship 
between maternal smoking and neurodevelopmental outcome is mediated by derangements in brain 
development needs to be elucidated. However as the brain overall is affected, one could reason that 
the cerebellum as a separate entity is not spared. In addition, reduced cerebellar growth might be a 
secondary network injury effect due to lack of innervation. Toxicity of tobacco may alter epigenetic 
mechanisms and vascular processes which in turn may directly and/or indirectly influence cerebellar 
growth and maturation [29].
Maternal use of alcohol
Although previous studies reported that cerebellar neurons are particularly susceptible to alcohol-
induced developmental disruptions [77-79], ultrasound studies did not demonstrate consistent 
associations between alcohol exposure and cerebellar size. One study provided evidence for reduced 
prenatal cerebellar growth in relation to heavy alcohol exposure compared to non-alcohol exposure 
or early-abstainers [59]. These findings may support the possible benefit of early abstinence for fetal 
growth measures including cerebellar growth. Although there is no comparable animal data available, 
decreased cerebellar weight and cerebellar neuronal loss was recorded due to ethanol induced 
neurotoxicity [80]. Alcohol-induced cerebellar alterations may result from underlying mechanisms, 
such as excitotoxicity, nutritional deficiencies, growth factor alterations, glial abnormalities, apoptosis, 
oxidative stress and compromised energy production [81]. However, adverse effects of maternal 
alcohol exposure on cerebellar growth were not detected in the other studies [60,61]. This may be 
due to the relatively small effect sizes and considerable variability in study populations, quality and 
methodology. In addition, reliance of self-reported alcohol consumption is limited. We speculate 
that the impact of maternal alcohol intake on the developing cerebellum may be revealed in larger 
ultrasound cohorts using more precise measures for alcohol consumption in contrast to the relatively 
crude measures for maternal alcohol intake at conception used previously [61]. However, to date 
prenatal ultrasound evaluation of fetal brain development in women using alcohol during pregnancy 
receives little attention.
 
Environmental toxicities
Environmental toxicities including IVF-mediums, mercury, mifepristone and aminopropionitriles were 
associated with a variety of cerebellar anomalies and altered development [64-68]. However, quality of 
the evidence was relatively low, based on two case-reports and studies with quality scores between 3 
and 7. One study reported the interesting finding that IVF culture mediums could influence cerebellar 
growth during the second trimester of pregnancy [67]. This suggests that already during in vitro 
stages, embryonic growth can be influenced, which also affects the cerebellum and connecting brain 
structures. This may indicate that the embryo’s own epigenetic programming and early neurogenesis 
by modulation of neurotrophic factors can be directly influenced by its environment, being a culture 
medium or the womb [23,41].
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Only one study reported on the neurotoxic effects of mercury in utero on the human cerebellum 
showing elevated levels of mercury in the brains of endemically exposed fetuses, in the absence of 
clear pathologic developmental alterations [66]. Although the evidence from this small sample is rather 
scarce, animal models provide clear evidence for neurotoxic effects of mercury including dose-related 
cerebellar damage, anomalous cerebellar development and altered Purkinje cell migration [82-86]. 
In addition, mercury levels in the cerebellum among other posterior fossa structures were reported 
higher than in the cerebral cortex. This finding is consistent with a rat model showing the highest 
mercury concentrations in the cerebellum and hippocampus after in utero exposure [84]. Potentially 
this indicates greater susceptibility of these structures to destructive neurotoxic effects of mercury 
[66]. Although the results of this prenatal study remained inconclusive, previously significantly reduced 
neonatal cerebellar measurements were reported after antenatal mercury exposure [87].
Considering that only two studies reflected on the potential teratogenic effects of mifepristone, this 
finding seemed of little significance as failed termination of pregnancy was reported in fewer than 
0.02% of cases [64]. In addition, causal relation between occupational aminopropionitriles exposure 
and cerebellar development cannot be concluded from one fetus diagnosed with Cantrell-sequence. 
Although the evidence of a neurotoxic impact of aminopropionitriles on cerebellar morphology seems 
limited, effects on a finer scale or on cerebellar connectivity cannot be excluded.
 
Intrinsic maternal factors
Two studies demonstrated that cerebellar size measured with TCD and cerebellar volume varied 
among different ethnicities. Ethnical differences in transcerebellar size are highly interesting, as this 
may impact obstetrical care and management, seeing that the TCD measurement is part of routine 
ultrasound examinations and used for second trimester estimation of gestational age [88]. Therefore, 
universal reference curves disregarding ethnical differences of cerebellar size may not be accurate for 
pregnancy dating in later pregnancy. However, to investigate a spectrum of ethnical backgrounds in 
association with fetal cerebellar growth warrant larger longitudinal cohorts.
Although large-scale studies have provided evidence on the impact of maternal stress on prenatal 
brain development and neurodevelopmental outcomes [89-92], the evidence for a detrimental impact 
on cerebellar development was limited to one study. Although Li et al. demonstrated a negative 
association between pre-labour cortisol levels and TCD [69], we note that the cortisol level was only 
determined once in this cross-sectional study. Previously this was demonstrated to be an unreliable 
recording of maternal stress because of its daily and pregnancy-related fluctuations [93-95]. Therefore, 
adjustment for these fluctuations in the statistical analyses, which was performed in this study, 
seemed insufficient. Animal studies provided more evidence for the neurotoxic effects of prenatal 
stress on Purkinje cell morphology but show no effects on cerebellar growth measurements [96,97]. To 
crystallize this issue in humans, prospective studies with repeatedly measured stress hormone levels 
could provide more robust conclusions. 
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Based on our review we conclude that cerebellar growth and development showed signs of susceptibility 
to maternal environmental exposures and intrinsic factors. For each factor that influenced the 
developing cerebellum, the level of impact may vary with the timing, severity and type of insult [47]. 
Potentially, effects may also differ among specific cerebellar regions [4,5]. Subsequent derangements 
in cerebellar development potentially affect downstream connectivity and development of other brain 
structures.
Despite our extensive literature search, we stress that the amount of evidence and its quality was 
relatively low. From the current literature no conclusions on causal relations can be drawn. Our 
search yielded the whole spectrum of developmental deformations and abnormal growth of the 
cerebellum. However we did not specifically include Arnold Chiari malformations often co-occurring 
with myelomeningocele. Although these malformations are often considered as cerebellar anomalies, 
they typically result from mechanical forces, without which the cerebellum otherwise would have 
developed normally. Furthermore, only a minority of the studies adjusted for confounding factors. 
Therefore, residual confounding may have influenced the reported associations. Because of the 
numerous potential confounders in human research, findings from animal studies may contribute 
to a great extent to the understanding of environmental effects on cerebellar development [46]. 
Nevertheless, human research is indispensable as the human cerebellum is significantly different from 
animals, engaging in a more extensive and complex set of tasks and functions and neuro-embryology 
follows different timelines. Caution is needed when translating animal experimental results to the 
human setting. Therefore, we did not incorporate animal data in this systematic literature search.
Currently, most human evidence concerns cerebellar development during the second half of 
pregnancy. However, new evidence indicates that embryonic growth can predict fetal growth with 
consequences for health and disease in later life [24,98]. Therefore, research needs to incorporate 
these earlier developmental stages to study causes of derangements in cerebellar development which 
may originate early in the embryonic period. More precise and reliable measures of cerebellar growth, 
as well as maternal environmental exposures and intrinsic factors are warranted to investigate the 
small cerebellar effects of these impacts. This kind of epidemiological evidence may be provided 
by large prospective cohort studies using three-dimensional ultrasound, biomarkers and epigenetic 
patterns [20,24].
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ABSTRACT
Background — We aimed to investigate whether periconceptional maternal folate status affects 
human embryonic cerebellar size and growth trajectories. 
Methods — In a prospective periconceptional cohort participants filled out questionnaires and 
received weekly transvaginal 3D-ultrasounds between 7+0 and 12+6 weeks gestational age (GA). Viable 
non-malformed singleton pregnancies were selected for cerebellar measurements; transcerebellar 
diameter, (TCD), left and right cerebellar diameters (LCD, RCD). Linear mixed models were performed 
to estimate associations between questionnaire data on the timing of maternal folic acid supplement 
initiation and longitudinal cerebellar measurements as a function of crown-rump length (CRL) and 
GA. Maternal red blood cell folate concentrations were analysed before 8 weeks GA to validate the 
associations. 
Results — A total of 263 serial high quality three-dimensional ultrasound scans of 135 pregnancies were 
studied. Preconceptional compared to postconceptional initiation of folic acid use was associated with 
slightly larger cerebellar diameters per millimetre increase of CRL (TCD: β= 0.260mm, 95%CI= 0.023-0.491, 
p<0.05; LCD: β= 0.171mm, 95%CI= 0.038-0.305, p<0.05; RCD: β= 0.156mm, 95%CI= 0.032-0.280, 
p<0.05) and with proportional cerebellar growth (TCD/CRL:β= 0.015mm/mm, 95%CI=0.005-0.024, 
p<0.01; LCD/CRL:β= 0.012mm/mm, 95%CI= 0.005-0.018, p<0.01; RCD/CRL:β= 0.011mm/mm, 
95%CI= 0.005-0.017, p<0.01). Cerebellar growth was significantly highest in the third quartile of 
maternal red blood cell folate levels (1538-1813nmol/L). 
Conclusions — These first findings show that periconceptional maternal folate status is associated 
with human embryonic cerebellar development. Implications of these small but significant variations 
for fetal cerebellar growth trajectories and the child’s neurodevelopmental outcome are yet unknown 
and warrant further investigation.
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INTRODUCTION
Last decades our understanding of the complex functions of the human cerebellum has expanded 
immensely. Previous literature demonstrated cerebellar involvement in motor and non-motor 
functions including perception, cognition and emotion [48,49]. Yet, prenatal studies of the cerebellum 
have mainly been focussing on abnormal cerebellar development and morphology in the second 
half of pregnancy when ultrasonography landmarks of development can be visualized [99-101]. 
However, the first trimester of pregnancy is known to be essential for organogenesis and deviations 
in growth and development are likely to originate during this particular period. Nowadays, ultrasound 
measurements of embryonic structures are more easily accessible through the improvements 
of ultrasound techniques. Growth charts of embryonic brain structures including the cerebellum 
were created with measurements performed between 7+0 and 12+6 weeks of gestation using three-
dimensional ultrasound and virtual reality ultrasound visualization [37]. Three-dimensional techniques 
provide very precise information on variations in first trimester cerebellar growth trajectories. 
Development of the cerebellum starts from the 6th week of gestation and extends to the first years of 
life [102]. Due to this protracted process, the cerebellum is extremely vulnerable to disturbances in its 
development caused by a complex interplay of genetic and environmental factors [45,103]. Perinatal 
environmental and genetic risk factors act at particular time windows when cerebellar development is 
most vulnerable to derangements [50]. Maternal exposures and conditions during the periconceptional 
period are known to influence embryonic growth [104-106]. These factors may also affect embryonic 
cerebellar growth with potential implications for fetal cerebellar growth and neurodevelopmental 
functions in later life [107,108]. 
Periconceptional maternal folate status plays a vital role in biological processes involved in cellular 
growth and differentiation [109]. Maternal folate deficiency is associated with a broad spectrum of 
reproductive failures [23]. In addition, maternal periconceptional folic acid supplement use is known 
to reduce the risk of congenital anomalies such as neural tube defects and probably also congenital 
heart disease and oral facial clefts and offspring born small for gestational age (SGA) [110-112]. 
Furthermore adequate maternal periconceptional folic acid use seems beneficial to early and late 
human neurodevelopmental outcome and may reduce the risk of neurodevelopmental disorders 
including autism spectrum disorder in which the cerebellum seems to play a key role [113-118]. Animal 
models show dramatic alterations in both prenatal and postnatal cerebellar growth and development 
when derangements of the folate pathway and changes in folate status occurred [119,120]. So far 
no human studies reported on consequences of maternal folic acid supplement use on the growth 
and development of the human cerebellum. From this perspective we aim to investigate whether the 
timing of maternal folic acid supplement initiation during the periconceptional period as measure 
of periconceptional maternal folate status affects human embryonic cerebellar size and growth 
trajectories in pregnancies ending in live births without congenital malformations.
Processed on: 7-4-2017
509071-L-bw-Koning
Chapter 336
MATERIALS AND METHODS
Study Population
This study is embedded in the Rotterdam Predict study, an ongoing prospective periconceptional 
cohort investigating the influence of gene-environment interactions and underlying mechanisms 
on reproductive, (extra-) embryonic and pregnancy outcome at the Erasmus MC University Medical 
Centre, Rotterdam, the Netherlands [24,106]. Pregnant women of at least 18 years of age with 
a gestational age (GA) of less than 8 weeks were eligible for participation and were followed until 
1 year after delivery. All pregnant women and their partners gave written informed consent before 
participation. The Central Committee of Human Research in The Hague and the regional Medical 
Ethical and Institutional Review Board of the Erasmus MC University Medical Centre approved the 
study (MEC 2004-227, 15 October 2004). 
We selected singleton pregnancies conceived spontaneously or through assisted reproductive 
techniques using biological oocytes from the participating mother with reliable GA only. GA was 
defined as reliable when; (1) GA was calculated using the first day of the last menstrual period (LMP) 
confirmed by first trimester ultrasound evaluation for spontaneously conceived pregnancies with 
regular menstrual cycles of approximately 28 days and was adjusted when the cycle was prolonged 
(>31 days) or shortened (<25 days). (2) In pregnancies assisted with in vitro fertilization (IVF), 
intracytoplasmic sperm injection (ICSI) and intra-uterine insemination, GA was calculated from the 
date of oocyte retrieval plus 14 days, from the day of embryo transfer plus 17 or 18 days cryopreserved 
embryo transfers, or from insemination date plus 14 days respectively. 
In our statistical analyses, we used Crown-rump Length (CRL) as outcome variable. Therefore when 
there was no reliable recall of the (LMP) or CRL measurements differed more than 7 days from the 
expected GA, pregnancies were dated on CRL and consequently excluded. Because this study aimed 
to investigate the initiation of periconceptional maternal folic acid supplement intake in pregnancies 
ending in live births without congenital malformations, we also excluded pregnancies ending in 
miscarriages, ectopic pregnancy and termination of pregnancy or pregnancies with adverse foetal 
outcome including minor and major congenital malformations, foetal or neonatal death. When data 
from questionnaires or maternal folic acid status was missing, pregnancies were also excluded from 
further analysis.
Measurements
The study visit before 8 weeks GA was used to verify self-administered questionnaires to obtain 
information on the current pregnancy with regard to maternal age, preconceptional weight and 
height, ethnicity, educational level, medical history, gynaecological and obstetric history, familial 
hereditary or congenital disorders and diseases, diet, lifestyle and the use of folic acid and/or other 
(multi)vitamin supplements. The accuracy of the self-reported questionnaires was enhanced by an 
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intake consultation at enrolment discussing unclear topics and questions. Follow-up on pregnancy, 
fetal and infant outcomes comprised of questionnaires validated by the structural ultrasound scan 
at 20 weeks GA and delivery reports. Periconceptional was defined as the period of 4 weeks before 
until 8 weeks after conception. Timing of initiation of folic acid use was defined as the initiation at any 
time before (pre) or after (post) conception of (multi)vitamin supplements containing folic acid either 
the standard low dosage of 0.4-0.5mg/day or high dosage of 5mg/day. Timing of folic acid initiation 
served as measure for duration of folic acid supplement use and implicitly the folate status during 
the first trimester of pregnancy. In a small subgroup (n= 57) a venous blood sample was collected 
at enrolment for determination of red blood cell folate according to the study protocol representing 
maternal folate status of 2-4 months previously [121]. Thereby red blood cell folate reflects the folate 
status of the periconceptional period and specifically the preconceptional period. As red blood cell 
folate is significantly higher in preconceptional folic acid users (p<0.01), we demonstrated that red 
blood cell folate concentration is an accurate indicator of the timing of initiation and duration of folic 
acid supplement use in our study population.
High resolution transvaginal three-dimensional ultrasounds were performed weekly between 6+0 
weeks and 12+6 weeks of gestation using a 4.5-11.9 MHz transvaginal probe of a Voluson E8 system 
(GE Medical Systems, Zipf, Austria). Series of three-dimensional ultrasound sweeps were obtained for 
biometry measurements focusing on the whole embryo or the head separately. Scans were evaluated 
off-line using specialised 3D-software (4D View, version 7.0, GE Medical Systems). Only high quality 
images of the fossa posterior in which the cerebellum could be clearly demarcated were accepted 
for further analysis. We selected only three-dimensional ultrasound scans between 8+0 weeks and 
12+6 weeks gestation, as success rates of cerebellar measurements before 8 weeks GA were very low 
[37]. Three-dimensional ultrasound scans were displayed in the orthogonal multiplanar mode in a 
standardized format ensuring that the left and right side corresponded to the viewer’s perspective 
(Figure 1). Cerebellar measurements were performed in a coronal section of the head at the level of 
the rhombencephalon enabling the visualisation of cerebellum, fourth ventricle and choroid plexus 
of the fourth ventricle as previously described [37]. In order to obtain a clearly defined image of the 
cerebellum at 12 weeks GA, the coronal plane was rotated slightly over the x-axis. The following 
cerebellar measurements were performed: Transcerebellar diameter (TCD) and left and right cerebellar 
diameters (LCD, RCD). The ‘distance two points’ function was used to measure the greatest diameter. All 
measurements were repeated three times in all eligible 3D sweeps, the mean of these measurements 
was used for analyses. The proportional cerebellar growth was calculated for all cerebellar parameters 
by dividing the parameter by CRL.
Two observers (IG and AG) measured the cerebellar parameters in the dataset conducted between 2009 
and 2010. Inter-observer reliability and agreement were calculated for 35 cerebellar measurements 
on randomly selected 3D volumes independently repeated by both measurers. Intra-observer 
reliability and agreement was evaluated by repeating measurements in 30 randomly selected volumes. 
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Reliability calculations included measurements from all gestational ages, with a minimum of 5 scans 
per gestational week. The observers were blinded to each other’s and previous results. 
Figure 1 — Protocolled display of the three-dimensional ultrasound scan.
Three-dimensional ultrasound image of an embryo at 9+2 weeks GA with the standardized cerebellum measurements TCD (1), 
LCD (2) and RCD (3) in 4D view.
Statistical analysis
Statistical analysis was performed using SPSS software version 21.0 (SPSS for Windows, SPSS Inc., 
Chicago, Illinois, USA) and SAS software version 9.3 (SAS Institute Inc., Cary, NC, USA). Results with 
p-values of 0.05 or lower were considered statistically significant. General characteristics were 
calculated for all pregnancies and compared between preconceptional and postconceptional folic acid 
supplement users. Continuous data of maternal age, BMI, birth weight and GA at birth were compared 
using the Mann Whitney U-test. Categorical data of ethnicity, education, primigravida, nulliparous, 
mode of conception, periconceptional use of tobacco and alcohol and infant gender were compared 
using the Pearson Chi-square test. 
To assess the association between timing of initiation of folic acid supplement use during the 
periconceptional period and first trimester cerebellar growth trajectories we performed linear 
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mixed model analyses. The linear mixed model takes into account the existing correlation between 
the measurements within one pregnancy. Interaction terms of the timing of initiation of folic acid 
supplement use with potential confounders were studied, but not included in the model as they 
yielded no significant contribution. A random intercept only was used to model the within subject 
correlation, a random slope did not improve the model fit. An unadjusted mixed model was estimated 
using TCD, LCD and RCD measurements as response variables and CRL and GA as predictors. Timing 
of initiation of folic acid supplement use was used as independent predictor for cerebellar growth. 
For the adjusted model we used maternal age, mode of conception, parity, preconceptional smoking, 
periconceptional alcohol use, BMI, ethnicity, and the measurer as potential confounders, based on 
literature and significant differences between the preconceptional and postconceptional user groups 
[106,122]. Stepwise backwards elimination of variables with p>0.20 was conducted to determine 
the final model. Additionally, quartiles of red blood cell folate were calculated and used to perform 
linear mixed models investigating the association with cerebellar growth trajectories. Including the 
interaction term between red blood cell folate and GA we were able to study the slope between the 
four quartiles using the third quartile (Q3) as reference [105]. 
RESULTS
In 2009 and 2010, 259 viable singleton pregnancies were eligible for this study. We excluded 
2 pregnancies conceived from oocyte donations, 43 miscarriages, 1 ectopic pregnancy, 12 pregnancies 
dated by CRL, 8 pregnancies with abnormal foetal outcome and 7 pregnancies with missing data. This 
resulted in a final evaluation of 186 pregnancies of 186 women. In 135 (73%) of all pregnancies scans 
were eligible for cerebellar measurements. All 135 women started folic acid supplements before or 
after conception. Only 7 women were administered folic acid in a high dosage of 5mg/day, 4 in the 
preconceptional users and 3 in the post conception users.
In Table 1 the baseline characteristics of the total group of pregnancies, pregnancies with 
measurements, and the groups of preconceptional and postconceptional initiation of folic acid 
supplement use are depicted. No significant differences were found between pregnancies with and 
without cerebellar measurements, except for BMI. Comparing preconceptional and postconceptional 
folic acid users, general characteristics showed significant differences in ethnicity, primigravida, 
nulliparous, periconceptional alcohol use, periconceptional smoking and mode of conception via 
IVF/ISCI procedures. Red blood cell folate is significantly higher in the preconceptional folic acid user 
group (p<0.01). Education level, BMI, neonatal birth weight, GA at birth and gender were comparable 
between both groups.
A total number of 880 three-dimensional ultrasounds between 8+0 weeks and 12+6 weeks gestation 
were available for detailed cerebellar measurements. The number of measurements per pregnancy 
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is shown in Table 2 Cerebellar measurements could be performed in 263 volumes, demonstrating an 
overall success rate of 29.9%, with the highest success rate of 41.0% in gestational week 8. Table 3 
shows the means of all measurements per gestational week with the corresponding SD values, and the 
success rate per gestational week.
Table 1 — General Characteristics of the study groups
Characteristics All pregnancies 
(n=186)
Pregnancies with 
measurements 
(n=135)
Preconceptional 
Folic acid users 
(n=108)
Postconceptional  
Folic acid users 
(n=27)
Maternal
Age, years 32.1 (18.9-42.7) 32.1 (18.9-42.3)1 32.1 (20.3-42.1) 32.7 (18.9-42.3)
Ethnicity
Dutch 144 (77.8) 99 (73.3)2 84 (77.8) 15 (55.5)*
Western-other 16 (8.6) 14 (10.4) 11 (10.2) 3 (11.1)
Non-western 25 (13.5) 20 (14.8) 11 (10.2) 9 (33.3)
Education
Low 15 (8.5) 12 (8.9)3 10 (9.3) 2 (7.4)
Intermediate 54 (30.5) 40 (29.6) 31 (28.7) 9 (33.3)
High 108 (61.0) 77 (57.0) 63 (58.3) 14 (51.9)
BMI, kg/m2 23.8 (18.6-38.3) 23.5 (18.6-34.9)** 23.2 (18.6-34.9) 24.1 (19.1-28.7)
Primigravida 69 (37.1) 48 (35.6) 45 (41.7) 3 (11.1)**
Nulliparous 119 (64.0) 83 (61.5) 73 (67.6) 10 (37.0)**
Periconceptional use of alcohol 85 (45.7) 67 (49.6) 49 (45.4) 18 (66.6)*
Periconceptional smoking 31 (16.7) 24 (17.8) 14 (12.9) 10 (37.0)**
Red blood cell folate, nmol/L 1500 (814-2936) 1537 (814-2936) 1626 (844-2936) 1063 (814-1815) **
Mode of Conception IVF/ICSI 57 (30.6) 40 (29.6) 40 (37.0) 0 (0)**
New-born outcome
Birth weight, grams 3378 (450-4700) 3430 (1715-4700) 3410 (1715-4700) 3440 (2150-4110)
Gestational age at birth, days 276 (187-294) 276 (228-294) 277 (228-294) 276 (258-291)
Gender, male 88 (47.3) 62 (45.9) 50 (46.3) 12 (44.4)
Continuous data is presented as median, range, categorical data as n (%). BMI, body mass index; IVF/ICSI, in vitro fertilization 
with or without intra-cytoplasmic sperm injection; Missing data was due to incomplete questionnaires. Missing: 1 n= 3, 2 n= 2, 
3 n= 6, * p<0.05, ** p<0.01
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Table 2 — 3D-Ultrasound data and the success rate of measurements
TCD RCD LCD
Images 880 880 880
Measurements 263 (29.9) 259 (29.4) 259 (29.4)
Pregnancies with measurements 135 135 135
 ≥ 2 measurements 77 (57.1) 75 (55.6) 75 (55.6)
1 measurement 58 (42.9) 60 (44.4) 60 (44.4)
2 measurements 37 (27.4) 36 (26.7) 36 (26.7)
3 measurements 31 (22.9) 31 (22.9) 31 (22.9)
4 measurements 7 (5.1) 6 (4.4) 6 (4.4)
5 measurements 2 (1.5) 2 (1.5) 2 (1.5)
Presented is the number of images (%) eligible for measurement per pregnancy. TCD, transcerebellar diameter; LCD, left 
cerebellar diameter; RCD, right cerebellar diameter.
Intra-observer reliability analysis showed no significant differences in the mean cerebellar parameters 
(TCD= 0.020mm, 95%CI= -0.054 to 0.094, LCD= 0.007mm, 95%CI= -0.043 to 0.057, RCD = 0.030mm, 
95%CI= -0.027 to 0.087). ICC values for all parameters were above 0.99, representing an excellent 
reliability between measurements. Analysis of the inter-observer agreement showed a significant 
mean difference between the two measurers (TCD= 0.501mm, 95%CI= 0.260 to 0.742, LCD= 0.310mm 
95%CI= 0.134 to 0.485, RCD= 0.200mm 95%CI= 0.063 to 0.337). A good reliability was established with 
ICC for TCD, LCD and RCD of respectively 0.92, 0.84, 0.89. 
Table 3 — Measurements per gestational week, with corresponding mean and SD values
Ultrasound 
characteristics
Number of 
measurements
CRL, mm TCD, mm RCD, mm LCD, mm
GA 8 weeks 73/178 (41%) 18.65 (3.44) 4.38 (0.74) 2.58 (0.35) 2.58 (0.35)
GA 9 weeks 70/177 (40%) 26.15 (4.50) 5.56 (0.97) 3.06 (0.43) 3.07 (0.47)
GA 10 weeks 44/178 (25%) 36.45 (5.82) 7.18 (1.17) 3.78 (0.56) 3.79 (0.54)
GA 11 weeks 39/181 (22%) 48.43 (6.70) 8.97 (1.03) 4.62 (0.48) 4.61 (0.57)
GA 12 weeks 37/166 (22%) 61.46 (6.95) 10.34 (1.16) 5.20 (0.57) 5.21 (0.58)
Presented are the number of images eligible for analysis relative to the total number and the cerebellar parameters per 
GA. CRL, crown-rump length; TCD, transcerebellar diameter; LCD, left cerebellar diameter; RCD, right cerebellar diameter; 
GA, gestational age.
Table 4 depicts the results of both crude and adjusted linear mixed model analyses for all 3 cerebellar 
diameters and the proportional cerebellar growth trajectories by the timing of initiation of folic acid 
supplement use. Maternal age, mode of conception, periconceptional smoking, periconceptional 
alcohol use, ethnicity and the measurer were designated confounders in the final model. Subsequently, 
models for TCD, LCD, RCD and proportional growth (cerebellar diameters divided by CRL) were all 
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adjusted for these final confounders. Both crude and adjusted linear mixed models showed small but 
significant effects on cerebellar size and proportional cerebellar growth by the timing of initiation of 
folic acid supplement use as function of CRL Repeating the same analysis for all cerebellar diameters 
and the timing of folic acid supplement use initiation as a function of GA, no significant differences were 
observed in either crude or adjusted models. Both crude and adjusted models showed significantly 
increased proportional cerebellar growth for all three cerebellar diameters when folic acid supplement 
use was initiated preconceptionally. 
Table 4 — Preconceptional compared to postconceptional initiation of folic acid supplement use and 
embryonic cerebellar size and growth trajectories as function of gestational age and crown-rump length
Model β (se) 95%CI p-value
TCD vs. CRL Crude 0.286 (0.098) 0.090; 0.482 0.005
Adjusted 0.257 (0.117) 0.023; 0.491 0.032
LCD vs. CRL Crude 0.153 (0.057) 0.038; 0.268 0.010
Adjusted 0.171 (0.067) 0.038; 0.305 0.013
RCD vs. CRL Crude 0.132 (0.054) 0.024; 0.240 0.018
Adjusted 0.156 (0.062) 0.032; 0.280 0.015
TCD vs. GA Crude 0.112 (0.142) -0.174; 0.398 0.436
Adjusted -0.078(0.154) -0.388; 0.232 0.616
LCD vs. GA Crude 0.093 (0.069) -0.045; 0.232 0.183
Adjusted 0.041 (0.078) -0.115; 0.197 0.601
RCD vs. GA Crude 0.048 (0.068) -0.090; 0.185 0.490
Adjusted 0.008 (0.076) -0.144; 0.159 0.918
TCD/CRL ratio vs. GA Crude 0.015 (0.004) 0,007; 0,024 0.001
Adjusted 0.015 (0.005) 0.005; 0.024 0.003
LCD/CRL ratio vs. GA Crude 0.010 (0.003) 0.004; 0.016 0.002
Adjusted 0.012 (0.003) 0.005; 0.018 0.001
RCD/CRL ratio vs. GA Crude 0.010 (0.003) 0.004; 0.015 0.001
Adjusted 0.011 (0.003) 0.005; 0.017 0.001
Crude and adjusted linear mixed models comparing effect estimates of preconceptional with postconceptional folic acid use 
of cerebellar growth trajectories. Estimates are depicted as embryonic cerebellar measurement (TCD, LCD and RCD) in mm 
per mm increase in CRL or days increase in GA. Crude model: Unadjusted model. Adjusted model, adjusted for designated 
confounders after stepwise backward elimination. TCD, transcerebellar diameter; LCD, left cerebellar diameter; RCD, right 
cerebellar diameter; CRL, crown-rump length; GA, gestational age; CI, confidence interval.
In Figure 2 we graphically display the results of the adjusted linear mixed models as regression lines. 
The coloured area represents the ninety-five percent prediction interval for both lines. Comparable 
results for the right and left cerebellar hemisphere were depicted; therefore we only display the TCD 
and RCD graphs. There is a clear linear display of data points showing slightly increased cerebellar 
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diameters as a function of CRL for TCD (A) and RCD (B). The linear functions of preconceptional and 
postconceptional initiation of folic acid supplement use as function of GA cross for both the total (C) 
and unilateral (D) cerebellar diameters. Figures 2E and 2F show the proportional growth trajectories 
as function of GA, with the associated prediction interval, which decreases with advancing gestation.
Figure 2 — Longitudinal cerebellar measurements and proportional growth by folic acid initiation
Adjusted linear mixed models represent the effects of preconceptional compared to postconceptional initiation of folic acid 
supplement use on cerebellar size and growth trajectories as function of CRL in millimetres (A and B) and GA in days (C and D) 
and proportional cerebellar growth trajectories (E and F).
In our subgroup of 57 patients quartiles for red blood cell folate were calculated (Q1: 814-1242nmol/L, 
Q2: 1243-1537nmol/L, Q3: 1538-1813nmol/L and Q4: 1814-2936nmol/L). Linear mixed models 
showed the highest cerebellar growth throughout all models of total, left and right cerebellar 
diameter in the third quartile of red blood cell folate levels compared to lowest first and second and 
highest fourth quartiles as a function of GA (Q1= -0.0721mm/day, 95%CI= -0.119 to -0.0250, p<0.01; 
Q2= -0.0438mm/day, 95%CI= -0.0865 to -0.0011, p<0.01; Q4= -0.0459mm/day, 95%CI= -0.0927 to 
0.0010, p= 0.05) and CRL (Q1= -0.0364mm/mm, 95%CI= -0681 to -0.0047, p<0.05; Q2= -0.0280mm/mm, 
95%CI= -0.0568 to 0.0008, p>0.05; Q4= -0.0232mm/mm, 95%CI= -0.0554 to 0.0089, p>0.05). The 
same accounts for proportional cerebellar growth which was the highest in Q3 (Q1= -0.0017mm/
mm/day, 95%CI= -0.0039 to 0.0001, p>0.05; Q2= -0.0010mm/mm/day, 95%CI= -0.0026 to 0.0006, 
p>0.05; Q4= -0.0459mm/day, 95%CI= -0.0018 to -0.0001, p<0.05). Figure 3 depicts cerebellar growth 
trajectories associated with the four quartiles of maternal red blood cell folate levels.
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Figure 3 — Associations between periconceptional red blood cell folate quartiles and cerebellar growth 
trajectories
Linear mixed models represent the effects of red blood cell folate quartiles on cerebellar growth trajectories as a function of 
CRL in millimetres and GA in days. The blue line represents the third quartile used as reference.
DISCUSSION 
This study shows increased, albeit slightly, embryonic cerebellar diameters and proportional cerebellar 
growth trajectories in ongoing non-malformed pregnancies in a tertiary hospital setting when maternal 
folic acid supplement use was initiated before conception compared to post conception. Hereby, we 
discriminate between overall embryonic growth and embryonic cerebellar growth. This data are 
validated in a subgroup by maternal red blood cell folate levels before 8 weeks GA which is a more 
reliable marker for periconceptional folate status. It is intriguing that the third quartile of red blood 
cell folate levels (1538-1813nmol/L) seems to be the optimum for embryonic cerebellar growth of 
which the implications for fetal cerebellar growth and future neurodevelopmental outcome needs 
further investigation. This first study investigating associations between periconceptional folate status 
and human embryonic cerebellar size and growth trajectories may substantiate to previous animal 
studies showing alterations in cerebellar growth and development in a folic acid deficient environment 
[119,123,124]. Besides, our results are in agreement with previous human studies demonstrating 
significant positive effects of periconceptional maternal folic acid supplement use and folate status on 
embryonic and fetal size [105,112,122] and DNA methylation of the growth gene IGF2 DMR [16,125].
By establishing a prospective dataset of serial first trimester three-dimensional ultrasound images 
together with periconceptional exposure data and follow-up information, we were able to study 
associations between periconceptional folic acid supplement use and embryonic cerebellar 
growth. We substantiate the validity of our questionnaire data by verification at the intake visit and 
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measurements of red blood cell folate concentrations in a subgroup. Although data on the precise day 
of folic acid initiation was not available, red blood cell folate levels were significantly higher when the 
timing of initiation of folic acid supplement use was defined as preconceptional. This agrees with the 
assumption that the timing of folic acid use initiation serves as measure for periconceptional folate 
status which may involve the embryonic environment as well. First trimester red blood cell folate levels 
follow an optimum curve in which the third quartile is associated with the highest cerebellar growth 
rates compared to the first two and upper quartile which corresponds to the available evidence of its 
effects on overall embryonic growth [105]. Because of the prospective and observational character 
of our study we were able to study associations, causality however could not be shown, since this 
warrants a randomised controlled trial.
The low success rates of the cerebellar measurements are comparable to previous publications and are 
due to non-targeted scanning for the purpose of embryonic biometry and volumetric measurements, 
motion artefacts, acoustic shadowing and maternal factors, such as BMI and an unfavourable position 
of the uterus [37]. Although differential confounding may be an issue, it seems unlikely as these factors 
are unrelated to the selected population, the timing of folic acid initiation, red blood cell folate levels 
and cerebellar outcome. Low success rates could compromise the longitudinal setting of the study. Yet, 
57% of the patients had 2 or more measurements. Since measurements within subjects are strongly 
correlated, linear mixed models are the most appropriate method for the statistical analyses of our 
data. Preconceptional and postconceptional folic acid users are in many ways not totally comparable. 
Hence, for statistical analyses we adjusted for known confounders of embryonic growth and maternal 
characteristics to minimize confounding. Demonstrating comparable effects in both crude and adjusted 
models for all cerebellar diameters strengthened the model fit. 
Differences in cerebellar size and proportional growth trajectories may be explained biologically 
by folates’ vital role in synthesis of DNA, RNA and proteins for cellular growth and differentiation 
processes. It could be hypothesized that in early embryonic development epigenetic modification of 
genes including those regulating the development of the cerebellum as part of the central nervous 
system is altered by the use of folic acid amongst other factors [16,126]. Also, the proportion of 
cerebellar size in relation to CRL increased when folic acid use was initiated before conception. 
This is either the result of a larger cerebellum, a smaller CRL, or a combination of the two. Since 
previous literature demonstrated larger embryonic and fetal biometric measurements in association 
with optimal folate status, proportional cerebellar growth seems to be increased due to a relatively 
larger cerebellum in particular [105,122]. However we did not find significant differences in cerebellar 
measurements between preconceptional and postconceptional folic acid users using GA as predictor. 
We assume that this is the result of inaccurate pregnancy dating, despite using strict criteria based on 
reliable LMP only. Inaccurate determination of GA is a recurrent issue in embryonic and foetal growth 
studies [122]. In this context, it is important to consider that our methodology for pregnancy dating is 
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stricter than methods used routinely for clinical practice. Hence, our method enables designation of 
very early growth deviations corrected by pregnancy dating using CRL. 
Prenatal modification of cerebellar growth potentially has consequences for neurodevelopmental 
outcome [107,108]. One could speculate that early changes in embryonic size affect neurodevelopmental 
functions in early and later life. However, exploring the association between the small differences of 
embryonic cerebellar growth and its possible clinical implications is beyond the scope of this study. This 
warrants larger periconceptional cohorts including biomarkers and pre- and postnatal neuroimaging 
combined with long term standardized neurodevelopmental follow-up. Also, considering the tertiary 
hospital setting, external validity of our results should be studied in a general population cohort.
In conclusion, our findings show small albeit significant associations between preconceptional 
initiation compared to postconceptional initiation of folic acid supplement use, used as measure 
of folate status in the embryonic environment, and increased size and growth trajectories of the 
embryonic cerebellum. Although the effects of these small differences for prenatal and postnatal 
neurodevelopment are unknown, this study further supports the importance of periconceptional 
maternal folic acid supplement use.
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ABSTRACT 
Background — The cerebellum is essential for normal neurodevelopment and has been associated 
with neurodevelopmental impairments and psychiatric diseases. Cerebellar development is 
particularly susceptible to harmful exposures during the prenatal period, including maternal folate 
status, smoking and alcohol consumption. Can we assess human prenatal cerebellar growth from the 
first until the third trimester of pregnancy and create growth trajectories to investigate associations 
with periconceptional maternal and fetal characteristics?
Methods — From 2013 until 2015, we included 182 singleton pregnancies during the first trimester 
as a subgroup in a prospective periconception cohort with follow-up until birth. For the statistical 
analyses, we selected 166 pregnancies ending in live born infants without congenital malformations. 
We measured transcerebellar diameter (TCD) at 9, 11, 22, 26 and 32 weeks gestational age (GA) 
on ultrasound scans. Growth rates were calculated and growth trajectories of the cerebellum were 
created. Linear mixed models were used to estimate associations between cerebellar growth and 
maternal age, parity, mode of conception, geographic origin, pre-pregnancy and first trimester body 
mass index (BMI), periconceptional smoking, alcohol consumption, timing of folic acid supplement 
initiation and fetal gender.
Results — 166 pregnancies provided 652 (87%) ultrasound images eligible for TCD measurements. 
Cerebellar growth rates increased with advancing GA by 0.1691mm/day in the first trimester, 
0.2336mm/day in the second trimester and 0.2702mm/day in the third trimester. Pre-pregnancy BMI, 
calculated from self-reported body weight and height, was significantly associated with decreased 
cerebellar growth trajectories (β= -0.0331mm, 95%CI= -0.0638; -0.0024, p= 0.035). A similar 
association was found between cerebellar growth trajectories and first trimester BMI, calculated from 
standardized measurements of body weight and height (β= -0.0325, 95%CI= -0.0642; -0.0008, p= 0.045 
respectively).
Conclusions — Prenatal growth trajectories of the human cerebellum between 9 and 32 weeks 
gestational age (GA) were created using three-dimensional ultrasound (3D US) and show negative 
associations with pre-pregnancy and early first trimester Body Mass Index (BMI) calculated from 
self-reported and standardized measured weight and height, respectively. The cerebellum may act 
as a mediator in the association between obesity and impaired neurodevelopmental outcome. Our 
findings further substantiate previous evidence for the detrimental impact of increasing maternal BMI 
on neurodevelopmental health of offspring in later life. As the study population largely consisted of 
tertiary hospital patients, external validity should be studied in the general population. Whether small 
differences in prenatal cerebellar growth due to increasing pre-pregnancy and first trimester BMI have 
consequences for neurodevelopmental outcome needs further investigation.
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INTRODUCTION
The cerebellum originates from 6 weeks gestational age (GA) onwards, preceding most human brain 
structures and expanding rapidly during the second half of pregnancy [43-45]. It is not surprising that this 
very early, fast and protracted course of development is particular susceptibility to prenatal disturbances 
caused by complex gene-environment interactions [45,103]. Impaired cerebellar development has 
been associated with several periconceptional and prenatal exposures including maternal folate 
status, smoking habit, alcohol consumption and environmental toxins [58,59,87,127,128]. 
Prenatal cerebellar alterations and injury are associated with an increased risk for neurodevelopmental 
impairment [46,51,52]. Recently, MRI studies demonstrated the relation between a reduced cerebellar 
diameter and adverse neurodevelopmental outcomes, including general motor function, mental 
development and major neurologic disability, in the young child [28,129]. 
In the clinical setting, prenatal cerebellar growth is usually evaluated during a routine or extended 
mid-trimester ultrasound scan by measuring the transcerebellar diameter (TCD) [130,131]. Nowadays, 
TCD can even be measured reliably from the early first trimester onwards using three-dimensional 
ultrasound (3D-US). This facilitates longitudinal assessment of cerebellar size providing precise 
information on variations in prenatal growth trajectories from early gestation onwards [37,127]. 
To provide new insights in the dynamic process of (ab) normal cerebellar growth, we conducted a 
prospective longitudinal 3D-US study including the first, second and third trimester with follow-up 
until birth.
The primary aim of the study was to create a reference curve and growth trajectories of TCD from the 
first trimester up to the third trimester of pregnancy. Second, we aimed to confirm the hypothesis that 
derangements in prenatal cerebellar growth may be associated with one or more periconceptional, 
maternal and fetal characteristics such as age, parity, in vitro fertilization / intra cytoplasmic sperm 
injection (IVF/ICSI), geographic origin, folate status, alcohol consumption, smoking habit and fetal 
gender.
MATERIALS AND METHODS
Study design and ethical approval
This study was conducted in the setting of the Rotterdam Periconceptional Cohort (Predict study); an 
ongoing prospective cohort study at the Department of Obstetrics and Gynaecology of the Erasmus 
MC, University Medical Center, Rotterdam, the Netherlands [24]. The study protocol was approved by 
the Medical Ethical and Institutional Review Board of the Erasmus MC, University Medical Center in 
Rotterdam, the Netherlands (MEC 2004-227). All participants and partners signed written informed 
consent at enrolment, also on behalf of their unborn child.
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Study population
From November 2013 until March 2015, pregnant women who volunteered for the Predict study 
during the first trimester with ongoing singleton pregnancies were invited to undergo another 
set of 3D-US examinations. For the current study, we selected pregnancies without congenital 
malformations, conceived either spontaneously or through assisted reproductive techniques using 
oocytes from the participating mother only. Exclusion criteria were oocyte donation and all minor and 
major fetal congenital malformations. For this study we excluded pregnancies without fetal 3D-US or 
questionnaire data due to withdrawal, termination of pregnancy or intra-uterine fetal death.
Study parameters and endpoints
Data on maternal characteristics, medical and obstetrical history, BMI and lifestyle behaviours were 
obtained through self-reported questionnaires upon enrolment before 12 weeks GA. A researcher 
verified the questionnaires and also standardized measured height and weight to calculate BMI at 
the study entry visit before 12 weeks GA. Educational level was categorized as low, middle or high 
and geographic origin was categorized as Dutch, Western and Non-western according to Statistics 
Netherlands [132]. Questionnaires filled out in the second and third trimesters provided follow-
up information on pregnancy course and neonatal outcomes. This data was validated by obstetric 
medical records and by ultrasound reports of the routine anomaly scan performed between 18 and 
22 weeks GA.
Estimation of GA was based on protocolled clinical methods using first trimester crown-rump length 
(CRL) measurements before 13 weeks GA [133]. In pregnancies conceived through IVF/ICSI procedures, 
the GA was calculated from the date of oocyte retrieval plus 14 days. In pregnancies conceived through 
intrauterine insemination, the GA was calculated using the insemination date. The GA in pregnancies 
conceived after the transfer of cryopreserved embryos was calculated from the day of embryo transfer 
plus 17 or 18 days, depending on the number of days between oocyte retrieval and cryopreservation. 
Ultrasound
All participants received serial 3D-ultrasound examinations at 9, 11, 22, 26 and 32 weeks GA and were 
followed until delivery. All ultrasound examinations were performed by one certified sonographer 
(IVK). All ultrasound scans were performed with the Voluson E8 system (GE Medical Systems, Zipf, 
Australia). During first trimester 3D-US scans a 6-12 MHz transvaginal transducer was used, during fetal 
ultrasounds we used a 1-7 MHz transabdominal transducer or a 6-12 MHz transvaginal transducer. All 
3D volumes were stored digitally as Cartesian and 4DView volumes. First trimester measurements of 
the transcerebellar diameter (TCD) were performed offline using 4D View Version 5.0 (GE Medical 
Systems) according to the protocol which was previously described [37,127]. Only 3D-US volumes 
at 9 and 11 weeks GA of good quality without motion artefacts were used. Standardized biometric 
measurements of the TCD were obtained online during fetal ultrasound examinations. All first, second 
and third trimester measurements were repeated three times and the mean values of the three 
measurements were used for statistical analyses. 
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Statistical analysis
For data analyses we used SPSS (SPSS release 21 for Windows, IBM, USA). All results with p-values 
<0.05 were considered statistically significant. Mean values and success rates of the TCD measurements 
were calculated per GA in weeks. To differentiate between first, second and third trimester cerebellar 
growth rates, we calculated the differences of two transcerebellar diameters and divided these by the 
difference in GA in days between the ultrasound examinations following the equations below:
First trimester cerebellar growth = TCD11-TCD9
GA11-GA9
Second trimester cerebellar growth = TCD26-TCD22
GA26-GA22
Third trimester cerebellar growth = TCD32-TCD26
GA32-GA26
To assess the associations between the periconceptional maternal and fetal characteristics and 
cerebellar growth we performed linear mixed model analyses, taking into account the existing 
correlation for repeated measurements within one pregnancy. A random intercept only was used 
to model the within subject correlation. Linear mixed models were estimated using the longitudinal 
cerebellar measurements as response and GA as predictor. Likelihood ratio tests were used to test 
which polynomials of GA best described the trajectory of the repeated cerebellar measurements. The 
quadratic polynomial model performed best; therefore both GA and GA squared were included in 
the final model. After designating the best model fit, an equation was calculated representing the 
relationship between the repeated measurements of TCD and GA. Linear mixed models were estimated 
to investigate the associations between TCD, GA and the individual maternal conditions (Model 1). As 
covariates we considered documented maternal conditions from our previous studies and literature 
including maternal age, BMI, geographic origin, moment of periconceptional initiation of folic acid 
supplement use, periconceptional smoking, periconceptional use of alcohol, parity, and IVF/ICSI as 
mode of conception and fetal gender. All covariates were entered simultaneously in the fully adjusted 
model (Model 2).
RESULTS 
Study population
Between November 2013 and March 2015, 182 pregnancies were included in the first trimester of 
pregnancy. We excluded pregnancies resulting from oocyte donation (3); pregnancies complicated 
with fetal congenital malformations (5); pregnancies without fetal ultrasound examinations due to 
withdrawal (4) intra-uterine fetal death (1) or termination of pregnancy (1) and when questionnaire 
data were missing (2). Table 1 lists the general characteristics of the included study population of 166 
pregnancies. In total 652 of 762 (86%) of ultrasound scans was eligible for TCD measurements. Mean 
values and success rates of TCD measurements per GA are shown in Table 2.
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Table 1 — General Characteristics
Characteristics All (n= 182) Selected (n= 166) Missing
Maternal
Age, year 32 (21-48) 32 (21-45) 3
Nulliparous 76 (43) 70 (42) 0
Mode of Conception IVF/ICSI 53 (30) 49 (30) 0
Geographic origin 1
 Dutch 133 (75) 124 (75)
 Western other 12 (7) 10 (6)
 Non-western 33 (19) 31 (19)
Educational level 1
 Low 21 (12) 20 (12)
 Intermediate 65 (37) 64 (39)
 High 91 (51) 81 (49)
BMI, pre-pregnancy, self-reported, kg/m2 23 (15-40) 23 (15-40) 10
BMI, first trimester, measured, kg/m2 24 (16-43) 24 (16-43) 36
Preconception folic acid initiation 124 (72) 114 (71) 6
Periconception alcohol consumption 51 (29) 45 (28) 3
Periconcepion smoking 29 (16) 28 (17) 2
New born
Gestational age at birth, days 273 (182-292) 273 (182-292) 2
Birth weight, grams 3293 (665-4380) 3285 (665-4380) 2
Gender, male 90 (50) 83 (50) 0
Data are presented as median and range or number (n) and percentage (%). BMI, body mass index; IVF/ICSI, in vitro fertilization 
with or without intra-cytoplasmic sperm injection; Missing data was due to incomplete questionnaires.
Table 2 — Ultrasound examinations and transcerebellar diameter per gestational age
Number US scans Number of 
measurements
Success rate, % TCD (±SD) mm
GA 9+0 to 9+6, weeks 114 78 68 6.41 (±0.64)
GA 11+0 to 11+6, weeks 162 99 61 8.60 (±0.67)
GA 21+3 to 23+3, weeks 166 166 100 24.08 (±0.94)
GA 25+0 to 27+6, weeks 165 163 99 30.67 (±1.34)
GA 31+4 to 34+0, weeks 155 146 94 41.89 (±1.56)
Presented are the number of images eligible for TCD measurements from the total available 3D-US scans per GA. Measurements 
per gestational week, with corresponding mean and SD values. TCD, transcerebellar diameter in millimetres; GA, gestational 
age in weeks.
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Figure 1A presents a spaghetti plot in which every line corresponds to the TCD measurements 
of each pregnancy. The mean growth rate of TCD increased during gestation with the highest 
growth rate during the third trimester (1st trimester= 0.1691mm/day, 95%CI= 0.0727 to 0.2655; 
2nd trimester= 0.2336 mm/day, 95%CI= 0.1731 to 0.2941; 3rd trimester= 0.2702 mm/day, 95%CI= 0.2216 
to 0.3175).
The relation between repeated TCD measurements and GA was estimated as the following equation: 
TCD= -2.8248 + 0.1124 * GA + 0.0004 *GA2. This resulted in an mean TCD of 3.58mm 
at 49 days GA, 5.74mm at 56 GA and 8.04mm at 77 days GA. The reference curve for the cerebellum 
between 9 and 32 weeks GA is presented in Figure 1B.
The results of the linear mixed models estimating the associations between the repeated cerebellar 
measurements and periconceptional maternal characteristics are shown in Table 3. A significant 
negative association between pre-pregnancy BMI and cerebellar growth was found in the crude model 
(Model 1). The associations sustained in the fully adjusted model (Model 2) in which the cerebellar 
growth trajectories are 0.033mm lower for every point increase in BMI. To validate the self-reported 
data of pre-pregnancy BMI, we repeated the analysis with standardized first trimester maternal BMI 
measurements. These results were comparable both in the crude (β= -0.0278, 95%CI= -0.0549 ; 
-0.0008, p= 0.044) and fully adjusted model (β= -0.0325, 95%CI= -0.0642 ; -0.0008, p= 0.045).
The analyses showed a trend towards a positive association between male gender and cerebellar 
growth. No significant associations were demonstrated between growth trajectories of the cerebellum 
and maternal age, parity, mode of conception, geographic origin, moment of folic acid supplement 
initiation, periconceptional alcohol consumption and smoking. 
 
To illustrate our findings we created a categorical variable of pre-pregnancy BMI according to the WHO 
classification: Underweight: <18.5kg/m2; normal: 18.5-24.99kg/m2; overweight: 25-29.99kg/m2; severe 
obesity: >30 kg/m2 [134]. Figure 1C shows the associations between cerebellar growth trajectories and 
these four categories (Blue= underweight, green= normal, yellow= overweight, red= severe obesity). 
Cerebellar growth trajectories are lowest in the overweight group (β= -0.298, 95%CI= -0.597 ; 0.002, p= 
0.05) and the obese group (β= -0.097, 95%CI= -0.526 ; 0.332, p= 0.66) and highest in the underweight 
group (β= 0.258, 95%CI= -0.220 ; 0.736, p= 0.29) all compared to the group with a normal BMI.
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Figure 1 — A reference curve and prenatal growth 
trajectories of transcerebellar diameter
(A) Growth trajectories of TCD measurements in 
millimetres are presented as a function of gestational 
age per individual. (B) The reference curve of TCD is with 
the 5th (dashed line), 50th (solid line) 95th (dashed line) 
percentile. (C) Mean growth trajectories per category 
of BMI. TCD, transcerebellar diameter; BMI, body mass 
index in kg/m2.
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Table 3 — Linear mixed models: Associations between periconceptional maternal and fetal factors and 
cerebellar growth trajectories
Model β 95%CI p
Maternal age 1 -0.0039 -0.0296 ; 0.0219 0.768
 2 -0.0013 -0.0319 ; 0.0293 0.932
Nulliparous 1 0.0280 -0.2162 ; 0.2724 0.821
 2 -0.0558 -0.3458 ; 0.2342 0.704
Mode of conception (IVF/ICSI) 1 0.0259 -0.2347 ; 0.2865 0.845
 2 0.0309 -0.2890 ; 0.3508 0.849
Geographic background (Dutch) 1 0.0020 -0.3138 ; 0.3178 0.990
 2 -0.0761 -0.4403 ; 0.2881 0.680
Geographic background (Western other) 1 -0.1104 -0.6873 ; 0.4666 0.706
 2 -0.5315 -1.1811 ; 0.1181 0.108
Pre-pregnancy BMI 1 -0.0323 -0.0596 ; -0.0050 0.021
 2 -0.0331 -0.0638 ; -0.0024 0.035
Folic acid (preconceptional) 1 0.2115 -0.0655 ; 0.4884 0.134
 2 0.2277 -0.1141 ; 0.5695 0.190
Periconception alcohol (Yes) 1 -0.0144 -0.2882 ; 0.2594 0.917
 2 -0.0494 -0.3806 ; 0.2819 0.769
Periconception smoking (Yes) 1 0.0593 -0.2665 ; 0.3851 0.720
 2 0.1210 -0.2693 ; 0.5113 0.541
Gender (male) 1 0.1720 -0.0697 ; 0.4137 0.162
 2 0.2349 -0.0338 ; 0.5036 0.086
Data is presented in ß values with corresponding 95%CI and p-values. Significant results are in bold. Model 1 represents the 
crude models with only gestational age and the covariate of interest as predictor. Model 2 represents the fully adjusted models 
with all covariates entered simultaneously. ß, beta value; 95%CI, ninety-five percent confidence interval; BMI, body mass index 
in kg/m2; IVF/ICSI, in vitro fertilization/intra-cytoplasmic sperm injection.
DISCUSSION
We successfully created cerebellar growth trajectories using repeated TCD measurements from the 
first, second and third trimester in a tertiary hospital population. Data analysis revealed that maternal 
BMI is negatively associated with cerebellar growth between 9 and 32 weeks GA. Interestingly, no 
significant associations were found between cerebellar growth and maternal age, parity, IVF/ICSI 
treatment, timing of initiation of folic acid supplements, periconceptional alcohol consumption 
and smoking. Male gender showed a trend towards a positive association with cerebellar growth. 
In agreement with previous literature, we demonstrated a nonlinear growth pattern (Figure 1A) 
with cerebellar growth rates increasing with advancing GA, thus being highest in the third trimester 
[135,136].
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Strengths and weaknesses
Our longitudinal study design enabled us to study cerebellar growth as a dynamic process during 
pregnancy. In contrast to a cross-sectional approach we studied actual growth patterns as opposed to 
size at one time point. To draw more robust conclusions on the impact of maternal BMI we analysed 
associations between cerebellar growth and self-reported BMI as well as measured BMI. Epidemiological 
studies consider self-reported pre-pregnancy BMI an adequate measure; however standardized BMI 
measurements are more precise and not influenced by recall bias. Our periconceptional cohort study 
is conducted in a tertiary hospital setting; therefore the results may not be valid for the general 
population. Moreover, residual confounding inherent to the observational design cannot be excluded. 
As TCD is strongly correlated to GA, small errors in pregnancy dating may be a confounder of cerebellar 
growth. Although a standardized clinical method was used to calculate GA, estimation of GA remains 
a challenge in prenatal growth studies as well as clinical practice [24].
Main findings
Our results add to the growing recognition that maternal obesity has an impact on neurodevelopmental 
health in offspring. We studied cerebellar growth in a tertiary hospital population without congenital 
malformations including abnormalities or hypoplasia of the cerebellum, and showed a negative 
association with periconceptional maternal BMI. This suggests that a higher BMI is associated with 
a slight decrease in cerebellar growth within the normal ranges of which the consequences for 
neurodevelopment in postnatal life need further investigation. Our findings are in agreement with 
the reported altered in white matter development in children of obese mothers [137]. Another study 
reported that every increase of 1 unit pre-pregnancy BMI was associated with a significant reduction of 
the intelligence coefficient in the child [138]. Several studies demonstrate that children born to obese 
mothers are at higher risk for intellectual disability or cognitive deficit [139-141] as well as impaired 
neurodevelopmental outcomes including attention-deficit hyperactivity disorder, autism spectrum 
disorders and other behavioural problems [142-145]. Interestingly, these particular impairments 
and mental health issues have also been associated with abnormal development of the cerebellum 
[51,52,146]. The cerebellum has been recognized as a key player in a spectrum of neurodevelopmental 
complications as it is involved in a variety of sensorimotor tasks and cognitive, emotional and 
language behaviour [47-50]. Therefore, we hypothesize that the cerebellum acts as an intermediate 
in the association between maternal BMI and neurodevelopmental outcome. A harmful intra-uterine 
environment resulting from an increasing BMI would then cause deviations in cerebellar growth 
which subsequently causes an increased risk for impaired neurodevelopment. Such a hypothesis is 
supported by accumulating evidence linking epigenetic modifications to early brain development and 
neurodevelopmental functioning [147,148]. More clues on such a relationship can be found in human 
and mouse models of autism disorders demonstrating similar patterns of cerebellar DNA damage and 
methylation [149].
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The association between maternal BMI and decreased cerebellar growth trajectories may be 
attributable to BMI as a composite determinant of several mechanisms. Potential mechanisms include 
dietary intake, nutritional status, chronic inflammation and excessive oxidative stress [150-155]. These 
mechanisms may act on the level of epigenetics causing derangements in DNA methylation in genes 
which play a crucial role in fetal, neonatal and adult health [156,157]. BMI can be a strong determinant 
of such epigenetic derangements [158]. In addition, neurodevelopment could also be influenced 
by downstream effects of gestational weight gain, fetal growth alterations and the increased risk 
of pregnancy complications [139]. Whether these mechanisms act alone or as a component of a 
multifactorial process influencing prenatal neurodevelopment needs to be elucidated. Nevertheless, 
a higher maternal BMI offers an altered genetic, hormonal and biochemical environment for the fetus 
and its developing brain.
No other significant associations between cerebellar growth and periconceptional maternal and fetal 
factors were demonstrated. The lack of an association with folate status in particular is in contrast 
with our previous results [127]. Possibly, the impact of the moment of periconceptional folic acid 
initiation on the growing cerebellum attenuates over this larger growth trajectory. Fetal head growth 
was previously reported to be negatively associated with maternal smoking [58,159]. We speculate 
that the cerebellum in comparison to overall brain growth might be relatively protected when harmful 
exposures pose a risk for causing alterations. Since the cerebellum is also mostly unaffected in growth 
restricted fetuses, [160] normal cerebellar growth seems preferential to head growth. Hence, finding a 
relation between BMI and cerebellum growth strengthens our case of an actual effect.
Future implications
As the proportion of obese women of reproductive-age worldwide has increased dramatically, the 
potential adverse effects on prenatal brain development deserve more attention. In particular, it 
would be interesting to know whether minor deviations in prenatal cerebellar growth affect long-
term neurodevelopmental outcome. Serial measurements of the cerebellum will be of additional 
value for studying the protracted process of cerebellar development. Future prospective birth cohorts 
with a focus on serial cerebellar growth measures and specific functional cerebellar outcome data are 
warranted. Preconception counselling and lifestyle interventions may encourage future mothers to 
attain a healthy weight prior to conceiving and thereby potentially decreasing the risk for impaired 
neurodevelopmental outcome in the new generation.
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ABSTRACT
Background — Fetal growth is influenced by periconceptional maternal conditions. We aim to 
investigate whether growth trajectories of the human embryonic head can be created using three-
dimensional ultrasound (3D-US) and virtual reality (VR) technology, and are associated with second 
trimester fetal head size and periconceptional maternal conditions?
Methods — Bi-parietal diameter (BPD) and occipital frontal diameter (OFD) to calculate head 
circumference (HC), head volume (HV) and crown-rump length (CRL) were measured weekly between 
9+0 and 12+6 weeks gestational age (GA) using 3D-US and VR. Fetal HC was obtained from second 
trimester structural anomaly scans. Growth trajectories of the embryonic head were created with 
general additive models and linear mixed models were used to estimate associations with maternal 
periconceptional conditions as a function of GA and CRL, respectively.
Results — We selected 149 singleton pregnancies with a live born non-malformed fetus from the 
Rotterdam periconception cohort. 303 3D-US images of 149 pregnancies were eligible for embryonic 
head measurements (intra-class correlation coefficients (ICC) >0.99). Associations were found between 
embryonic HC and fetal HC (ρ= 0.617, p<0.001) and between embryonic HV and fetal HC (ρ= 0.660, 
p<0.001) in Z-scores. Maternal periconceptional smoking was associated with decreased, and maternal 
age and IVF/ICSI treatment with increased growth trajectories of the embryonic head measured by HC 
and HV (All p<0.05).
Conclusions — Serial first trimester head circumference (HC) and head volume (HV) measurements 
were used to create reliable growth trajectories of the embryonic head, which were significantly 
associated with fetal head size and periconceptional maternal smoking, age and in vitro fertilization 
(IVF)/intra-cytoplasmic sperm injection (ICSI) treatment. The consequences of the small effect sizes for 
neurodevelopmental outcome need further investigation.
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INTRODUCTION
Fetal health determined by growth and development has consequences for health and disease in later 
life [15,16,41,161]. New evidence reveals that embryonic growth and development can be an early 
predictor of fetal health [15,24,98]. Neurodevelopmental health in particular may already originate 
during neurogenesis in the first weeks of gestation [162]. Therefore it is essential to etablish measures 
for the earliest possible prenatal detection of neurodevelopmental disorders. 
So far, measurements of fetal head circumference (HC) are performed to monitor growth and 
development of the fetal head and brain with suggested implications for neurodevelopmental outcome 
[9,163]. In contrast to actual brain volume measurements, which are notoriously difficult to assess in 
utero, HC is a feasible measure used from the first trimester until the neonatal period. However, HC 
measurements can be imprecise and associations with neurodevelopmental outcome remain subject 
to discussion [164,165]. During the last decade, three-dimensional (3D) ultrasound (US) techniques 
provide accurate and precise markers for actual growth, most accurately defined as an increase in 
volume, in addition to 2D-US crown-rump length (CRL) measurements [166-168]. Furthermore, virtual 
reality (VR) systems visualizing 3D volumes offer depth perception and interaction with projected 
images enabling precise semi-automated volume measurements [168]. In this context, to evaluate 
(ab) normal head growth using VR, head volume (HV) compared to conventional HC measurements 
may serve as a more accurate measure for prenatal neurodevelopment. Previous studies already 
demonstrated that 3D-US embryonic volume measurements provide more information and enable 
a more sensitive detection of altered or impaired growth including fetal growth restriction and 
chromosomally abnormal fetuses in the first trimester of pregnancy [169-172].
Prenatal head and brain development can be disrupted during pregnancy. As the mother serves as 
a direct environment for her growing fetus, maternal conditions, such as obesity, smoking and use 
of alcohol are associated with deviations in growth of the head and brain with consequences for 
neurodevelopment [29,58,152,173,174].
Monitoring small deviations in growth of the embryonic head by ultrasonography is still challenging. 
Therefore, we hypothesize that assessment of growth trajectories of embryonic HV using new 
sophisticated 3D-US and VR techniques may serve as a more accurate marker for embryonic head 
growth compared to the conventional HC measurements. Moreover, these precise embryonic head 
growth trajectories may enable us to study small deviations in head growth and associations with 
periconceptional maternal conditions and exposures. Therefore, we aim to create growth trajectories 
and reference curves of the embryonic head and investigate associations with fetal head size and 
periconceptional maternal conditions. 
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MATERIALS AND METHODS
This study is embedded in the Rotterdam Predict Study a prospective periconception cohort 
investigating the influence of gene-environment interactions and underlying epigenetic mechanisms 
on embryonic parameters and pregnancy outcome at the outpatient clinic of the Department of 
Obstetrics and Gynaecology, Erasmus MC University Medical Centre in Rotterdam, the Netherlands 
[24]. All pregnant women and their partners enrolled in 2009 and 2010 and gave written informed 
consent before participation.
Study population
Enrolment of pregnant women was aimed before the 6th week of gestation. We selected viable singleton 
pregnancies conceived spontaneously or conceived through assisted reproductive techniques using 
biological oocytes from the participating mother. Exclusion criteria were oocyte donation, miscarriages, 
ectopic pregnancy, intra-uterine fetal death, neonatal death, minor and major congenital anomalies 
and termination of pregnancies. We also excluded pregnancies with unreliable gestational age (GA). 
GA was defined as unreliable, when pregnancy dating relied on CRL measurements only, in case of; 
(1) Unknown or unreliable recall of last menstrual period (LMP), (2) irregular menstrual cycle (cycle 
<25 or >31 days), or (3) discrepancy of more than 6 days between expected GA based on LMP and 
first trimester CRL measurement according to the Robinson curve [133]. Pregnancies with missing 
questionnaires, unknown maternal folic acid status and ultrasound scans with low quality were also 
excluded. 
Maternal and pregnancy characteristics
Gestational age was calculated strictly according to the first day of the LMP in spontaneously conceived 
pregnancies with regular menstrual cycles. In case of in vitro fertilization (IVF), intra-cytoplasmic sperm 
injection (ICSI) or intrauterine insemination, GA was calculated from the conception date plus 14 days, 
plus 18 days in cryopreserved embryos or from the insemination date plus 14 days respectively. 
Information on maternal characteristics, dietary and lifestyle behaviours and medical and obstetrical 
history was obtained through a self-reported questionnaire upon enrolment before 8 weeks of 
gestation. From reports of the routine second trimester structural anomaly scans, which are carried out 
between 18 and 22 weeks GA as standard obstetrical care, we obtained fetal biometric measurements 
including HC. Data on pregnancy complications, congenital malformations and neonatal outcome were 
obtained from medical records of the hospitals registries. 
Ultrasound data 
3D-Ultrasound examinations were performed using a 4.5-11.9 MHz transvaginal probe of the Voluson 
E8 system (GE Medical Systems, Zipf, Austria). Weekly transvaginal 3D-ultrasound examinations were 
performed between 6+0 and 12+6 weeks gestational age, obtaining 3D volumes encompassing the whole 
embryo. All 3D-US volumes were stored as Cartesian volumes and analysed in the BARCO I-Space a 
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four walled CAVETM-like VR system in which investigators explore 3D images with depth perception 
[175]. Only high quality images, eligible for embryonic volume measurements were used for the 
measurements of the head. Images without clear reference points or without a clear delineation of the 
borders of the head were excluded for further analysis. We only performed measurements on scans 
between 9+0 and 12+6 weeks GA because the selected reference points to define the cutting plane 
needed for HV measurements only become visible at the end of gestational week 8. 
Figure 1 — Three dimensional ultrasound images for the 
measurements of human embryonic head parameters using 
the VR technique of the BARCO I-Space
Image of OFD and BPD measurement of an embryo at 12+4 gestational 
age (A). Reference points for embryonic HV measurement (B). Embryonic 
HV after segmentation of the head (C). OFD, occipital frontal diameter; 
BPD, bi-parietal diameter; HV, head volume; VR, virtual reality. Images 
with permission.
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The following parameters were measured: CRL (mm), bi-parietal diameter (BPD) (mm), occipital frontal 
diameter (OFD) (mm) and HV (cm3). The BPD and OFD measurements were performed in an axial plane 
of the embryonic head with visualization of both lateral ventricles and a vertical midline (Figure 1A). 
In scans of gestational week 9 and 10, this plane also includes visualization of diencephalon and 
mesencephalon. Both diameters were measured by placing callipers on the outer borders of the skull; 
BPD perpendicular to the midline and OFD along the midline [35]. To verify correct placement of the 
callipers, the embryo was turned in a coronal plane for BPD measurements and to a mid-sagittal plan 
for OFD measurements. The HC was calculated using the formula from GE medical systems: 
HC= pi[0.75(BPD+OFD) -                        ]BPD+OFD4
HV measurements were performed using the V-scope application in a standardized manner as 
described in detail before [171,176]. Prior to measuring HV, the cutting plane was defined. The lowest 
point of the chin and the lowest point of the fourth ventricle in the mid-sagittal plane were selected as 
reference points. Next, a line was drawn between these two points to indicate the cutting level below 
which the embryonic body could be ‘erased’ (Figure 1B). Firstly, in order to measure HV, hyperechoic 
structures were segmented using a region growing approach, selecting an upper (255) and lower (60) 
grey level threshold and an upper (80-90) threshold for the standard deviation, before placing the 
seed point. Secondly, hypo-echoic regions including the brain ventricles were segmented by directly 
marking the voxels using a virtual ‘brush’. Volume measurements were performed by two independent 
examiners (S.C.H and L.B.). Inter- and intra-observer reliability and agreement were calculated for a 
subset of 34 randomly selected images of 34 pregnancies including all GA from 9 to 12 weeks. For 
analyses measurements were repeated by two examiners who were blinded to previous and each 
other’s results. 
Statistical analyses
For data analyses we used SPSS (SPSS release 21 for Windows, IBM, United States of America) and 
R (R: A language and Environment for Statistical Computing, version 3.1.3 2015 for Windows, R Core 
Team, Vienna, Austria). All results with p-values below 0.05 were considered statistically significant. 
General characteristics were calculated for all pregnancies and pregnancies with and without volume 
measurements. A sensitivity analysis was performed to compare pregnancies with and without 
measurements using Mann Whitney U-test for continuous data and Chi-square test for categorical 
data.
To assess intra- and inter-observer reproducibility of HV measurements mean difference and mean 
percentage difference with corresponding 95% limits of agreement (mean (percentage) difference 
± 1.96SD) are calculated. To assess agreement between and within the two examiners Bland-Altman 
plots were created. Intra-class correlation coefficients (ICCs) were calculated to quantify inter- and 
intra-observer reliability.
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Embryonic head growth trajectories and regression equations were calculated and visualized for HV 
as a function of GA and CRL. Fourth root transformations of HC and HV were calculated to approach 
linearity for the regression lines in relationship to GA. A root transformation for HV was used for 
the regression line in relationship to CRL. Square of HC was used for the regression line with CRL. 
Reference curves for HV were created based on the Generalized Additive Model for Location, Scale and 
Shape [177]. Based on Akaike Information Criterion (AIC) and Worm plots we observed that the use 
of a normal model after Box-Cox transformation was the optimal model [178]. With these reference 
curves we calculated the average first trimester Z-score for HC and HV and second trimester HC. For 
each pregnancy, the mean of the longitudinal embryonic Z-scores of HC and HV was plotted against the 
second trimester Z-scores of the HC-measurements. 
Linear mixed models were estimated using PROC MIXED. To study associations with growth of the 
embryonic head and maternal conditions we considered maternal age, moment of periconceptional 
initiation of folic acid supplement use, periconceptional smoking, periconceptional use of alcohol, 
parity, and IVF/ICSI as mode of conception [106]. Linear mixed models were estimated using the 
longitudinal embryonic head measurements as response and GA or CRL and maternal conditions as 
covariates. The same transformations for HV and HC were used to approach linearity. In the model we 
used random intercept and random coefficients of GA and CRL as well as a power variance function 
to fit the covariance structure [179]. Firstly we performed univariate analyses for both GA and CRL 
and all individual maternal conditions. Secondly, in the multivariable model we entered all maternal 
conditions simultaneously in the fully adjusted model.
Ethical Approval
The Central Committee on Research Involving Human Subjects in The Hague and the regional Medical 
Ethical and Institutional Review Board of the Erasmus MC, University Medical Centre in Rotterdam 
approved the study (MEC 2004-227).
RESULTS
In total, 259 pregnant women underwent longitudinal 3D-US scans. We excluded pregnancies according 
to the exclusion criteria because of oocyte donation (n= 2), miscarriage (n= 43), ectopic pregnancy 
(n= 1), unreliable gestational age (n= 12), fetal or neonatal death and termination of pregnancy 
(n= 5), congenital anomaly (n= 3), missing data (n= 7). Of the 186 remaining pregnancies, 37 more 
pregnancies were excluded because the quality of the 3D-US did not allow volume measurements. 
General characteristics of the total study population, our selected study group with embryonic head 
measurements and the excluded pregnancies without measurements are shown in Table 1. No 
significant differences were found except for a higher maternal age and BMI in the excluded group.
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Table 1 — General Characteristics
Characteristics Pregnancies
All  
(n = 186)
With measurements 
(n = 149)
Without measurements 
(n=37)
Maternal
Age, years1 32.0 (4.8) 31.6 (4.8) 33.7 (4.6)*
Ethnicity2 
 Dutch 144 (77.4) 116 (78.4) 28 (77.8)
 Western-other 16 (8.6) 12 (8.1) 3 (8.3)
 Non-western 25 (13.4) 20 (13.4) 5 (13.9)
Education3 
 Low 15 (8.1) 9 (6.0) 6 (17.6)
 Intermediate 54 (29.0) 43 (28.9) 11 (32.4)
 High 108 (58.1) 91 (61.1) 17 (50.0)
BMI, median (range), kg/m2 23.8.(18.6-38.3) 23.5 (19.1-35.0) 25.5 (18.6-38.3)*
Primigravida 69 (37.1) 57 (38.3) 12 (32.4)
Nulliparous 119 (64.0) 96 (64.4) 23 (62.2)
Mode of conception IVF/ICSI 57 (30.6) 45 (30.2) 12 (32.4)
Periconceptional use of alcohol 85 (45.7) 72 (48.3) 13 (35.1)
Periconceptional smoking 31 (16.7) 27 (18.1) 4 (10.8)
Preconceptional initiation of folic acid 150 (80.6) 122 (81.9) 28 (75.7)
Neonatal outcome
Birth weight, median (range), grams 3378 (450-4700) 3390 (450-4700) 3235 (1540-4045)
GA at birth (range), days 276 (187-294) 276 (187-294) 275 (220-290)
Infant gender, male 88 (47.3) 68 (45.6) 20 (54.1)
Data is presented as mean and standard deviations (SD) or number (%) unless otherwise specified. Missing data was due 
to incomplete questionnaires. 1 missing n= 3; 2 missing n= 1; 3 missing n= 9; *p<0.05. BMI; Body Mass Index; IVF/ICSI, in vitro 
fertilization/intra-cytoplasmic sperm injection; GA, gestational age; CRL, Crown-rump length.
Table 2 depicts the success rates and means of HV and HC measurements per gestational week with 
the corresponding SD values. A total of 415 ultrasound scans between gestational ages 9+0 to 12+6 
weeks from 149 pregnancies were available for volume measurements. We were able to perform 303 
(73%) HV measurements and 305 (74%) HC measurements, achieving the highest success rates (77%) 
in gestational week 10. Two or more measurements were available in 100 (67%) pregnancies. 
Intra-observer and inter-observer reliability analyses show no significant differences for the mean HV 
(intra: -0.013 cm3, 95%CI= -0.039; 0.014, p= 0.334; inter: 0.012 cm3, 95%CI= -0.029; 0.053, p= 0.544). 
The mean percentage differences for the intra-observer and inter-observer are respectively 0.455% 
(95% limits of agreement -4.940 ; 5.850) and -0.411% (95% limits of agreement -7.564 ; 6.742). Both 
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ICC values were >0.99, representing excellent reliability. The Bland-Altman plots for both intra-observer 
and inter-observer reliability (Figure 2) show excellent agreement.  
Table 2 — Embryonic head measurements and success rates per gestational age
Embryonic Head Volume Embryonic Head Circumference
GA N (%) Mean (cm3) SD N (%) Mean (mm) SD
Total 303/415 (73) 305/415 (74)
9 97/135 (72) 0.954 0.398 98/135 (73) 37.135 5.828
10 90/117 (77) 2.049 0.766 90/117 (77) 48.676 5.694
11 76/100 (76) 4.010 1.360 76/100 (76) 59.506 6.217
12 40/63 (64) 6.750 1.721 41/63 (65) 70.395 7.261
Number of measurements (N), success rates (%), means and standard deviations (SD) of embryonic head volume and head 
circumference. GA, gestational age.
Figure 2 — Bland Altman plots
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Reference curves and regression lines
Figure 3 displays the individual growth trajectories, reference curves and regression lines of HV as a 
function of GA and CRL. Growth patterns of HV are non-linear and variance seems to increase with 
advancing gestational age in all models. In order to approach linearity to model regression lines for HV 
and HC we performed transformations as below, resulting in the following equations:
 HV1/4  = -1.0947 + 0.0315 x GA (days)
 HV1/2 = -0.27713 + 0.04761 x CRL (mm)
 HC1/4  = 1.0738 + 0.0214 x GA (days)
 HC2 = -1320.03 + 105.01 x CRL (mm)
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The correlation coefficients between embryonic and fetal head measurements in Z-scores are depicted 
in Figure 4 (HC vs fetal HC: ρ= 0.617, p<0.001; HV vs fetal HC: ρ= 0.660, p<0.001). 
Figure 4 — Associations between embryonic and fetal 
head parameters in Z-scores
Associations between first trimester embryonic head 
circumference and head volume, and second trimester fetal 
head circumference in Z-scores. HV, head volume; HC, head 
circumference.
Linear mixed models
The effect estimates, standard errors and corresponding p-values of the linear mixed models of HV 
and HC as a function of GA and CRL and the association with maternal conditions are depicted in 
Table 3. Maternal age is associated with significantly increased growth trajectories of HV and HC as a 
function of GA. This effect is attenuated to non-significant, modelling HV as a function of CRL. Maternal 
periconceptional smoking is associated with decreased head growth trajectories of both HV and HC in 
all models. We show significantly decreased HV in univariate and multivariable models as a function 
of CRL and in the multivariate model for HC as a function of CRL. Significantly increased embryonic 
head growth trajectories were assessed in IVF/ICSI pregnancies as a function of GA, although these 
associations were attenuated to non-significant associations in the models as a function of CRL. 
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Preconceptional folic acid use was associated with significantly increased growth trajectories of HC 
in the multivariable model as a function of GA only. There were no significant associations between 
periconceptional use of alcohol, parity and embryonic head growth trajectories.
DISCUSSION
In this periconceptional cohort we show that growth trajectories of HV and HC can serve as possible 
and reproducible marker for detecting small deviations in human embryonic head growth in the first 
trimester of pregnancy. Interesting findings are the establishment of associations between maternal 
periconceptional smoking, maternal age and IVF/ICSI treatment and growth trajectories of the 
embryonic head. Furthermore, embryonic head measurements are associated with fetal head size, 
thereby supporting our hypothesis that embryonic growth trajectories may serve as early marker of 
fetal head growth.
Since the study population of our periconceptional cohort is largely derived from a tertiary hospital 
setting, external validity is a limitation to consider. Moreover, inherent to the observational cohort 
design residual confounding cannot be excluded completely. Duration of pregnancy is a strong 
confounder in studies on embryonic growth; therefore we used a very precise method for pregnancy 
dating. Nevertheless, we observe a larger variance of growth trajectories as a function of GA compared 
to CRL. Hence, it cannot be excluded that GA is still a confounder in the studied associations between 
embryonic head growth and maternal conditions. As growth of the embryo depends on physiological 
processes involved in implantation and programming, it is challenging to develop an optimal measure 
to estimate GA for research and clinical practice. Also, we are aware that the results of significant 
associations with small effect estimates which were not always consistent in the GA and CRL models 
should be assessed with care. The study was challenged by moderate success rates of embryonic head 
measurements, partially due to the use of 3D-US sweeps comprising the entire embryo, as no specific 
sweeps of the embryonic head were available. Moreover, high Body Mass Index (BMI), unfavourable 
position of the uterus, acoustic shadowing and motion artefacts affect ultrasound image quality and 
consequently affected these moderate success rates. In the majority of pregnancies however, we 
were able to measure embryonic HV and HC repeatedly (≥2), therefore linear mixed models could 
be applied for longitudinal data analysis. We are aware that the interpretation of the effect estimates 
may be complicated by the use of different transformations in the various models and that clinical 
interpretation requires a larger sample size and further follow up studies. Our study was not aimed 
to investigate associations between embryonic and neonatal head measurements and therefore 
we cannot draw conclusions on associations between maternal conditions and neonatal head size, 
although it is an interesting issue for future research.
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Considering these limitations, this study is the first to provide reliable growth trajectories of embryonic 
head volume obtained from longitudinal high resolution transvaginal 3D-ultrasound data. We observe 
a more than six fold increase of the trajectory of HV and doubling of the HC between 9 and 12 weeks 
GA, which is supported by embryonic volume measurements in chromosomally normal and abnormal 
fetuses [172,180,181]. We found a non-linear growth trajectory of the HV, which is consistent with 
previous growth trajectories of embryonic volume [169,182]. Linear growth of embryonic volume 
measured between 11 and 13 weeks of gestation demonstrated by Falcon et al. could be due to the 
short span of 3 weeks [181]. 
Our finding of the association between maternal periconceptional smoking and decreased embryonic 
head growth is supported by other studies investigating head growth from the first trimester onwards 
[29,58]. In addition, a Magnetic Resonance Imaging study also showed that maternal smoking was 
associated with reduced brain volume in the second half of pregnancy [76]. Toxicity of tobacco 
influences epigenetic mechanisms and vascular processes [29,183] which may directly influence 
growth trajectories of the embryonic head. In addition smoking is often accompanied by other 
poorer lifestyles as well, which may enhance the detrimental effects. Although we observed positive 
association between maternal age and IVF/ICSI pregnancies on both embryonic head parameters, 
these findings were not consistent in all models. Nevertheless, maternal age has previously been 
reported in association with an increased embryonic growth [15,106,184]. We hypothesize that this 
finding may be explained by epigenetic changes due to aging including global DNA hypomethylation 
or hypermethylation of specific genes essential for embryonic growth [16]. The significantly increased 
embryonic head growth trajectories in IVF/ICSI pregnancies are probably due to an overall larger 
embryo. This is in line with Eindhoven et al. showing positive associations, albeit not significant, 
between IVF/ICSI treatment and CRL or embryonic volume as a function of GA [182]. The hypothesis of 
an overall larger embryo is further supported by the attenuation of the β’s in the CRL models. Although 
the differences are very small, we consider IVF/ICSI treatment to be another environmental exposure 
that interferes in epigenetic programming of embryonic growth genes, such as insulin growth factor 2 
(IGF2) differentially methylated region (DMR) and other biological mechanisms as a result of ovarian 
stimulating hormones, use of progesterone and other maternal conditions and exposures [16,23]. The 
association between preconceptional folic acid supplement use and growth trajectories of HC is in 
line with previous embryonic studies [105,106]. Correlation between first and second trimester head 
measurements is in correspondence with previous results revealing associations between embryonic 
growth and estimated fetal weight and birth weight [98]. This may establish embryonic HV as a separate 
entity in search for prenatal measures for (ab) normal head and brain development. As such, HV may 
add new insight in our understanding of prenatal neurodevelopment.
In conclusion, growth trajectories of the embryonic head can be precisely assessed as early as 
the first trimester. Future research is recommended to establish whether first trimester head 
parameters can contribute to the early detection of deviations in head growth with consequences for 
neurodevelopmental outcome. 
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ABSTRACT
Background — Brain abnormalities in newborns with congenital heart defects (CHD) may well originate 
in the prenatal period. We hypothesized that CHD are associated with prenatal derangements in 
cortical folding. In this study we used a three-dimensional ultrasound (3D-US) method for measuring 
fetal brain fissure depths to investigate growth trajectories of cortical folding in fetuses with CHD and 
controls.
Methods — In a subgroup of 227 women recruited from a prospective cohort, we performed 
longitudinal 3D-US examinations of the fetal brain at 22, 26 and 32 weeks gestational age (GA). The 
Sylvian, insula and parieto-occipital fissure (POF) depths were measured. Intra- and inter-observer 
reliability and agreement were evaluated with intra-class correlation coefficients (ICC’s) and the Bland-
Altman method. Doppler pulsatility indices of the umbilical artery and middle cerebral artery were 
measured to calculate the cerebro-placental ratio (CPR). The association between CHD and cortical 
folding was estimated using linear mixed models with adjustment for potential confounders.
Results — We included 213 pregnancies (20 CHD fetuses and 193 controls) providing 44 and 532 
3D-US scans, respectively. Brain fissure measurements were successful in over 80% of 3D-US scans, 
except for the POF at 32 weeks GA (65%). All measurements showed a good reliability (ICCs>0.84). 
After adjustment for maternal alcohol consumption, fetal head circumference (HC) and gender, 
growth trajectories of the left insula depth (β= -2.753, 95%CI= -5.375 ; -0.130, p= 0.040) and right 
POF (β= -3.762, 95%CI= -7.178 ; -0.346, p= 0 .031) were significantly decreased in CHD compared to 
controls, whereas their growth rates were slightly increased (β= 0.014, 95%CI= 0.001 ; 0.027, p= 0.036 
and β= 0.024, 95%CI= 0.007 ; 0.041, p= 0.006). In contrast to controls, we found no associations 
between CPR and cortical folding in CHD.
Conclusions — Cortical folding can be evaluated reliably by measuring brain fissure depths. We 
showed that regional trajectories of cortical folding were delayed in CHD compared to controls but 
showed accelerated growth rates. In CHD, no associations were found between cerebro-placental 
redistribution and cortical folding, which suggests that besides hemodynamic mechanisms other 
mechanisms play a role in the prenatal origin of CHD-related neurodevelopmental disorders.
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INTRODUCTION
Brain abnormalities occur in up to 49% of new borns with congenital heart defects (CHD) [26]. 
Accumulating evidence support a prenatal origin for these brain abnormalities [185]. As the majority of 
these infants today reach adulthood, efforts are directed to decrease morbidity and improve long-term 
neurodevelopmental outcome [186,187]. In order to contribute to these objectives research should 
focus on unravelling the underlying pathophysiologic mechanisms contributing to alterations in brain 
development in CHD fetuses.
In this context, the effects of deranged intra-uterine hemodynamic conditions on the developing 
brain in CHD fetuses have received much attention. In severe CHD, specifically left side obstructive 
lesions fetal hemodynamics, can be drastically changed, with as a consequence cerebro-placental 
redistribution to maintain cerebral perfusion [188-190]. However, this fetal autoregulation response 
preserving cerebral blood flow may not be sufficient to spare to brain from adapting.
 
Prenatal CHD-related brain abnormalities include alterations in white matter microstructure and 
volume, reduced (sub) cortical grey matter volume amongst others. These alterations are spread over 
time and are preceded by derangements in cortical folding [191-194]. Cortical folding is a complex 
process strongly correlated to gestational age (GA) [195-197]. Gender differences and left-right 
asymmetry in cortical folding have been documented and are considered physiologic phenomena 
[198-200]. However, derangements in both global and regional cortical folding can also be a sign of 
pathological processes observed in neuropsychiatric disorders [201,202]. Therefore, it was suggested 
that prenatal cortical folding parameters are associated with neurodevelopmental outcome.
Previous ultrasound studies used a scoring system based on the degree of tortuosity to evaluate the 
development of various brain fissures, which appeared to be feasible and reliable [203,204]. Recently 
however, simple depth measurements of brain fissures including the Sylvian, parieto-occipital (POF), 
cingulate and calcarine fissures have been demonstrated to be applicable with two-dimensional 
and three-dimensional (3D) ultrasound (US) [200,205-207]. In contrast to MRI, ultrasound is readily 
available, cheap and allows serial examinations of cortical folding [208].
From this background we aimed to study (1) the reliability of measuring fetal brain fissure depths 
for the non-invasive evaluation of fetal cortical folding using 3D-US and (2) the influence of CHD on 
trajectories of prenatal cortical folding.
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MATERIALS AND METHODS
Study design and population
From the Rotterdam periconception cohort (Predict study), a prospective observational study 
conducted at the Erasmus MC University Medical Center, a subgroup of women with a singleton 
pregnancy was recruited for longitudinal 3D-US examinations of the fetal brain at set moments [24]. 
All participants signed written informed consent at enrolment and also on behalf of their unborn child. 
The Central Committee of Human Research in The Hague and the Medical Ethical and Institutional 
Review Board of the Erasmus MC, University Medical Center in Rotterdam approved the study (MEC 
2004-227, date of approval 25-01-2013). 
Pregnant women were enrolled before 12 weeks of GA, from November 2013 until March 2015. 
Additionally, women with a pregnancy complicated by a case of isolated fetal CHD confirmed before 
32 weeks GA by an extended structural US examination were recruited from the outpatient clinic at the 
Erasmus MC University Medical Center, Rotterdam, the Netherlands. For this study exclusion criteria 
were withdrawal before 3D-US examinations, intra-uterine fetal death, termination of pregnancy, 
multiple congenital anomalies or malformations other than CHD.
Study parameters and endpoints
Maternal characteristics and data on medical and obstetrical history were obtained through self-
reported questionnaires upon enrolment and verified at the study entry visit. Data on pregnancy 
course and outcomes were obtained from questionnaires filled out in the second trimester and 
around delivery. The reports of the second trimester structural US examination and the delivery were 
used to validate the questionnaire data. Pregnancies were dated at the routine clinical intake visit 
using crown-rump length (CRL) measurements before 13 weeks GA [133]. Pregnancies resulting from 
artificial reproductive techniques were dated using the oocyte retrieval date plus 14 days or date of the 
embryo transfer plus 17-18 days in cryopreserved transfers.
Ultrasound and measurements
All participants were scheduled to undergo serial 3D-US examinations at 22, 26 and 32 weeks GA. 
Ultrasound scans were performed with the use of a 1-7 MHz transabdominal transducer and a 6-12 MHz 
transvaginal transducer of the Voluson E8 system (GE Medical Systems, Zipf, Australia). Detailed 
neurosonography was performed by one certified sonographer (IVK) using a transabdominal approach 
primarily; a transvaginal approach was considered when the fetus was in vertex presentation. Standard 
3D-US volumes according to the ISUOG guidelines were acquired of the transventricular plane and 
a plane directly above the transventricular plane [130,209]. In addition, we performed biometric 
measurements of the bi-parietal diameter (BPD) and head circumference (HC). Doppler measurements 
of the umbilical artery (UA) and middle cerebral artery (MCA) were obtained and cerebro-placental 
ratio (CPR) was calculated as a measure of brain sparing [210,211].
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Figure 1 — Brain fissure measurements using 3D-Ultrasound
Brain fissure measurements and corresponding ISUOG standard planes. The insula and Sylvian fissure depths were measured 
in the transventricular plane. The Sylvian fissure (1A) was measured from the midpoint of the internal face of the fissure to the 
inner table of the parietal bone. The insula depth (2) was measured from the interhemispheric fissure to the midpoint of the 
external face of the fissure roof. The POF was measured in the plane directly above the transventricular plane slightly changing 
the angle and measured from the interhemispheric fissure to the outer border of the fissure’s apex. Adapted from ISUOG 
guidelines [130]. ISUOG, International Society of Ultrasound in Obstetrics and Gynaecology; CHD, congenital heart defect; POF, 
Parieto-occipital fissure.Images with permission.
Brain fissure depth measurements were performed offline using 4D View Version 5.0 (GE Medical 
Systems). All measurements were performed by one observer (AWG) to exclude inter-observer 
variability and enhance precision. Measurements were performed perpendicular to the midline fissure. 
Perpendicularity was ensured by drawing a guiding line over the midline fissure. The insula and Sylvian 
fissure depths were measured in the transventricular plane and included the following reference points; 
cavum septum pellucidum, posterior horns of the lateral ventricles, the choroid plexus and the atrium 
[130]. The insula depth (Figure 1A) was measured from the interhemispheric fissure to the midpoint of 
the external face of the fissure roof [205,206]. The Sylvian fissure (Figure 1A) was measured from the 
midpoint of the internal face of the fissure to the inner table of the parietal bone [200,205,206]. After 
positioning the reference dot in the cavum septum pellucidum, the head was rotated along the z-axis 
until the maximal depth of the POF was visualized. The POF was measured in the plane directly above 
the transventricular plane slightly changing the angle (Figure 1B), using the cavum septum pellucidum 
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as reference point [130,212]. The distance was measured from the interhemispheric fissure to the 
outer border of the fissure’s apex [200,206,207]. Differentiation between the left and right side was 
ensured by reorientation of the 3D-US image according to a standard approach [209].
Statistical analysis
For data analyses we used SPSS (SPSS release 21 for Windows, IBM, USA). Differences in general 
characteristics between the case and control groups were assessed using Mann Whitney U-tests for 
continuous data, and Chi-square tests for categorical data. Reliability analyses were performed on 
30 randomly selected ultrasound examinations of 30 different fetuses at all three time points. Two 
observers, blinded to the outcomes, independently performed the measurements in threefold. Both 
intra-observer and inter-observer reliability was analysed with intraclass correlation coefficients (ICCs). 
The extent of agreement was examined according to Bland Altman. All results with p-values <0.05 
were considered statistically significant.
In all 3D-US scans, measurements of the Sylvian fissure, insula and POF were repeated three times per 
time point. We calculated the means of the three measurements to use in the statistical analyses. We 
calculated success rates, medians and ranges for all brain fissure depth measurements per time point 
(Supplemental data – Table A). Trajectories of brain fissure measurements per individual comprised of 
the repeated measurements at 22, 26 and 32 weeks of gestation. Linear mixed models were estimated 
to investigate the association between CHD and trajectories of cortical folding, taking into account 
the subject correlation for repeated measurements. In the model we used a random intercept only. 
A maximum likelihood approach was applied to assess whether polynomials contributed to the best 
model fit. The linear mixed models were estimated using GA and GA squared as predictors and the 
longitudinal brain fissure depths as response. In the final models, the relationship between CHD and 
cortical folding were investigated by analysing the associations with (1) the height of the trajectory and 
(2) the growth rate (slope) of the trajectory represented by the interaction term (CHD*GA). Potential 
confounders of cortical folding were entered simultaneously as covariates and their independent 
associations with trajectories of cortical folding were investigated in addition. Potential confounders 
were derived from literature and were selected when there were significant differences in general 
characteristics between CHD cases and controls [189,200]. In addition, associations were investigated 
between Doppler pulsatility indices and trajectories of brain fissures in CHD and controls.
RESULTS
Fourteen of the 227 pregnant women were excluded from the analysis because of withdrawal (n= 6), 
intra-uterine fetal death (n= 1), termination of pregnancy (n= 1), multiple congenital anomalies (n= 1) 
or anomalies other than CHD (n= 3) and trisomy 21 (n= 2). The study population of 213 pregnancies 
comprised of 20 cases and 193 controls. CHD cases included Tetralogy of Fallot (n= 6), transposition of 
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the great arteries (n= 6), hypoplastic left heart syndrome (n= 2), perimembranous ventricular septal 
defect (n= 3), atrio-ventricular septal defect (n= 1), truncus arteriosus (n= 1) and aortic coarctation with 
tricuspid valve insufficiency (n= 1). Table I lists the general characteristics of the study group stratified 
for CHD and controls. The only significant difference between the groups concerned periconceptional 
alcohol consumption, which was higher in the CHD group. CPR values were lower than 1.0 in only 3 
fetuses at 32 weeks GA, which were all controls.
Table 1 — General characteristics
Population Total (n= 213) CHD (n= 20) Control (n= 193) p-value Missing
Maternal characteristics  
Maternal age, years 31.9 (21-48) 33.0 (22-48) 31.8 (21-45) 0.81 7
Nulliparous 96 (46) 11 (58) 85 (45) 0.29 6
Geographic background 6
 Western 169 (82) 18 (90) 151 (81) 0.46 6
 Non-western 38 (18) 2 (10) 36 (19)
 Pre-pregnancy BMI, kg/m2 23.1 (15.2-43.4) 23.4 (18.0-35.8) 23.0 (15.2-43.4) 0.87 19
Educational level 8
 low 25 (12) 0 (0) 25 (13) 0.20
 middle 83 (40) 7 (39) 76 (40)
 high 97 (47) 11 (61) 86 (46)
Mode of conception (IVF/ICSI) 56 (27) 2 (11) 54 (28) 0.10 3
Periconception folic acid use 195 (95) 18 (95) 177 (95) 0.99 7
Periconception smoking 34 (17) 3 (16) 31 (17) 0.92 8
Periconception alcohol use 60 (29) 10 (53) 50 (27) 0.02 9
Neonatal characteristics
Birth weight, grams 3200 (400-4380) 3420 (1650-4140) 3190 (400-4380) 0.47 2
Gestational age at birth, days 272 (182-292) 274 (200-292) 271 (182-292) 0.12 2
Gender (male) 111 (52) 13 (65) 98 (51) 0.44 0
General characteristics of the total study population and the two subpopulations, CHD fetuses and controls. Data is presented 
as median and range or number (n) and percentage (%). Significant differences are in bold font. BMI, body mass index in 
kilograms/square meter; IVF/ICSI, in vitro fertilization/intra-cytoplasmic sperm injection.
Reliability analysis
The mean number of 3D-US scans in the case group was 2.2 and 2.8 in the controls. Overall success 
rates of the insula and Sylvian fissure depth measurements were above 82%. Success rates of the 
POF decreased from 96% at 22 weeks to 65% at 32 weeks gestation. The intra- and inter-observer 
reliability and agreement statistics are shown in Table 2. The means differences of the Sylvian fissure 
are significantly different when repeated by one observer and between the two observers, although 
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the mean percentage differences are 2.8% and 5.0%, respectively. The intra-observer analysis does 
not show significant differences between the measurements of the same observer. All ICC values were 
above 0.84, representing good reliability. Intra- and inter-observer agreement of the Sylvian fissure 
and insula were good, the agreement of the POF was moderate.
Table 2 — Intra- and inter-observer reproducibility for measurements of the Sylvian fissure, insula and POF
  Mean  
difference  
(mm)
95%CI mean 
difference  
(mm)
95% limits of 
agreement  
(mm)
Mean 
difference  
(%)
95% limits of 
agreement  
(%)
ICC
Intra-
observer
Sylvian -0.282 -0.563 ; -0.002 -2.298 ; 1.733 -2.8 -22.3 ; 16.8 0.902
Insula 0.229 -0.082 ; 0.540 -2.007 ; 2.465 1.2 -10.9 ; 13.4 0.944
POF 0.070 -0.237 ; 0.377 -2.091 ; 2.232 2.1 -25.2 ; 29.5 0.955
Inter-
observer
Sylvian 0.508 0.127 ; 0.890 -2.176 ; 3.193 5.0 -19.7 ; 29.7 0.846
Insula 0.308 -0.124 ; 0.739 -2.734 ; 3.349 1.9 -14.4 ; 18.2 0.879
POF -0.480 -1.048 ; 0.089 -4.441 ; 3.913 -5.0 -60.0 ; 50.4 0.841
Intra- and inter-observer reliability analyses for all brain fissure depth measurements in a random selection of 30 3D-US. POF, 
parieto-occiptial fissure; ICC, intraclass correlation coefficient; %, percentage. 
Longitudinal analyses
Table 3 shows the results of the crude and multivariate linear mixed models. Trajectories of the left 
insula and right POF were significantly decreased between 22 and 32 weeks GA whereas the growth 
rates (slope) in millimetres per day (CHD*GA) were slightly increased in CHD compared to controls 
(Model 1). Adjustment for periconceptional alcohol consumption, fetal HC and gender did not change 
the estimates considerably (Model 2). In addition, CHD was significantly associated with an increased 
growth rate of the left POF. No significant associations were demonstrated between CHD and the 
trajectories of the left and right Sylvian fissures and the right insula. Figure 2 graphically displays the 
results of the multivariate linear mixed models (Table 3. Model 2). The mean trajectories of the left 
and right POF start smaller in CHD fetuses but due to the significantly increased growth rates cross the 
trajectories of the controls around 24 weeks GA. The same is shown for the left insula around 27 weeks 
GA. Moreover, significantly positive associations were revealed between HC and all brain fissures. 
Male gender was significantly positively associated with the Sylvian fissure and insula depth; although 
in the multivariate model this association only remained significant in trajectories of the left insula.
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Table 3 — Linear mixed models: Associations of CHD in the fetus and longitudinal brain fissure measurements
 Model 1 Model 2
Fissure β 95%CI P β 95%CI P
Sylvian L CHD 1.040 -1.575 ; 3.6456 0.435 0.153 -2.427 ; 2.732 0.907
CHD * GA -0.008 -0.021 ; 0.004 0.198 -0.004 -0.016 ; 0.009 0.575
Gender male 0.420 0.075 ; 0.765 0.017 0.164 -0.127 ; 0.455 0.267
Alcohol 0.136 -0.254 ; 0.525 0.493 0.028 -0.293 ; 0.348 0.865
HC 0.078 0.065 ; 0.090 <0.001 0.076 0.062 ; 0.090 <0.001
Sylvian R CHD -0.422 -3.003 ; 2.158 0.748 -1.270 -3.846 ; 1.307 0.333
CHD * GA 0.001 -0.012 ; 0.013 0.929 0.005 -0.008 ; 0.018 0.446
Gender male 0.393 0.072 ; 0.714 0.017 0.171 -0.105 ; 0.446 0.224
Alcohol 0.099 -0.256 ; 0.454 0.583 0.007 -0.293 ; 0.307 0.964
HC 0.067 0.054 ; 0.079 <0.001 0.063 0.050 ; 0.077 <0.001
Insula L CHD -2.959 -5.601 ; -0.316 0.028 -2.753 -5.375 ; -0.130 0.040
CHD * GA 0.014 0.001 ; 0.028 0.031 0.014 0.001 ; 0.027 0.036
Gender male 0.475 0.236 ; 0.715 <0.001 0.385 0.154 ; 0.616 0.001
Alcohol -0.092 -0.367 ; 0.183 0.509 -0.194 -0.448 ; 0.059 0.132
HC 0.041 0.030 ; 0.053 <0.001 0.036 0.024 ; 0.048 <0.001
Insula R CHD 0.770 -2.217 ; 3.756 0.613 0.977 -2.021 ; 3.976 0.522
CHD * GA -0.006 -0.021 ; 0.008 0.391 -0.007 -0.022 ; 0.008 0.352
Gender male 0.297 0.006 ; 0.588 0.046 0.234 -0.040 ; 0.507 0.094
Alcohol 0.038 -0.281 ; 0.357 0.813 -0.033 -0.330 ; 0.264 0.827
HC 0.052 0.039 ; 0.065 <0.001 0.048  0.034 ; 0.063 <0.001
POF L CHD -2.520 -5.823 ; 0.783 0.134 -2.825 -6.109 ; 0.458 0.091
CHD * GA 0.016 -0.000 ; 0.033 0.051 0.018 0.002 ; 0.034 0.031
Gender male 0.206 -0.173 ; 0.585 0.284 -0.070 -0.439 ; 0.298 0.707
Alcohol 0.181 -0.241 ; 0.603 0.399 0.050 -0.351 ; 0.452 0.805
HC 0.059 0.042 ; 0.076 <0.001 0.057 0.039 ; 0.075 <0.001
POF R CHD -3.529 -6.941 ; -0.117 0.043 -3.762 -7.178 ; -0.346 0.031
CHD * GA 0.022 0.005 ; 0.039 0.010 0.024 0.007 ; 0.041 0.006
Gender male 0.290 -0.133 ; 0.713 0.178 -0.010 -0.414 ; 0.395 0.963
Alcohol 0.095 -0.373 ; 0.562 0.690 0.091 -0.531 ; 0.349 0.683
HC 0.062  0.044 ; 0.081 <0.001 0.058 0.038 ; 0.078 <0.001
Data of the linear mixed models is presented in β values with corresponding 95%CI and p-values. Significant results are in 
bold. Model 1 represents the univariate models investigating all covariates separately and model 2 is the multivariate model 
adjusted for periconception alcohol consumption, fetal gender and HC. β, beta value; 95%CI, ninety-five percent confidence 
interval; P, p-value; L, left; R, right; CHD, congenital heart defect; GA, gestational age; HC, head circumference.
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No significant associations between CHD and pulsatility indices of UA, MCA and CPR were found (UA: 
β= -0.026, 95%CI= -0.105 to 0.053, p= 0.519, MCA: β= 0.006, 95%CI= -0.074 to 0.086, p= 0.876; CPR: 
β= 0.001, 95%CI= -0.-0.126 to 0.128, p= 0.984). Associations between the CPR and trajectories of brain 
fissures were analysed in the same manner (Table 4). These analyses showed significant associations 
between the CPR and the trajectories of the right Sylvian, left insula, right and left POF in controls. No 
significant associations between the CPR and brain fissures were found in CHD cases. 
Table 4 — Associations between the cerebro-placental ratio (CPR) as measure of ‘brain sparing’ and 
longitudinal brain fissure measurements
Controls CHD
Fissures β 95%CI P β 95%CI P
Sylvian L 0.3260 -0.0548 ; 0.7067 0.093 -0.4136 -1.869 ; 1.0418 0.569
Sylv R 0.5937 0.2444 ; 0.9431 0.001 -0.0375 -1.5338 ; 1.4588 0.960
Insula L 0.4293 0.0943 ; 0.7643 0.012 -0.3682 -1.8151 ; 1.0787 0.610
Insula R 0.3577 -0.0031 ; 0.7186 0.052 -0.9370 -3.1205 ; 1.2465 0.391
POF L 0.7265 0.2584 ; 1.1945 0.002 0.2037 -1.7125 ; 2.1199 0.830
POF R 0.8290 0.3426 ; 1.3154 0.001 1.0570 -1.0850 ; 3.1990 0.324
Data is presented in β values with corresponding 95%CI and p-values. Significant results are in bold. β, beta value; 95%CI, 
ninety-five percent confidence interval; P, p-value; L, left; R, right; CHD, congenital heart defect.
DISCUSSION
From this study we conclude that measuring brain fissure depths by 3D-US is reliable for evaluating 
cortical folding. Trajectories of the left insula and right POF in CHD were significantly decreased 
compared to controls whereas their growth rates were slightly increased in both crude and fully 
adjusted models. The delay in cortical folding is in agreement with recent imaging studies [189,191-
194,213-215]. Yet, we are the first to describe the accelerated growth rates of brain fissures in the 
second half of pregnancy. No associations were demonstrated between CHD and the left and right 
Sylvian fissures and the right insula. Most interestingly, the CPR was significantly associated with 
trajectories of cortical folding in controls, but not in CHD. Moreover, HC and male gender were 
positively associated with cortical folding.
Strengths and limitations
Measuring three brain fissures allows conclusions on regional patterns of cortical folding only. The 
reliability of our measurements was good but not excellent and intra- and inter-observer agreement was 
largely comparable with previous studies [200,204,207]. The prevalence of CHD is low and therefore we 
were only able to include a small number of cases. This number was too small to study trajectories of 
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cortical folding in the separate phenotypes. Moreover, residual confounding due to the observational 
study design cannot be excluded. External validity is limited because the study was conducted in a 
tertiary hospital setting. Strengths of our study are the prospective and longitudinal design, providing 
insight in cortical folding as a dynamic process as opposed to a cross-sectional approach [203,216]. 
Using multivariate linear mixed model analyses enabled drawing conclusions without confounding of 
HC, alcohol consumption and gender. In particular, by adjusting for HC we were able to discriminate 
between smaller brain fissures due to the CHD itself and smaller brain fissures due to delayed head 
growth [189,215]. The 3D-US method using standard axial ultrasound planes facilitated simple but 
precise measurements by the reconstruction of orthogonal planes for longitudinal evaluation of brain 
fissures [216-218].
Main findings
This study showed that increased growth rates of brain fissures can co-occur with a delayed trajectory 
[189,191-194,213-215]. This implies a delay in cortical folding, which paradoxically may even result in 
increased fissure depths at the end of pregnancy in CHD (Figure 2). These findings contradict most 
literature except a study by Masoller et al. which showed an increased left insula depth between 36 and 
38 weeks GA in CHD [191,215,219]. Since the precise mechanisms driving this strictly organized process 
of gyrification remain largely unknown, we can only speculate about the origin of these findings. 
Considerable changes in the normal process of cortical folding occur between 25 and 30 weeks GA, 
with the steepest growth around 30 weeks GA, coinciding with white matter development [13]. This 
suggests that the most distinct changes in cortical folding occur during our study period. As decreased 
cortical thickness is inversely related to cortical folding one might argue that cortical thinning may 
lead to deeper brain fissures. Consequently, deeper brain fissures in CHD fetuses do not necessarily 
imply that the cortex is more or better developed. In addition, atypical cortical development has been 
described in infants with Tetralogy of Fallot, with deeper, broader and more simplistic sulcal patterns 
[194]. Nevertheless, the increased growth rates in addition to the delayed regional cortical folding 
emphasize that longitudinal evaluation of cortical folding is recommended. 
The associations between CHD and brain fissures depths appear to be regional and asymmetrical 
which is in line with studies investigating the impact of SGA on cortical folding [206,220]. Our results 
in CHD are substantiated by a MRI study showing significantly decreased depths of the POF and left 
insula among other fissures and another study showing profound morphological differences in the POF 
and Sylvian fissures and other regions [189,191]. The wide variety of measures and methods evaluating 
cortical folding may explain the observed discrepancies in the reported findings [221]. We suggest 
that the susceptibility to adverse prenatal conditions, such as hemodynamic variations, varies among 
different brain regions, since every region of the cortex follows a different developmental timeline 
[196,197,222]. 
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Of interest is the finding that trajectories of cortical folding were significantly associated with CPR 
in controls, but not in CHD. We speculate that besides adaptive hemodynamic mechanisms other 
mechanisms may play a role in the origin of abnormal brain development in CHD [215,223]. An 
explanation may be sought in the simultaneous development of the fetal heart and brain which 
share morphogenetic programs. Moreover, the small derangements in cortical folding without finding 
associations between hemodynamic features of cerebro-placental redistribution in CHD suggest 
that derangements in brain development, can arise as a consequence of subtle undetected prenatal 
hemodynamic derangements [223]. This supports the assumption that normal Doppler indices do not 
guarantee proper cerebral perfusion, metabolism, oxygen delivery and uptake in the brains of CHD 
fetuses [189,215,224].
The associations of delayed cortical folding and CHD were independent of head growth in CHD. 
However, the significant associations between cortical folding and head circumference confirm 
that brain fissure measurements are dependent on head size. Therefore, adjustment for fetal head 
size in future research is recommended. Furthermore, trajectories of cortical folding were also 
positively associated with male gender, which is in agreement with physiology and previous literature 
[198,200,221]. Still, the contribution of gender seems rather small as these associations attenuate to 
non-significant after full adjustment.
Future implications
Our results suggest that fetal CHD impact prenatal brain development. However, whether the small 
regional derangements in trajectories of cortical folding have implications for neurodevelopmental 
outcome needs to be studied further in larger prenatal cohorts with postnatal neurodevelopmental 
follow-up. Such studies may elucidate whether the clinical type of CHD is an independent predictor of 
the level of impact on cortical folding [215,225]. Therefore, future prenatal care should focus on the 
assessment of the dynamic process of prenatal neurodevelopment in CHD as pre-operative neurologic 
conditions are an important determinant of neurodevelopmental outcome [226].
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ABSTRACT
Background — Preterm infants are at risk for neurodevelopmental impairment, but reliable, bedside-
available markers to monitor preterm brain growth during hospital stay are still lacking. The aim of this 
study was to assess the feasibility of corpus callosum fastigium (CCF) length as a new cranial ultrasound 
(CUS) marker for monitoring of preterm brain growth.
Methods — In this longitudinal prospective cohort study, CUS was planned on day of birth, day 1, 2, 
3 and 7 of life, and then weekly until discharge in preterm infants born before 29 weeks of gestation. 
Reproducibility and associations between clinical variables and CCF growth trajectories were studied. 
Results — One to eight CUS were performed in 140 infants (median gestational age at birth 27+2 weeks 
(interquartile range 26+1-28+1), 57.9% male infants). CCF measurements showed good to excellent 
agreement for inter- and intra-observer reproducibility (intraclass correlation coefficients>0.89). 
Growth charts for preterm infants between 24-32 weeks of gestation were composed. Male gender 
and birth weight SD score were positively associated with CCF growth rate. 
 
Conclusions — CCF length measurement is a new reproducible marker that is applicable for bedside 
monitoring of preterm brain growth during neonatal intensive care stay.
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INTRODUCTION
Brain growth is an important predictor of neurodevelopmental outcome in preterm infants [28,227-
229]. In neonatal intensive care units (NICU) brain growth is usually monitored by manual measurement 
of the head circumference (HC). However, HC measurement has a low interrater agreement and does 
not correspond well with actual brain development [230,231]. Therefore, there is a need for a new 
reliable bedside marker for monitoring preterm brain growth in clinical practice.
Brain structures measured by cranial ultrasonography (CUS) could provide clinically applicable markers 
for brain growth. A few ultrasound markers of brain growth have been used in the past, mainly 
measuring the corpus callosum (CC) or cerebellum, thereby reflecting growth of a small part of the 
brain only [163,232-235]. In addition to currently available markers of preterm brain development, we 
propose that the length between genu of the CC and the fastigium (roof of the fourth ventricle) could 
serve as a new marker for brain growth.
The aim of this study was to evaluate the usefulness of corpus callosum – fastigium (CCF) length, and 
that of CC length, an existing marker, as markers for monitoring of brain growth in preterm infants 
during NICU stay. We assessed the reproducibility of CC and CCF length measurements, developed 
growth charts for preterm infants between 24-32 weeks of gestation, and evaluated prenatal and 
postnatal characteristics possibly associated with CC and CCF growth trajectories. We hypothesize that 
both measurements are highly reproducible. Furthermore, we hypothesize that CCF and CC growth 
trajectories are associated with prenatal and postnatal determinants of neurodevelopmental outcome 
in preterm infants.
MATERIALS AND METHODS
This prospective observational cohort study was performed at the level III NICU of the Sophia Children’s 
Hospital, Erasmus MC, Rotterdam, the Netherlands. The local medical ethics review board approved 
this study. Written parental consent was obtained before participation. Between 2010 and 2012, all 
newly admitted singleton, preterm infants born before 29 weeks of gestational age (GA) were eligible 
for enrolment. The following exclusion criteria were applied; (1) unknown GA at birth; (2) major 
congenital abnormalities and (3) extensive brain injury (including IVH grade III, post haemorrhagic 
ventricular dilatation and venous infarction). The latter complications are expected to influence the 
validity of the measurements due to possible midline shift and expected altered brain growth. GA 
at birth was dated using the first day of last menstrual period and was confirmed by first trimester 
crown rump length measurement on ultrasound. Postnatal age was expressed by post menstrual age, 
calculated as GA at birth + weeks and days of postnatal age. Pregnancy and neonatal characteristics 
were collected prospectively. Maternal characteristics were collected retrospectively from medical 
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records. Pregnancy complications, including intra-uterine growth retardation, pre-eclampsia and 
HELLP syndrome, are obtained from obstetrical records and are defined based on clinical definitions 
according to national guidelines [236].
Cranial ultrasound and measurements
CUS was performed according to the standard local protocol on the day of birth, on day 1, 2, 3 and 
7 of life and then weekly until discharge. The protocol was only violated on clinical grounds (e.g. 
hemodynamic instability). One researcher (MR) performed all CUS using an Esaote MyLab 70 (Genoa, 
Italy), with a convex neonatal probe (7,5 MHz). Measurements were performed off line using Mylab 
software of Esaote. Measurements of CC and CCF length were performed on a standard sagittal plane. 
In this plane a complete corpus callosum (genu to splenium) and distinct vermis of the cerebellum, 
including the fastigium, had to be visualized. CCF length was measured from the genu of the corpus 
callosum (outer border) to the fastigium. CC length was measured from outer to outer border (genu 
to splenium, Figure 1). All measurements were performed by one investigator (MR). To establish 
the reliability, 30 randomly selected scans of varying quality and of infants with different GA were 
measured by a second investigator (JR) who was blinded for previous results.
Figure 1 — An ultrasound and schematic image of the corpus callosum and corpus callosum-fastigium length 
measurements
S. Cinguli
CC Length
CCF Length
In the upper part, we show the coronal view of the brain and the position of the sonography probe for assessment of the 
corresponding correct sagittal plane below. Measurements of the corpus callosum-fastigium and corpus callosum length are 
displayed in the sagittal sonography view (left) and schematically (right). S. Cinguli indicates sulcus cinguli.
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Statistical methods
Data were analysed using SPSS (SPSS release 21 for Windows, IBM, USA) and R (R: A language and 
Environment for Statistical Computing, version 3.1.3 2015 for Windows, R Core Team, Vienna, Austria). 
P-values below 0.05 were considered statistically significant. Median value and (inter quartile) range 
((IQ)R) and mean and standard deviations (SD) were used as appropriate.
Intra-observer and inter-observer agreements for CC and CCF lengths were evaluated using intraclass 
correlation coefficient (ICC) and Bland-Altman plots [237]. ICC was analysed using a two-way mixed 
model. Cut-off values were in accordance to Landis et al. [238]. Growth charts were developed for CCF 
and CC growth as a function of post menstrual age (weeks) and weight (gram). To model the relation 
between the measured CCF and CC lengths and a predefined list of covariates linear mixed models 
were estimated using lme (in the R nlme package) [239]. To account for the within-subject correlation 
a random intercept and random coefficient of GA as well as a power variance function to model 
the residual covariance have been used. The predefined covariates were GA at birth, birth weight 
(BW) standard deviation score (SDS), gender, intra-uterine growth retardation (defined as expected 
fetal weight <p10), pre-eclampsia/HELLP, chorioamnionitis, death, sepsis and days on mechanical 
ventilation. In all models both GA and GA2 (square of GA) were used as covariates. To this basic model 
the additional predictors were added separately (termed univariable models below) and also all at 
once (the multivariable model). 
Figure 2 — Reproducibility analyses
Figure 2 shows the Bland Altman plots of the intra- and inter-observer reliability.
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RESULTS
Of 336 infants admitted to our NICU during the study period, 152 were eligible for inclusion. Twelve 
infants were excluded as they met the exclusion criterion of extensive brain injury, resulting in a 
sample size of 140 infants. Baseline maternal and neonatal characteristics are listed in Table I. The 
median gestational age at birth was 27+2 weeks (IQR 26+1-28+1), the median birth weight was 955 (IQR 
780-1125) gram. The number of ultrasound scans per infants ranged from one to eight. 
Table 1 — Baseline characteristics
n= 140 Missingb
Maternal characteristics
Maternal age, years (mean) (SD) 30 (5.6) 0
Ethnicity  0
 Dutch 74 (52.9%)  
 Other Western 9 (6.4%)  
 Non-western 57 (40.7%)  
Maternal smoking during pregnancy 26 (18.6%) 17
IVF/ICSI 9 (6.4%) 0
IUGR 42 (30%) 4
PE/ HELLP syndrome 37 (26.4%) 0
Chorioamnionitis 37 (26.4%) 0
PPROM 32 (22.9%) 0
Neonatal characteristics
GA at birth, weeks + days  27+2 (26+1 -28+1) 0
Male gender 81 (57.9%) 0
Birth weight, gram 955 (780-1125) 0
Use of antenatal steroids 127 (90.7%) 2
Apgar score at 5’ minutes 8 (7-9) 0
CRIB score 3 (1-6) 1
Death 17 (12.1%) 0
Days on mechanical ventilation 5 (1-14) 3
Days to regain birth weight 9 (7-12) 14
Sepsis 67 (47.9%) 0
IVH grade I or II 32 (22.9%) 0
Severe BPD 15 10.7%) 33
Baseline maternal and neonatal characteristics are presented as median (interquartile range) or n (%) unless otherwise specified. 
IVF/ICSI, in vitro fertilization with or without intra-cytoplasmic sperm injection; IUGR, intra-uterine growth retardation; PE, 
pre-eclampsia; PPROM, prolonged premature rupture of membranes; CRIB, clinical risk index for babies; IVH, intra-ventricular 
haemorrhage; BPD, bronchopulmonary disease. b Missing data was mainly due to early transfer to a secondary hospital. 
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The mean inter-observer difference was -0.3207 (SD 1.4527) mm for CCF (p= 0.244) and 0.4600 (SD 
1.8463) mm for CC length (p= 0.183). The ICCs for inter-observer and intra-observer analysis showed 
excellent agreement for both CCF and CC length (respectively intra: 0.958 (95%CI 0.912-0.980), inter: 
0.885 (95%CI 0.770-0.944) and intra: 0.922 (95%CI 0.844-0.962) and inter: 0.893 (95%CI 0.783-
0.948)). Figure 2 shows Bland-Altman plots of inter-observer and intra-observer agreements for both 
measurements.
The CC and CCF measurements
The mean CCF length was 40.9 (SD 2.97) mm, with a range from 34.0 to 54.3 mm. The mean CC length 
was 36.3 (SD 3.33) mm, with a range from 26.6 to 48.8 mm. Growth charts of CCF and CC lengths by 
post menstrual age and by weight are shown in Figure 3. Results of univariable analyses are shown in 
Table II for CC and CCF growth. The multivariable analysis confirmed a positive association between 
BW SDS and CCF growth rate, and a negative association between female gender and CCF growth rate. 
For CC growth rate, a positive association was found with BW SDS using multivariable analysis.
Figure 3 — Reference curves of CC and CCF length as a function of post menstrual age and weight
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DISCUSSION
In this report we demonstrated that CCF length, measured using CUS, is a reproducible and feasible 
marker that could serve as a new bedside tool to monitor preterm infants’ brain growth during NICU 
stay. We provided growth charts of CCF and CC length for preterm infants, from 24 to 32 weeks post 
menstrual age. We identified that a higher BW SDS results in increased CCF and CC growth rate during 
hospital stay, while female infants have a slower CCF growth compared to male infants. 
Previous ultrasound studies have evaluated only a limited number of brain structures as potential 
markers for brain growth or predictors for neurodevelopmental outcome in preterm infants [163,232-
234]. One explanation for this is the fact that the brain has few easily recognizable and consistent 
landmarks for reliable measurements on CUS. The CC, a flat bundle of white matter, that connects the 
left and right hemispheres, is one of the brain structures that are easily visualized and recognizable on 
CUS [240]. Prematurity is known to affect CC development, by the early transition from intra-uterine 
to extra-uterine life and by postnatal stress and injury [241], leading to both structural and functional 
impairment [242,243]. Associations have been found between length and thickness of the CC and 
brain volumes and neurodevelopmental outcome [235,244,245]. Further studies should elucidate if 
CC length can be considered a proxy of telencephalon development, creating an impression of white 
matter development and brain maturation. The advantages of using CCF length in the monitoring 
of brain growth rely on anatomic and practical issues. CCF length may be considered a marker of 
diencephalon and mesencephalon development and vermis growth. The diencephalon includes the 
thalamus, a neural relay centre crucial for adequate cognitive function [246]. Altered development 
of the thalamus, and thus of the diencephalon, may lead to adverse neurodevelopmental outcome. 
Several studies showed impaired thalamus volume and extreme vulnerability of the thalamus to 
neonatal risk factors after preterm birth [247,248]. Whether thalamic injury or growth impairment 
directly influences CCF length needs to be further studied. 
One of the other advantages of CCF length measurement is the use of CUS instead of MRI or HC 
measurement. In Table 3 the pros and contras of every method are depicted. Although volumetric 
MRI is increasingly used for growth assessment of the preterm brain, its use for serial assessment is 
still very limited [228]. HC measurement has a low interrater agreement, limited association with long-
term outcome and it does not measure actual brain growth, but also growth of the skull and of the 
subarachnoid spaces, which are frequently enlarged in preterm infants [230,231,249]. Measurement 
of CCF length is not considered a burden compared to HC measurement as it can be performed on 
routine CUS, which are often recommended to perform weekly in preterm infants [250]. Both CCF 
length and CC length can already be measured prenatally, as the CC and the fastigium are already 
visible on ultrasound around 18 weeks of gestation, allowing to use the same marker prenatally and 
postnatally for monitoring of brain growth [251].
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Table 3 — Pros and contras of different methods for assessment of brain growth
HC CUS MRI
Patient friendly
Bedside available
Serial measurement possible
Fast measurement
Reproducible
Reflecting actual brain growth
Low costs
Dimension
++
++
++
++
+-
-
++
1D
++
++
++
+
+
+
+
2D
-
-
-
-
++
++
-
3D
++= very good; += acceptable; -= bad agreement with the corresponding item. HC, head circumference; CUS, cranial ultrasound.
In accordance with previous studies, we showed satisfactory reproducibility for CC length [232]. CCF 
reproducibility was excellent too, suggesting that both measurements are feasible for longitudinal 
evaluation of brain growth. Increasing lengths with increasing ages and weights, as shown in the 
growth charts, support the use of these markers in clinical practice.
We observed a non-linear growth pattern for CC and CCF length. Previous studies found an intra-
uterine constant growth rate of 0.20-0.22mm/day of the CC [252,253]. Also in preterm infants a 
constant, though slower, growth rate was observed [232]. In contrast to previous studies, we performed 
longitudinal measurements (1-8 scans per infant), allowing for a more reliable estimation of CC growth. 
Other brain structures, such as the vermis of the cerebellum, show a non-linear growth pattern as well 
[233]. As we are the first to evaluate the use of CCF length, no literature is available for comparison. We 
did expect a non-linear growth pattern, based on current literature. 
In Figure 3 parts of the weight charts are coloured grey, as we would advise not to use these parts of 
the curves as a reference curve. We chose to analyse and present the complete original data of infants 
with a post menstrual age between 24-32 weeks and not to select ideal reference cases. The drawback 
is seen in in the upper part of the weight charts; the curves appear to go down above 1400 gram and, 
despite the very small numbers, the confidence interval narrows. This, of course, does not reflect 
an incline of brain size, but rather selection and censoring. These data are not “first measurements” 
(reflecting intrauterine accomplished growth), but are follow-up data of patients with prolonged NICU 
admission, representing the most complex cases, e.g. with severe chronic lung disease, that were not 
stable enough to be discharged early. In conclusion, we state that the last part of this curve depicts 
valid data you would expect in a NICU population but we consider these not representative for normal 
growth in preterm infants.
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The decreased growth rate of CCF length in female infants is in accordance with previous studies, 
which identified gender differences in brain structures and neurodevelopmental outcome [254,255]. 
The positive association between BW SDS and CCF and CC growth rate is also in accordance with 
current literature [256].
One investigator who was trained in visualizing a standard sagittal plane performed all scans. This likely 
improved the quality of the scans and may have enhanced the reproducibility. We realize therefore 
that the clinical applicability is probably overestimated in our cohort. Reliable measurements and 
a correct sagittal plane using CUS depend on the experience of the observer but are easy to learn. 
Recently developed software to identify the sagittal plane automatically may further increase the 
reproducibility and clinical applicability [257].
This study has some limitations. First of all, in the Netherlands preterm infants are transferred to 
a secondary hospital relatively early, accounting for very few data in our cohort of infants born at 
29 weeks of gestation and limited data of infants after 30 weeks of gestation. Although white matter 
injury is already visible on scans after a few days, brain atrophy is often only noticeable after weeks 
to months [258]. Our short follow up time could explain why we did not find an association between 
expected clinical variables, such as sepsis and days on mechanical ventilation, and CCF or CC growth 
rate. Second, including all scans between 24-32 weeks PMA may have influenced the reliability of the 
growth charts; it is a common finding that preterm infants lose weight after birth and start to grow 
days later. Brain growth may be limited before regain of birth weight (usually after 10 days). This may 
have increased variation in CC and CCF lengths. Extremely preterm and clinically unstable infants have 
a longer NICU stay and are likely to receive more CUS. This might have biased our growth charts. On 
the other hand, our data reflect clinical practice in a neonatal intensive care setting.
In future studies it would be interesting to compare fetal and preterm CCF growth. Currently, we are 
scanning fetuses in the second and third trimester of pregnancy to develop reference curves for fetal 
brain growth, which could also serve as an ideal growth curve for preterm infants. We were not able 
yet to assess the association between feeding regimens and growth during NICU stay and CCF growth 
trajectories. This is of interest as it may have clinical implications for nutritional practices. Moreover, 
CCF length can possibly be used as an outcome measure in nutritional, and other, intervention studies. 
It would be of main interest to assess whether CCF length, possibly combined with other available 
markers of brain growth such as CC length, could serve as predictor for neurodevelopmental outcome. 
The clinical applicability may extend beyond the NICU stay into the outpatient follow-up period as the 
anterior fontanelle can be used as an acoustic window until approximately 6 months in most infants. 
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CONCLUSION
There is a lack of bedside markers for brain growth in preterm infants during NICU stay. We propose 
a feasible, new ultrasound measurement entitled ‘corpus callosum – fastigium length’ with high 
reproducibility for monitoring of brain growth in preterm infants during hospital stay. This marker 
may help clinicians to determine if preterm infants show adequate postnatal brain growth and may 
eventually be used as outcome measure in nutritional and other intervention studies. Further research 
is warranted to assess whether this marker could also serve as an early predictor for short-term and 
long-term neurodevelopmental outcome.
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ABSTRACT 
Background — Most ultrasound markers for monitoring brain growth can only be used in either the 
prenatal or the postnatal period. We investigated whether corpus callosum (CC) length and corpus 
callosum-fastigium (CCF) length could be used as markers for both prenatal and postnatal brain growth.
Methods — In the setting of a prospective cohort, we performed a three-dimensional ultrasound study 
in fetuses with fetal growth retardation (FGR), fetuses with congenital heart defects (CHD) and controls 
at 22, 26 and 32 weeks gestational age (GA). Postnatally, cranial ultrasound was performed at 42 weeks 
GA. CC and CCF measurements were performed offline and reliability was evaluated. Associations 
between prenatal and postnatal CC and CCF length were investigated. We created reference curves 
and compared growth trajectories of CC and CCF length of controls with those of fetuses with FGR and 
CHD.
Results — We included 199 fetuses; 22 FGR fetuses, 20 CHD fetuses and 157 controls. Reliability of 
both measurements was excellent (ICC≥0.97). CC growth trajectories were significantly decreased in 
FGR and CHD (β= -2.295, 95%CI= -3.320 ; -1.270, p<0.01; β= -1.267, 95%CI= -0.972 ; -0.562, p<0.01 
respectively). CCF growth was decreased in FGR fetuses (β= -1.295, 95%CI= -2.595 ; 0.003, p= 0.05).
Conclusions — CC and CCF length may serve as reliable markers for monitoring brain growth from the 
prenatal to the postnatal period. Clinical applicability of these markers for monitoring brain growth 
was established by the significantly different CC and CCF growth trajectories in fetuses at risk for 
abnormal brain growth compared to controls.
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INTRODUCTION 
In preterm and small-for-gestational age (SGA) infants, brain growth is an important predictor for long-
term neurodevelopmental outcome [28,227-229]. Although prenatal growth often predicts postnatal 
growth [98], there is a traditional division between fetal and neonatal growth charts. This is probably 
due to the lack of consistent measures of brain growth which can be used in both the prenatal and 
postnatal period.
Markers of brain growth that can theoretically be used in both the prenatal and postnatal period 
include head circumference (HC) and some ultrasound (US) or MRI measures. HC measured postnatally 
however, lacks precision and does not correspond well with neurodevelopmental outcome [230,231]. 
Prenatal and postnatal US markers are largely based on individual brain structures, only reflecting on 
growth of a specific part of the brain [163,232-235]. Moreover, these brain structures are not measured 
consistently during the prenatal and postnatal period due to the discrepancy between standard US 
planes. Although MRI provides more precise measures of brain growth, volume and development, this 
technique is expensive and therefore not suitable for serial measurements.
Recently, we demonstrated that corpus callosum-fastigium length (CCF) is a reliable bedside-available 
US marker that can be used to monitor brain growth during NICU stay in preterm infants [259]. CCF 
length is considered a composite marker of both diencephalon and mesencephalon size and adds 
information to the more widely used corpus callosum (CC) length [259]. We hypothesized that these 
two postnatal cranial ultrasound (CUS) markers are feasible to use during second and third trimester 
US examinations. Thereby, these markers would provide a continuum for monitoring brain growth 
bridging the period before and after birth.
Our main aim is to investigate whether CC and CCF length can be used as reliable US markers for 
monitoring both fetal and neonatal brain growth. First, we assessed the reliability of the measurements. 
Second, we created reference curves from 22 weeks to 42 weeks gestational age (GA) by combining 
fetal and neonatal measurements. Finally, as a first step to establish the clinical applicability of these 
US markers, we investigated CC and CCF growth trajectories in fetuses at risk for abnormal brain 
growth compared to controls. 
METHODS
Study design and populations
This three-dimensional (3D) US study was conducted in the setting of the Rotterdam Periconceptional 
Cohort (Predict study); an ongoing prospective cohort study at the Department of Obstetrics and 
Gynaecology, Erasmus MC University Medical Center, Rotterdam, the Netherlands [24]. At enrolment, 
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all participating women and their partners gave written informed consent on behalf of themselves and 
their unborn child. This study was approved by the regional Medical Ethical and Institutional Review 
Board of the Erasmus MC, University Medical Center in Rotterdam approved the study (MEC 2004-227, 
date of approval 25-01-2013). 
Pregnant women enrolled between November 2013 and July 2015. They were either enrolled before 
12 weeks GA or between 22 and 32 weeks GA. Controls enrolled before 12 weeks GA and were defined 
as fetuses without FGR before 32 weeks GA, who were born after 37 weeks GA and without congenital 
malformations. The cases included those pregnancies referred to our outpatient clinic with fetal 
growth restriction (FGR) or isolated fetal congenital heart defect (CHD). Diagnosis was confirmed by an 
extended structural US examination at our hospital. FGR was defined as abdominal circumference (AC) 
or estimated fetal weight (EFW) percentile of less than 5 according to Hadlock [260]. For this analysis 
we excluded pregnancies ending in intra-uterine death, termination of pregnancy or preterm birth. We 
also excluded fetuses with congenital anomalies other than CHD, trisomy 21 and without US images.
Study parameters
According to Dutch clinical practice, GA in spontaneously conceived pregnancies was calculated based 
on first trimester crown-rump length (CRL) measurements before 13 weeks GA [133]. In pregnancies 
conceived through in vitro fertilization (IVF), with or without intra-cytoplasmic sperm injection (ICSI) 
procedures, GA was calculated from the date of oocyte retrieval plus 14 days or from the day of 
embryo transfer plus 17 or 18 days after cryopreserved embryo transfer, depending on the number of 
days between oocyte retrieval and cryopreservation. 
Data were collected on maternal characteristics, medical and obstetrical history, pregnancy course 
and neonatal outcome from self-administered questionnaires in the first trimester, second trimester 
and around delivery. Follow-up data on pregnancy outcomes were validated based on US report of the 
routine second trimester anomaly scan and on the obstetric medical records.
Prenatal ultrasound
Prenatal 3D US examinations were performed on the Voluson E8 system (GE Medical Systems, Zipf, 
Australia) using a 1-7 MHz transabdominal transducer or a 6-12 MHz or MHz transvaginal transducer. 
Primarily, we used an abdominal approach, but a transvaginal approach was considered when the 
fetus was in head-down presentation. Serial prenatal 3D-US examinations and measurements were 
performed at 22, 26 and 32 weeks of gestation by one certified sonographer (IVK). Standard biometry 
was measured including bi-parietal diameter (BPD), HC, AC and femur length. An estimation of fetal 
weight was calculated using the Hadlock equation [260]. Biometry was followed by detailed 3D-US 
neuro-sonography. The mid-sagittal plane and two bilateral parasagittal oblique planes were obtained 
according to ISUOG guidelines [209]. CC and CCF length measurements were performed offline in an 
exact mid-sagittal plane (Figure 1). CC length is measured from genu to splenium, outer-outer border 
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and CCF length represents the length between the genu of the CC and the fastigium (roof of the fourth 
ventricle) [259]. CCF length was only measured in images in which the CC measurement was successful. 
Manipulation of the 3D-US volume to ensure an exact mid-sagittal plane for the measurements was 
performed in 4D View Version 5.0 (GE Medical Systems).
Figure 1 – CC and CCF length measured on three-dimensional ultrasound
Prenatal measurements of Corpus callosum length (1) and Corpus callosum – Fastigium length (2). Image with permission.
Postnatal assessments
After birth, CUS was planned between 42+0 to 42+6 weeks postmenstrual age, independent of GA at 
birth. CUS were performed by an experienced team of researchers using an Esaote MyLab 70 (Genoa, 
Italy) with a convex neonatal probe (7.5 MHz). CC and CCF length were performed offline by one 
researcher (JR) according to the method described above, using MyLab software of Esaote.  
 
To enhance precision, all prenatal and postnatal measurements were repeated three times. The mean 
values were used in the statistical analyses.
Statistical analysis
For data analyses we used SPSS (SPSS release 21 for Windows, IBM, United States of America) and R 
(R: A language and Environment for Statistical Computing, version 3.1.3, 2015 for Windows, R Core 
Team, Vienna, Austria). Results with p-values ≤0.05 were considered statistically significant.
Previously, we demonstrated that postnatal measurements of CC and CCF length had good intra- and 
inter-observer agreement [259]. To evaluate reliability and reproducibility of prenatal measurements, 
we randomly selected 30 US examinations of 30 different fetuses from the whole study population 
divided over the three prenatal time points. CC and CCF measurements were then performed in 
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threefold by two independent observers (1) IVK and 2) JAR). Reliability analyses for intra- and inter-
observer reliability were performed, calculating the mean differences with 95%CIs and intraclass 
correlation coefficients (ICC). Moreover, the extent of agreement was examined with the Bland-Altman 
method.
Generalized Additive Models for Location and Scale were used to create reference ranges of CC and 
CCF measurements between 22 and 42 weeks GA in controls [177]. To investigate whether cases 
are associated with deviations in CC and CCF growth, we created growth trajectories of the serial 
measurements of CC and CCF length between 22 and 42 weeks GA. A maximum likelihood approach 
was used to test whether polynomials of GA contributed to the best model fit. In the same manner, 
we tested the contribution of random and fixed effects of the intercept and slopes for all included 
polynomials. A quadratic model of GA with random intercept and slopes was designated as the best 
model. We placed the origin of the GA scale at 140 days GA. In this model was used the variable 
indicating whether a fetus was FGR, CHD or control as the covariate of interest (Model 1). Finally, the 
final model (Model 2) was adjusted for serial measurements of fetal weight and gender as potential 
confounders.
RESULTS
In total 227 pregnant women were enrolled prenatally. After excluding pregnancies ending in intra-
uterine fetal death (1), termination of pregnancy (1), preterm birth (14), congenital anomalies other 
than CHD (4), trisomy 21 (2) and withdrawals (6), the study population consisted of 199 pregnancies. Of 
those 199 fetuses, 22 fetuses were FGR, 20 had CHD and 157 were controls. The general characteristics 
of the study populations including 157 controls, 22 FGR and 20 CHD infants are listed in Table 1.
Success rates and reliability analyses
Of 542 prenatal 3D US scans 377 contained a high quality mid-sagittal plane eligible for CC and CCF 
measurements. Means and success rates of CC and CCF measurements per gestational age are listed 
in Table 2. Success rates of prenatal CC and CCF measurements ranged between 61 and 75% and 
between 59 to 72%, respectively. Postnatally, CC and CCF measurements were successful in 97%. In 
83% of the subjects CC length was measured at least at two time points during the whole study period 
and CCF length in 65%. The intra- and inter-observer reliability and agreement are shown in Table 3. CC 
lengths measured by observer 1 were slightly smaller (mean difference= -1.109mm, mean percentage 
difference= -3.4%) than those measured by observer 2. Ninety-five percent limits of agreement for all 
measurements represent excellent agreement when the CC and CCF measurements were repeated 
by the same observer and good agreement when repeated by a second observer. ICC values of both 
intra- and inter-observer were ≥0.97, which represents excellent reliability.  
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Table 1 — General characteristics
Characteristics Controls  
(n= 157 )
FGR  
(n= 22)
CHD  
(n= 20)
Missing
Maternal
Age at enrolment, years 32.3 (21-44) 29.7 (21-41) 33.0 (22-48) 7
Nulliparous 69 (44) 13 (68) 11 (58) 6
Mode of Conception (IVF/ICSI) 48 (31) 2 (10) 2 (11) 3
Geographical background 6
 Western other 126 (81) 15 (79) 18 (90)
 Non-western 29 (19) 4 (21) 2 (10)
Educational level 8
 Low 20 (13) 4 (20) 0
 Intermediate 56 (36) 12 (60) 7 (39)
 High 79 (51) 4 (20) 11 (61)
Pre-pregnancy BMI, kg/m2 22.9 (15.2-39.7) 22.9 (17.6-43.4) 23.4 (18.0-35.8) 19
Periconception folic acid initiation (yes) 149 (96) 15 (79) 18 (95) 6
Periconcepion smoking (yes) 25 (16) 3 (16) 3 (16) 8
Periconception alcohol consumption (yes) 44 (29) 4 (21) 10 (53) 9
Neonatal
Birth weight, grams 3345 (2035-4380) 1400 (400-2900) 3420 (1650-4140) 2
Gestational age at birth, days 274 (259-292) 240 (185-276) 274 (200-292) 2
Gender, male 82 (52) 11 (50) 13 (65) 0
Data are presented as median and range or number (n) and percentage (%). BMI, body mass index; IVF/ICSI, in vitro fertilization 
with or without intra-cytoplasmic sperm injection; Missing data was due to incomplete questionnaires.
Table 2 — Intra-observer and inter-observer reproducibility for prenatal measurements of the corpus 
callosum and corpus callosum fastigium length
Mean 
difference 
(mm)
95%CI mean 
difference  
(mm)
95% limits of 
agreement  
(mm)
p-value Mean 
difference 
(%)
95% limits of 
agreement 
(%)
ICC
Intra observer CC 0.011 -0.228 ; 0.250 -1.373 ; 1.396 0.923 0.1 -4.1 ; 4.3 >0.99
CCF 0.180 -0.157 ; 0.517 -1.711 ; 2.071 0.284 0.4 -4.7 ; 5.4 >0.99
Inter observer CC -1.109 -1.702 ; -0.515 -4.546 ; 2.329 0.001 -3.4 -14.9 ; 8.1 0.97
CCF -0.125 -0.741 ; 0.492 -3.589 ; 3.340 0.684 -0.4 -9.5 ; 8.6 0.97
Intra- and inter-observer reliability analyses for prenatal CC and CCF measurements in a random selection of thirty 3D-US. 
CC, Corpus Callosum length; CCF, Corpus Callosum – Fastigium length; mm, millimetres; 95%CI, ninety-five percent confidence 
interval; %, percentage; ICC, intraclass correlation coefficient.
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Table 3 — Linear mixed models: Growth trajectories of CC and CCF influenced by fetal growth restriction and 
congenital heart defects compared to controls
Model 1 Model 2
β 95%CI p-value β 95%CI p-value
CC FGR -2.384 -3.262 ; -1.505 <0.01 -2.295 -3.320 ; -1.270 <0.01
CHD -1.252 -1.954 ; -0.549 <0.01 -1.267 -1.972 ; -0.562 <0.01
CCF FGR -1.413 -2.500 ; -0.326 0.01 -1.295 -2.595 ; 0.003 0.05
CHD  0.012 -0.829 ; 0.963 0.98 0.000 -0.835 ; 0.835 0.99
Data is presented in β values with corresponding 95%CI and p-values. Significant results are in bold. Model 1 represents the 
crude model using GA and its polynomials as predictor and type of case as covariate of interest. Model 2 is the fully adjusted 
model adjusted for serial measurements of fetal weight and gender. β, beta value; 95%CI, ninety-five percent confidence 
interval.
Linear mixed model analyses
In Figure 2A the reference curves and individual growth trajectories of the CC and CCF measurements 
are shown. The results of the linear mixed models estimating differences in the mean growth 
trajectories of CC and CCF length between controls, fetuses with FGR and CHD are shown in Table 
4. Growth trajectories of CC length are significantly decreased in FGR and CHD fetuses compared to 
those of controls. CCF growth trajectories were only significantly decreased in FGR fetuses compared 
to those of controls. In Figure 2C this is graphically displayed.
DISCUSSION 
Here, we demonstrate that CCF and CC length are reliable markers for monitoring pre- and postnatal 
brain growth. By combining fetal and neonatal measurements in one reference chart we created a 
practical US tool to bridge the gap between the fetal and neonatal period when monitoring brain 
growth. FGR fetuses showed decreased growth of both CC and CCF while CHD showed only decreased 
CC growth between 22 and 42 weeks GA.
Our results show that we are able to bridge the traditional division between fetal and neonatal US 
growth charts. To date, studies that combine fetal and neonatal US markers of brain growth in a single 
cohort are scarce. One explanation for this can be that standard prenatal US planes containing easily 
recognizable landmarks of the brain do not correspond well to the standardized planes accessible 
by CUS. This results in differences in prenatal and postnatal measures and measuring methods. 
For example, HC assessed prenatally, calculated from the bi-parietal diameter and occipital frontal 
diameter, correlates poorly to direct postnatal measurement using tape [231,261]. This difference is 
further amplified by changes in head shape, e.g. due to skull moulding, oedematous swelling and 
hematoma’s. 
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Figure 2 — Reference curves and growth trajectories of transcerebellar diameter from 9 until 32 weeks 
gestational age
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In contrast to other markers, we showed excellent reliability for prenatal measurements which is 
comparable to the postnatal findings [259]. Based our data we suggest that CCF length is the most 
reliable and relevant measure for monitoring brain growth. Compared to CC length, CCF length is 
assumed to be a composite marker of brain structures with different embryological origins including 
the diencephalon and mesencephalon. Therefore CCF length may be a better representative of global 
brain growth than previous sonographic markers based on individual brain structures [163,232-235].
Growth trajectories of CC and CCF were decreased in fetuses at risk for abnormal brain growth and 
long-term neurodevelopment. While CCF length has not been published in literature before, the 
CC findings are in line with previous literature. The decreased CC growth trajectories in FGR are in 
accordance with findings of a recent MRI study which showed significantly reduced CC length in FGR 
fetuses compared to appropriate-for-gestational-age controls [262]. Results from our previous study 
in preterm infants demonstrated a similar association between CCF length and birth weight SD-score 
[259]. There are, to the best of our knowledge, no publications on CC length in CHD fetuses to compare 
our results with, although previous studies did report anomalies of the CC and reduction of CC volume 
in CHD children [263,264]. The decreased growth trajectory of CC length in CHD fetuses is, however, 
supported by accumulating evidence reporting that CHD fetuses are at risk for abnormal brain growth 
and development [26,189,265,266]. However to our knowledge there are no publications on CC length 
in CHD fetuses to compare our results with.
Brain growth is an important predictor for long-term neurodevelopment [9,227,229]. Therefore, 
we hypothesize that decreased CC and CCF growth in cases may have consequences for 
neurodevelopmental outcome. In preterm infants, a shorter CC length is related to a higher risk 
for adverse neurodevelopmental outcome at 2 years corrected age [28]. Moreover, a significantly 
smaller corpus callosum was found in individuals with schizophrenia and autism [267,268]. CCF length 
represents diencephalon and includes thalamus development which is crucial for normal cognitive 
functioning. Derangements in thalamus development are associated with adverse neurodevelopmental 
outcome [246]. Yet, the clinical relevance of the differences in CC and CCF growth trajectories for 
neurodevelopmental outcome needs further investigation.
Clinical applicability
Landmarks for CC and CCF measurements are relatively easy to distinguish on US images. Prenatally, 
the main challenge is obtaining an exact mid-sagittal US plane. Predominantly, prenatal success 
rates are influenced by both acoustic shadowing and fetal position. 3D US can enhance precision by 
manipulating volumes to reconstruct the exact mid-sagittal plane [216-218]. When a mid-sagittal plane 
is obtained, both measurements take less than 1 minute in experienced hands. Postnatally, a standard 
mid-sagittal plane is easy to obtain, and the offline measurement of both CC and CCF take less than 1 
minute. Newly developed software which enables the identification of the midline automatically could 
still improve the measurements for clinical practice [269].
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Strengths and limitations 
Some considerations should be taken into account. First, our study was conducted in a tertiary hospital 
setting, with a relatively high maternal age, women mainly of western origin and a high educational 
level. Therefore, replication of the data is warranted to validate our findings for the general populations. 
Second, the small number of cases limits the conclusions of our study. Therefore, we cannot exclude 
that absence of statistical significant findings may be due to a lack of power. Third, growth charts are 
based on measurements at 4 time points and may improve by validation in a cohort that included 
intermediate time points to further smooth the curves. Finally, the US scans and measurements were 
performed by experienced observers which potentially enhanced quality of the mid-sagittal images 
and thereby success rates and reliability. Clinical applicability may be overestimated as a consequence. 
Success rates of the measurements was mostly influenced by fetal position, therefore selection bias 
due to the success rates seems less likely. We consider the prospective and longitudinal study design 
as strength of our study. Combining prenatal and postnatal measurements in one reference curve is an 
innovative method to facilitate monitoring brain growth in fetuses at risk for impaired brain growth.
Future implications for clinical care and research
Tight collaborations between obstetrical and neonatal researchers and caregivers are needed for 
bridging the gap when monitoring fetal and neonatal brain growth. This is of great importance for 
optimizing neurodevelopmental care in fetuses and infants at risk for abnormal brain growth and 
neurodevelopmental impairment. Easily applicable US tools that can be used without constraints of 
a prenatal or postnatal environment will have clinical implications. We consider our reference curves 
useful for age-equivalent preterm infants as they are largely comparable to the postnatal reference 
curves between 24 and 32 weeks in preterm infants from Roelants et al. [259]. In addition, CC and CCF 
measurements may be applicable from mid-gestation onwards and may theoretically be prolonged 
until closure of the anterior fontanelle in the first year of life. Future research should explore the link 
between the growth measures and functional neurodevelopmental outcome.
CONCLUSIONS
In this prospective cohort we demonstrated that CC and CCF measurements are reliable markers for 
brain growth from the fetal until the early neonatal period. By combining prenatal and postnatal CC 
and CCF measurements in one reference curve a continuum for monitoring brain growth was created 
irrespective of an intra- or extra-uterine environment. We demonstrated that fetuses at risk for 
abnormal brain growth, i.e. CHD and FGR, showed significantly decreased CC and CCF growth between 
22 and 42 weeks GA. Whether these markers could serve as an early predictor for neurodevelopmental 
outcome in later life warrants further research.
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This thesis provides evidence for the feasibility and validity of the assessment of early growth and 
development of a spectrum of human brain structures by three-dimensional ultrasound (3D-US) 
techniques. Growth trajectories of the cerebellum, head volume (HV), brain fissures, corpus callosum 
(CC) and corpus callosum – fastigium (CCF) have been associated with several periconceptional 
maternal and fetal characteristics (Figure 1). In this chapter, I will discuss the main findings and their 
clinical implications, some methodological considerations and future perspectives.
MAIN FINDINGS
The vulnerable human brain
The complexity of the structural development of the human brain implicates a high susceptibility 
for developing disorders. The developing brain is subject to adverse environmental influences, 
affecting early growth and developmental programming as a blue print for a lifelong susceptibility to 
neurodevelopmental disorders and psychiatric disease [270]. During pregnancy an adequate intake 
of nutrition, avoidance of harmful maternal behaviours and adequate oxygenation are essential for 
optimal growth and development of the rapidly developing human brain [270]. In this thesis we show 
that periconceptional maternal conditions that influence overall embryonic and fetal growth, are also 
associated with growth of the human cerebellum and head (Chapter 3, 4 and 5) [105,106].
The evolutionary expansion of cerebellar size in humans is thought to be fundamental to the 
human’s unique cognitive abilities [271]. The human cerebellum is involved in motor and non-motor 
functions essential for normal neurodevelopment [48,49]. Although overwhelming evidence from 
animal studies establishes the particular susceptibility of the cerebellum to adverse intra-uterine 
environmental conditions [5,46,53], human evidence for such impacts are scarce (Chapter 2). In 
addition to the evidence from the reviewed literature, we demonstrated that first trimester cerebellar 
growth trajectories are influenced by the periconceptional folate status of the mother (Chapter 3). 
Similar evidence was demonstrated in animal models showing that the cerebellum is susceptible 
to a folate rich or deficient environment [119,123,124]. Underlying mechanisms of the impact of 
maternal folate status may lie in epigenetic processes relating to the one-carbon pathway including 
DNA methylation of embryonic growth genes [16,125]. Our findings add to the widely known positive 
effects of periconceptional maternal folic acid supplement use, reducing the occurrence of neural tube 
defects and other congenital malformations [110-112]. However, our data show that mothers-to be 
can achieve a folate status optimal for cerebellar growth. In addition to similar findings for embryonic 
size, the highest levels of folate may not relate to the most optimal cerebellar growth [105]. This 
implies that we need to be cautious with high dosages of synthetic folic acid intake in the absence 
of clinical need. However, Chapter 4 shows that the impact of folate attenuates as cerebellar growth 
progresses into the fetal period. This supports that folate is particularly important during very early 
gestation [23]. Furthermore, we demonstrated a negative association between maternal body mass 
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(BMI) and cerebellar growth between 9 and 32 weeks gestational age (GA). An increasing maternal 
BMI can reflect derangements in a spectrum of biological pathways including inflammation, oxidative 
stress, metabolism and vascularization which continuously expose the developing brain [150-154,272]. 
Specifically, the increased inflammatory state and circulating cytokines play a key role in fetal brain 
inflammation inducing neuronal damage and mal programming of neonatal brain genes and subsequent 
abnormal neurodevelopment in the offspring [150,152]. To intervene in these pathways and improve 
neurodevelopmental health in offspring of obese mothers, the effect of metformin treatment, nutrient 
supplementation, lifestyle and dietary changes were explored [273-277]. However to date, evidence is 
insufficient to recommend any of these exploratory therapies.
This thesis also reveals that embryonic HV is positively associated with maternal age and IVF/
ICSI treatment and negatively associated with periconceptional smoking (Chapter 5). Although 
interpretation of these results is complicated by the use of transformations in the models, there are 
several explanations. Decreased head size due to maternal smoking could be explained by direct toxic 
effects on embryonic tissues [29]. Also, epigenetic alterations in DNA methylation and down regulation 
of genes that are important for normal brain development could play a role [278,279]. Moreover, 
maternal aging is related to global hypomethylation potentially leading to decreased DNA methylation 
in the embryo. When this involves growth genes, it may also explain why in general embryonic 
growth is increased in aging mothers [106]. Furthermore, IVF/ICSI treatment may be considered as 
an environmental factor that influences programming and gene expression patterns in the embryo as 
well [182,280]. 
Our data is important as a large proportion of women of reproductive-age struggle daily with one or 
more of these potentially harmful periconceptional behaviours [148,281,282]. Since the demonstrated 
associations involve periconceptional maternal factors that have been related to epigenetic pathways, 
our findings may even have transgenerational effects. Therefore, we speculate that preconceptional 
counselling and public health policies targeting these modifiable factors, can contribute to the 
improvement of neurodevelopmental health in the next generations. However, as time passes 
potential new threats including limited physical exercise, recreational drug use, phthalates and the use 
of mobile phones invade our daily lives and warrant our attention.
The early brain adapts
The critical window of exposures is not restricted to the periconceptional and embryonic period. 
The fetal and neonatal brain adapts to its prenatal and postnatal environment. In addition, an 
adverse environment may contribute to developmental disorders, growth restriction or preterm 
birth and indirectly affect brain development. Literature indicates that fetuses with congenital heart 
defects (CHD) growth-restricted fetuses and preterm born infants are at risk for abnormal brain 
development and consequently impaired neurodevelopment [26,283,284]. Cerebro-placental blood 
flow can be redistributed in these cases to preserve an adequate cerebral oxygenation as an auto-
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regulative response [188,190,285]. Such an adaptive process favours short-term survival but can be 
disadvantageous for long-term functional outcome [270,285]. Therefore, it seems obvious to monitor 
early brain development already during pregnancy in these infants at risk. However, reliable markers 
to monitor brain growth during prenatal and neonatal life are lacking.
From this perspective, we investigated new early markers of head and brain development including 
cortical folding, CC length and CCF length in Chapter 6, 7 and 8 in addition to the previously discussed 
HV (Chapter 5). HV was measured using the Barco I-Space virtual reality system. We proposed HV 
as a new measure for first trimester head size and possible early marker of fetal head size. Since the 
CAVE-like virtual reality system is bound to a spacious room and measurements warrant extensive 
training, clinical implementation of this technique is limited. A desktop version of the same virtual 
reality software, which can be used next to the ultrasound equipment, may facilitate this in the future.
Fetal cortical development can be evaluated with a wide variety of measures and methods from both 
ultrasound and magnetic resonance imaging studies [200,203,205,207]. In Chapter 6 we showed the 
feasibility of fetal brain fissure depth measurements using 3D-US. Our findings of altered cortical folding 
in CHD fetuses are supported by accumulating evidence that brain abnormalities co-occurring with 
CHD have a prenatal origin [26,185]. However, our conclusions may be limited because it is not clear 
whether the three brain fissure depths represent the complex process of global cortical folding. We 
demonstrated that cortical folding can be altered without signs of hemodynamic adaptation. Therefore, 
other mechanisms seem to play a role in the prenatal origin of CHD-related brain abnormalities. This 
also supports why growth restricted fetuses show a different patterns of cortical folding alterations 
[206]. The simultaneous development and shared morphogenetic programs of the heart and brain 
may bring a new perspective placing more emphasis on early gestation [286]. This creates a window 
of opportunity for prenatal diagnostic screening. Furthermore, we need to consider that the brains 
of these fetuses are challenged to overcome a series of events including hemodynamic changes, 
delivery, closure of the ductus arteriosus and cardiac surgery that all contribute to derangements in 
brain development. Therefore, it is recommended to monitor brain development, not only cerebro-
placental blood flow indices, and screen for adverse functional outcome [187].
Monitoring brain growth in the neonatal period is mostly limited to imprecise HC measurements. CCF 
length, a new cranial ultrasound (CUS) marker that we proposed in Chapter 7 was demonstrated to 
be a reliable tool for monitoring brain growth in preterm infants. The marker was relatively stable as 
no associations were found with gestational or neonatal complications. However, the short follow-up 
period and little data after 30 weeks GA should be considered when interpreting these non-significant 
findings. In Chapter 8 we confirmed that the CCF length could also be measured reliably using prenatal 
3D-US. In addition prenatal and neonatal CC and CCF measurements were combined in one reference 
chart. The reference charts from Chapter 7 and 8 were largely comparable. Therefore, we suggest that 
these new curves can be useful for both fetuses and age-equivalent preterm infants. Clinical value 
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of these markers is established by the decreased CC and CCF growth trajectories in fetuses at risk 
for abnormal brain growth and adverse neurodevelopmental outcome. In theory, applicability of CC 
and CCF measurements can be prolonged from mid-gestation until closure of the anterior fontanelle. 
However, before implementing these practical, relatively cheap and reliable markers in clinical practice, 
we need to explore its predictive value and relationship with neurodevelopmental outcome.
METHODOLOGICAL CONSIDERATIONS
We conducted a longitudinal 3D-US study (Dream study) in the setting of the Rotterdam periconception 
cohort (Predict Study) and a longitudinal ultrasound study in preterm infants during hospital stay 
(Submarine study). In these studies we combined first, second, third trimester and postnatal brain 
measurements. The submarine study collected serial postnatal brain measurements in preterm infants. 
Previously, ultrasound studies predominantly studied growth and developmental disorders with a 
cross-sectional approach, which limited conclusions on actual growth of brain structures. In addition, 
embedding the dream study in the Predict study had the advantage that data was obtained from the 
periconceptional period until the early neonatal period. This is in contrast to most studies limiting data 
collection to the third trimester of pregnancy and delivery [24]. However, interpretation of our findings 
should be done with caution as the observational study design limits the ability to demonstrate 
causation. Additionally, the study was carried out in a tertiary hospital setting which contributed to 
our population consisting of high risk pregnancies and a large proportion of pregnancies resulting from 
IVF/ICSI treatment. Therefore, external validity of the findings needs to be established. During the 
study we were often challenged by moderate or even low success rates of 3D-US measurements. This 
could have compromised the longitudinal setting of the study. However, in all analyses more than half 
of the subjects did have repeated measurements, which supports that the linear mixed models which 
we have estimated are the most suitable statistical method. How the small deviations in the growth of 
the investigated brain structures are related to the child’s functional outcome needs to be assessed in 
follow up studies. Small derangements in early brain development potentially lead to larger functional 
effects in later life. However, conclusions on neurodevelopmental consequences are beyond the scope 
of this thesis. Replication of our study is warranted to draw more robust conclusions on the observed 
associations.
In studies with embryonic and fetal growth outcomes, GA remains an important confounder. Although 
all statistical analyses were adjusted for GA, inaccuracies in pregnancy dating may still have influenced 
the observed associations despite the strict method of pregnancy dating in the Predict study. However, 
in the Netherlands reference charts of CRL measurements from Robinson et al. 1975 are still used in 
daily clinical practice [133]. One may argue that these charts are outdated and lack the image quality 
which can be ensured by current ultrasound equipment. Innovative methods for pregnancy dating 
by Carnegie stages may enhance precision of designating the true developmental age of the embryo 
Processed on: 7-4-2017
509071-L-bw-Koning
General Discussion 127
1
9
[287]. However, this is a time consuming method and currently not ready for clinical implementation. 
Until we have found a more optimal method, we need to take into account inaccuracies of pregnancy 
dating (both in clinical practice and for research purposes), as studying trajectories of growth warrant 
a time scale.
FUTURE PERSPECTIVES
The DOHAD paradigm is a hot topic in research, demonstrating accumulating new evidence for the 
prenatal origins of non-communicable diseases in later life. However, the contribution of adverse 
conditions during pregnancy on the developmental programming of neurodevelopmental and 
psychiatric disorders has comparatively been ignored. Nevertheless, it is an important issue as one in 
six children in the industrialized world are at risk for neurodevelopmental disorders and the prevalence 
of ADHD and ASD is rising [6-8].
Figure 2 — Examples of the use of three-dimensional ultrasound
(A) measurements of the embryonic cerebellum, (B) segmentation of the embryonic head for head volume measurements in 
the Barco I-Space, (C) Manipulating 3D-US volumes for a precise mid-sagittal plane for corpus callosum measurements and (D) 
Render mode of 3D image of a fetus of 32 weeks gestational age. Images with permission.
Evaluating early human brain development may contribute to a better understanding of developmental 
phases in which the brain is most vulnerable to specific environmental insults. Redirecting our focus 
to even earlier prenatal measures of brain growth is of great importance and creates new windows 
of opportunity for prenatal diagnostics. Although we demonstrated that 3D-US measures of a 
spectrum of brain structures were feasible and reliable, measuring small brain structures remains 
a challenge and warrant a trained neurosonographer. Therefore, clinical implementation of such 
complex measurements at this moment is rather limited. One may argue that MRI provides more 
detailed and sophisticated measures to evaluate brain development. Yet, in a society in which we 
constantly deliberate on health care costs and the burden for the patient, ultrasound will remain the 
first choice for imaging, especially during pregnancy. The multiplanar mode of 3D-US shows the three 
orthogonal planes enabling a precise reconstruction of the plane needed for measurements with 
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minimal deviation [216-218,288]. Improvements in 3D-US applications will enhance image quality and 
usability and thereby clinical implementation of early human brain measurements. Then, monitoring 
brain development from the first trimester onwards may become within reach.
\It is crucial for clinical practice that we use precise and reliable measures of early human brain 
development. The question is however, what is precise and reproducible? What is an acceptable level 
of measurement error? In literature we find a wide variety of statistical analyses to calculate reliability 
and to classify the ‘extend of agreement’. Throughout this thesis we used the same methods for the 
reliability analysis including intraclass correlations and the Bland Altman approach. Although clinical 
applicability of measurements depends on the level of agreement, literature provides no consensus on 
the level of agreement required for specific measurements.
Another important issue is the traditional division between fetal and neonatal reference charts for 
monitoring weight and head circumference for example. This leaves a gap when monitoring brain 
growth in fetuses and infants at risk for abnormal neurodevelopment. To provide sustainable 
neurodevelopmental care for these high risk patients, it is essential that we find continuous measures 
for brain growth that can be used irrespective of an intra or extra uterine situation. Extending our 
focus to a more protracted perspective on neurodevelopment of the embryo, fetus and neonate will 
open up a whole new field of research and clinical care. Such a perspective however requires a strong 
collaboration between obstetrical and neonatal health care professionals and researchers. Combining 
knowledge of these fields will enable monitoring the unborn child from conception until the first 
weeks of life irrespective of an intra or extra-uterine environment.
Large follow-up studies need to elucidate whether the deviations in size and growth of the studied 
brain structures have consequences for neurodevelopmental functioning. Functional outcome tests 
that specifically target the exact set of functions of the individual brain structure are essential. In 
this context, human research is mandatory as the human brain is significantly different from animals, 
following different embryologic timelines and engaging in a more extensive and complex set of 
functions. However, to provide evidence for causal relations between adverse intra-uterine conditions 
for prenatal brain development, animal studies are indispensable. Human trials in this context are 
neither ethical nor feasible. Combining evidence from both animal and human studies may lead to an 
increasing understanding of the underlying mechanisms driving derangements in neurodevelopment 
due to periconceptional behaviours, maternal characteristics and fetal factors subsequently influencing 
postnatal neuro-psychological functioning.
This thesis provides evidence for the impact of periconceptional maternal and fetal factors on early 
human brain development. Hopefully this knowledge will contribute to more awareness of the 
periconceptional and prenatal period as window of opportunity for the modification of preventable risk 
factors that affect early neurodevelopment. Ultimately, future research will contribute to efficacious 
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periconceptional counselling supporting a healthier lifestyle for parents-to-be which will contribute to 
an optimal environment for the developing fetus and its brain.
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SUMMARY
Early human brain development is an extremely complex process which is highly susceptible to genetic 
and environmental conditions. These factors may cause subtle changes in early brain development 
and subsequent neurodevelopmental impairment. The main objective of this thesis is to provide more 
insight in early human brain development during the embryonic, fetal and early neonatal period and 
factors that disrupt this process. 
In Chapter 1 the background this thesis is described. We also introduce the three-dimensional 
ultrasound (3D-US) technique which facilitates neuro-sonography; the evaluation of embryonic, fetal 
and neonatal brain development. Standardized 3D-US measures of various brain structures were 
developed to create reference curves. Moreover, we investigate the impact of periconceptional, 
maternal and fetal characteristics on early human brain development. In this thesis we describe the 
results from three studies; the Rotterdam periconception cohort, the DREAM study and the Submarine 
study.
In PART I we focus on early human development of the cerebellum. A systematic literature search is 
conducted to provide an overview of parental environmental exposures and intrinsic factors influencing 
prenatal cerebellar growth and development in humans (Chapter 2). We have found 15 eligible studies 
reporting associations between maternal smoking, use of alcohol, in vitro fertilization mediums, 
mercury, mifepristone, aminopropionitriles, ethnicity, cortisol levels and cerebellar development. We 
conclude that current literature on factors impacting the human cerebellar development is scarce and 
not always consistent. 
Therefore, a 3D-US study is conducted to study the development of the cerebellum during the first, 
second and third trimester of pregnancy. In Chapter 3 we show that preconceptional maternal folic acid 
supplement initiation compared to postconceptional initiation is associated with increased embryonic 
cerebellar size and growth trajectories. Although the variations in cerebellar growth are small, we 
validated our findings by establishing an optimal level of red blood cell folate. Growth trajectories of 
the cerebellum between 9 and 32 weeks of gestation were created in Chapter 4. By creating these 
growth trajectories we are able to study associations with a spectrum of periconceptional behaviours, 
maternal characteristics and fetal gender. We demonstrate that maternal pre-pregnancy body mass 
index is negatively associated to cerebellar growth from the first until the third trimester. As maternal 
obesity has previously been associated to increased risks for neurodevelopmental impairment, we 
hypothesized that prenatal cerebellar growth acts as a mediator in this association. 
To evaluate early brain development, new and reliable early imaging markers are warranted. In PART II 
several serial measurements of embryonic, fetal and neonatal brain structures are studied. In Chapter 5 
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we demonstrate that first trimester head volume measured with a virtual reality technique (Barco 
I-Space) are positively associated with fetal head size. This supports the hypothesis that embryonic 
head growth may serve as early marker of fetal head size. Furthermore we demonstrate that head 
growth is negatively associated with periconceptional maternal smoking and positively associated 
with maternal age and in vitro fertilization (IVF)/intra-cytoplasmic sperm injection (ICSI) treatment. 
Implications of these small but significant variations in growth of the embryonic head for the child’s 
neurodevelopmental outcome are yet unknown and warrant further investigation.
Chapter 6 describes the 3D-US method to evaluate brain fissure depths as a measure for prenatal 
cortical folding. Congenital heart defects show delayed growth trajectories of the left insula and 
right parieto-occipital fissure while their growth rates were slightly increased compared to controls. 
These findings cannot be explained by hemodynamic adaptation as the cerebro-placental ratio is not 
significantly associated to cortical folding in CHD, which is in contrast to controls. In addition we show 
a positive association between male gender and growth trajectories of the Sylvian fissure and the 
insula depths. 
In the Submarine study, we study the feasibility of a new bedside available ultrasound marker 
for preterm brain growth; corpus callosum – fastigium (CCF) length. Reference curves of this new 
marker are presented in Chapter 7. In addition we show that CCF length was positively associated 
to birth weight and male gender. No other associations with gestational complications including pre-
eclampsia, chorioamnionitis, ventilation days, perinatal death or sepsis are demonstrated. Thereafter, 
we investigate whether the same marker is feasible for evaluating fetal brain growth (Chapter 8). 
Furthermore we provide reference curves of CC and CCF length between 22 weeks until 42 weeks 
gestational age to monitor fetal and neonatal brain growth as continuum. Reference curves of CC and 
CCF in fetuses (Chapter 8) are largely comparable to those in preterm infants (Chapter 7). Furthermore, 
CC and CCF growth trajectories of CHD and FGR fetuses are decreased compared to those of controls. 
In the general discussion we address the main findings and their clinical implications, some 
methodological considerations and future perspectives. In addition, recommendations for future 
neurodevelopmental research in the field of the DOHaD paradigm are discussed.
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SAMENVATTING
Vroege ontwikkeling van het menselijk brein is een uiterst complex proces waarbij zowel 
genetische factoren als omgevingsfactoren een belangrijke rol spelen. Deze factoren kunnen 
subtiele veranderingen in vroege breinontwikkeling tot gevolg hebben. Dit zou kunnen leiden tot 
neurologische ontwikkelingsstoornissen. Het doel van dit proefschrift is meer inzicht te krijgen in de 
vroege ontwikkeling van het brein gedurende de embryonale, foetale en vroege neonatale periode en 
factoren die dit proces kunnen verstoren.
In Hoofdstuk 1 wordt de achtergrond van dit proefschrift beschreven en de driedimensionale 
echografietechniek (3D-US) geïntroduceerd die gebruikt wordt voor neurosonografie, de evaluatie 
van embryonale, foetale en neonatale breinontwikkeling. Gestandaardiseerde 3D-US metingen 
van verschillende breinstructuren zijn ontwikkeld en referentiecurves zijn gemaakt. Bovendien 
wordt de invloed bestudeerd van periconceptionele maternale en foetale factoren op de vroege 
breinontwikkeling. In dit proefschrift worden de resultaten beschreven van de studies die zijn 
uitgevoerd in het Rotterdam periconceptie cohort, de DREAM studie en de Submarine studie.
In DEEL I ligt de focus op de vroege ontwikkeling van het cerebellum bij de mens. Een systematische 
literatuurstudie is uitgevoerd waarin een overzicht wordt gegeven van ouderlijke omgevingsinvloeden 
en intrinsieke factoren die de prenatale groei en ontwikkeling van het cerebellum beïnvloeden 
(Hoofdstuk 2). Er worden 15 geschikte studies gevonden die associaties rapporteerden tussen roken, 
alcoholconsumptie, media die gebruikt worden voor in vitro fertilisatie (IVF), kwik, mifepristone, 
amino-propaannitrilen, etniciteit en cortisolspiegels en cerebellaire ontwikkeling. De conclusie is dat 
de huidige literatuur over factoren die de cerebellaire ontwikkeling bij de mens beïnvloeden schaars 
en bovendien niet altijd consistent is. 
Dit is aanleiding geweest voor het opzetten van een 3D-US studie waarin de ontwikkeling van het 
cerebellum wordt bestudeerd gedurende het eerste, tweede en derde trimester van de zwangerschap. 
In Hoofdstuk 3 wordt preconceptioneel starten met foliumzuursupplementen door de aanstaande 
moeder geassocieerd met een groter cerebellum en toegenomen cerebellaire groeitrajecten in het 
eerste trimester vergeleken met postconceptioneel starten. Hoewel de variaties in de groei van het 
cerebellum klein zijn, werden de bevindingen gevalideerd met het vaststellen van een optimum 
concentratie van maternaal foliumzuur in erytrocyten. In Hoofdstuk 4 zijn de groeitrajecten van het 
cerebellum tussen 9 en 32 weken zwangerschap gecreëerd. Hierdoor werd het mogelijk om associaties 
met verschillende periconceptionele gewoonten, maternale kenmerken en het foetale geslacht te 
bestuderen. In dit hoofdstuk laten wij zien dat de body mass index van de moeder vóór de zwangerschap 
en gedurende de vroege zwangerschap negatief geassocieerd is met de groei van het cerebellum 
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van het eerste tot en met het derde trimester. Aangezien maternale obesitas eerder geassocieerd 
werd met een verhoogd risico op neurologische ontwikkelingsstoornissen, veronderstellen wij dat de 
prenatale groei van het cerebellum optreedt als een intermediair in deze associatie.
Om de vroege breinontwikkeling te beoordelen zijn nieuwe betrouwbare vroege markers nodig. 
In DEEL II bestuderen we verschillende seriële metingen van embryonale, foetale en neonatale 
breinstructuren. In Hoofdstuk 5 tonen wij aan dat het hoofdvolume in het eerste trimester, gemeten 
met de Barco I-Space virtual reality-techniek, positief geassocieerd is met de foetale hoofdomtrek. 
Dit ondersteunt de hypothese dat de embryonale groei van het hoofd een vroege marker kan zijn 
voor de foetale hoofdgroei. Bovendien wordt de groei van het hoofd negatief geassocieerd met 
periconceptioneel roken en positief geassocieerd met de leeftijd van de moeder en het ondergaan van 
een IVF/intracytoplasmatische sperma-injectie behandeling. De consequenties van deze kleine, doch 
significante variaties in de groei van het embryonale hoofd voor de neuropsychologische ontwikkeling 
van het kind zijn nog onbekend en moeten verder onderzocht worden.
Hoofdstuk 6 beschrijft de 3D-US methode opgesteld voor het evalueren van foetale breinfissuren 
als een maat voor de prenatale corticale ontwikkeling. Foetussen met een congenitale hartafwijking 
(CHA) tonen vertraagde groeitrajecten van de linker insula en rechter parieto-occipitale fissuur met 
een verhoogde groeisnelheid vergeleken met een controlegroep. In tegenstelling tot de controles is 
de cerebro-placentaire ratio niet significant geassocieerd is met de corticale ontwikkeling van CHA-
foetussen. Dit suggereert dat hemodynamische mechanismen hier niet verantwoordelijk voor lijken 
te zijn. Daarnaast vinden wij een significant positieve associatie tussen het mannelijke geslacht en 
groeitrajecten van de insula en fissuur van Sylvius.
In de Submarine studie, wordt de toepasbaarheid onderzocht van een nieuwe aan-het-bed-beschikbare 
echomarker voor premature breingroei; corpus callosum – fastigium (CCF) lengte. Referentiecurves 
van deze nieuwe meting worden gepresenteerd in Hoofdstuk 7. CCF lengte is positief geassocieerd 
met het geboortegewicht en het mannelijke geslacht. Er worden geen andere associaties aangetoond 
met zwangerschapscomplicaties zoals pre-eclampsie, chorio-amnionitis, aantal dagen mechanische 
ventilatie, perinatale sterfte of sepsis. Vervolgens wordt onderzocht of dezelfde marker bruikbaar is voor 
het evalueren van de groei van het foetale brein (Hoofdstuk 8). Referentiecurves tussen de 22 en de 42 
weken zwangerschapsduur worden gemaakt zodat breingroei als continuüm kan worden gemonitord 
in de foetale en neonatale periode. Deze foetale referentiecurves komen grotendeels overeen met die 
van de prematuren beschreven in Hoofdstuk 7. Bovendien blijkt dat CC and CCF groeitrajecten van 
foetussen met groeirestrictie en CHA verlaagd waren ten opzichte van de controlegroep. 
In de algemene discussie gaan wij in op de belangrijkste bevindingen van dit proefschrift. We bespreken 
de klinische implicaties, methodologische aspecten en het toekomst perspectief. Daarnaast doen we 
aanbevelingen voor toekomstig onderzoek naar de vroege ontwikkeling van het menselijk brein in het 
kader van het DOHaD paradigma.
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CHAPTER 3 – APPENDIX A
Literature search 4 September 2015
Embase 2226
MedLine OvidSP 279
Web-of-science 1091
PubMed publisher 95
Cochrane 0
Google Scholar 181
Total 3872
Embase 
((‘cerebellum agenesis’/de OR ‘cerebellum atrophy’/de OR ‘cerebellum hypoplasia’/de OR ‘cerebellum 
injury’/de OR ((cerebell* NEAR/3 (agenes* OR atroph* OR hypoplas*))):ab,ti) OR ((cerebellum/exp OR 
(cerebell* OR Purkinje OR transcerebel*):ab,ti) AND (‘growth, development and aging’/de OR growth/
exp OR development/exp OR ‘central nervous system malformation’/exp OR ‘brain injury’/exp OR 
‘brain size’/de OR ‘brain weight’/de OR ‘growth disorder’/exp OR measurement/de OR hypoplasia/de 
OR (growth* OR develop* OR matur* OR malform* OR defect* OR deficit* OR anomal* OR damag* 
OR formation* OR size OR dysmorphogen* OR dysgenes* OR abnormal* OR measure* OR ((cerebel* 
OR transcerebel*) NEAR/3 (weight OR volume* OR diameter* OR small* OR large*)) OR hypoplas* 
OR hypogen*):ab,ti))) AND (((risk/exp OR obesity/exp OR (‘body weight’/exp NOT ‘birth weight’/
exp) OR nutrition/exp OR ‘nutritional disorder’/exp OR smoking/exp OR ‘Smoking Cessation’/de OR 
nicotine/de OR lifestyle/de OR ‘lifestyle modification’/de OR ‘folic acid’/de OR ‘folic acid deficiency’/
de OR alcohol/de OR ‘fetal alcohol syndrome’/de OR addiction/exp OR abuse/de OR ‘alcohol abuse’/
exp OR ‘drug abuse’/exp OR ‘substance abuse’/de OR ‘drug exposure’/de OR ‘adverse drug reaction’/
exp OR ‘adverse drug reaction’:lnk OR exposure/de OR drug/exp OR opiate/de OR methadone/de OR 
intoxication/exp OR ‘ethnic or racial aspects’/exp OR ‘ethnic and racial groups’/exp OR parity/de OR 
multipara/de OR ‘social status’/exp OR ‘parental age’/exp OR (risk* OR nutrition* OR malnutrit* OR 
malnourish* OR underfe* OR undernourish* OR undernutrit* OR macronutrient* OR micronutrient* 
OR nutrient* OR supplement* OR additive* OR deficien* OR behav* OR obes* OR overweight* OR 
adipos* OR (weight NOT ‘birth weight’) OR cigarette* OR smok* OR nicotin* OR lifestyle OR ‘life style’ 
OR ‘folic acid’ OR folate OR alcohol* OR ethanol OR addict* OR abuse OR substance* OR drug* OR 
cannabis OR cocaine OR opiate* OR opioid* OR methadone* OR intoxicat* OR abus* OR exposure 
OR ethnic* OR race OR racial OR parity OR multipar* OR primipar* OR nullipar* OR ((social OR socio 
OR socioeconomic) NEAR/3 (status* OR rank OR class* OR background*)) OR poverty OR income OR 
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((parent* OR matern* OR patern* OR mother* OR father*) NEAR/3 (age OR old* OR young* OR ‘birth 
weight’ OR birthweight OR SGA OR small OR LBW OR VLBW OR ELBW))):ab,ti) AND (pregnancy/exp 
OR ‘gestation period’/de OR ‘Gestational Age’/de OR ‘perinatal period’/de OR ‘prenatal period’/de 
OR ‘prenatal development’/exp OR ‘prenatal diagnosis’/de OR ‘embryonic and fetal functions’/exp 
OR fetus/de OR (pregnan* OR ‘child bearing’ OR gravid* OR primigravid* OR fetus* OR foetus* OR 
fetal* OR foetal* OR embryo* OR gestation* OR prenatal OR perinatal OR offspring* OR newborn* 
OR mother* OR intrauter* OR trimester):ab,ti)) OR (‘maternal nutrition’/de OR ‘maternal behavior’/
de OR ‘prenatal drug exposure’/de OR ‘perinatal drug exposure’/de OR ‘prenatal exposure’/de OR 
(maternal* OR paternal*):ab,ti)) NOT ([animals]/lim NOT [humans]/lim)
MedLine OvidSP 
((((cerebell* ADJ3 (agenes* OR atroph* OR hypoplas*))).ab,ti.) OR ((cerebellum/ OR (cerebell* OR 
Purkinje OR transcerebel*).ab,ti.) AND (exp “Growth and Development”/ OR exp brain/ab OR exp 
“Brain Injuries”/ OR (growth* OR develop* OR matur* OR malform* OR defect* OR deficit* OR 
anomal* OR damag* OR formation* OR size OR dysmorphogen* OR dysgenes* OR abnormal* OR 
measure* OR ((cerebel* OR transcerebel*) ADJ3 (weight OR volume* OR diameter* OR small* OR 
large*)) OR hypoplas* OR hypogen*).ab,ti.))) AND (((exp risk/ OR exp Overweight/ OR “body weight”/ 
OR exp “Nutritional Physiological Phenomena”/ OR exp “Nutrition Disorders”/ OR exp smoking/ OR 
“Smoking Cessation”/ OR nicotine/ OR “life style”/ OR exp “folic acid”/ OR “folic acid deficiency”/ OR 
exp alcohols/ OR exp “Alcoholic Beverages”/ OR “Behavior, Addictive”/ OR exp “Substance-Related 
Disorders”/ OR “Alcoholism”/ OR “Abnormalities, Drug-Induced”/ OR exp “Drug-Related Side Effects 
and Adverse Reactions”/ OR “adverse effects”.xs. OR “Maternal Exposure”/ OR exp “Analgesics, 
Opioid”/ OR methadone/ OR exp “Ethnic Groups”/ OR parity/ OR “Social Class”/ OR (risk* OR nutrition* 
OR malnutrit* OR malnourish* OR underfe* OR undernourish* OR undernutrit* OR macronutrient* 
OR micronutrient* OR nutrient* OR supplement* OR additive* OR deficien* OR behav* OR obes* 
OR overweight* OR adipos* OR (weight NOT “birth weight”) OR cigarette* OR smok* OR nicotin* 
OR lifestyle OR “life style” OR “folic acid” OR folate OR alcohol* OR ethanol OR addict* OR abuse OR 
substance* OR drug* OR cannabis OR cocaine OR opiate* OR opioid* OR methadone* OR intoxicat* 
OR abus* OR exposure OR ethnic* OR race OR racial OR parity OR multipar* OR primipar* OR 
nullipar* OR ((social OR socio OR socioeconomic) ADJ3 (status* OR rank OR class* OR background*)) 
OR poverty OR income OR ((parent* OR matern* OR patern* OR mother* OR father*) ADJ3 (age OR 
old* OR young* OR “birth weight” OR birthweight OR SGA OR small OR LBW OR VLBW OR ELBW))).
ab,ti.) AND (exp pregnancy/ OR “Pregnant Women”/ OR exp “Pregnancy Trimesters”/ OR “Gestational 
Age”/ OR exp “Embryonic Development”/ OR exp fetus/ OR (pregnan* OR “child bearing” OR gravid* 
OR primigravid* OR fetus* OR foetus* OR fetal* OR foetal* OR embryo* OR gestation* OR prenatal 
OR perinatal).ab,ti.)) OR (“maternal behavior”/ OR “Maternal Exposure”/ OR “paternal Exposure”/ 
OR “Maternal Nutritional Physiological Phenomena”/ OR (maternal OR paternal).ab,ti.)) NOT (exp 
animals/ NOT humans/)
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cochrane 
((((cerebell* NEAR/3 (agenes* OR atroph* OR hypoplas*))):ab,ti) OR (((cerebell* OR Purkinje OR 
transcerebel*):ab,ti) AND ((growth* OR develop* OR matur* OR malform* OR defect* OR deficit* 
OR anomal* OR damag* OR formation* OR size OR dysmorphogen* OR dysgenes* OR abnormal* 
OR measure* OR ((cerebel* OR transcerebel*) NEAR/3 (weight OR volume* OR diameter* OR 
small* OR large*)) OR hypoplas* OR hypogen*):ab,ti))) AND ((((risk* OR nutrition* OR malnutrit* OR 
malnourish* OR underfe* OR undernourish* OR undernutrit* OR macronutrient* OR micronutrient* 
OR nutrient* OR supplement* OR additive* OR deficien* OR behav* OR obes* OR overweight* OR 
adipos* OR (weight NOT ‘birth weight’) OR cigarette* OR smok* OR nicotin* OR lifestyle OR ‘life style’ 
OR ‘folic acid’ OR folate OR alcohol* OR ethanol OR addict* OR abuse OR substance* OR drug* OR 
cannabis OR cocaine OR opiate* OR opioid* OR methadone* OR intoxicat* OR abus* OR exposure 
OR ethnic* OR race OR racial OR parity OR multipar* OR primipar* OR nullipar* OR ((social OR socio 
OR socioeconomic) NEAR/3 (status* OR rank OR class* OR background*)) OR poverty OR income OR 
((parent* OR matern* OR patern* OR mother* OR father*) NEAR/3 (age OR old* OR young* OR ‘birth 
weight’ OR birthweight OR SGA OR small OR LBW OR VLBW OR ELBW))):ab,ti) AND ((pregnan* OR 
‘child bearing’ OR gravid* OR primigravid* OR fetus* OR foetus* OR fetal* OR foetal* OR embryo* 
OR gestation* OR prenatal OR perinatal OR offspring* OR newborn* OR mother* OR intrauter* OR 
trimester):ab,ti)) OR ((maternal* OR paternal*):ab,ti)) 
Web-of-science 
TS=(((((cerebell* NEAR/3 (agenes* OR atroph* OR hypoplas*)))) OR (((cerebell* OR Purkinje OR 
transcerebel*)) AND ((growth* OR develop* OR matur* OR malform* OR defect* OR deficit* OR 
anomal* OR damag* OR formation* OR size OR dysmorphogen* OR dysgenes* OR abnormal* OR 
measure* OR ((cerebel* OR transcerebel*) NEAR/3 (weight OR volume* OR diameter* OR small* OR 
large*)) OR hypoplas* OR hypogen*)))) AND ((((risk* OR nutrition* OR malnutrit* OR malnourish* OR 
underfe* OR undernourish* OR undernutrit* OR macronutrient* OR micronutrient* OR nutrient* OR 
supplement* OR additive* OR deficien* OR behav* OR obes* OR overweight* OR adipos* OR (weight 
NOT “birth weight”) OR cigarette* OR smok* OR nicotin* OR lifestyle OR “life style” OR “folic acid” OR 
folate OR alcohol* OR ethanol OR addict* OR abuse OR substance* OR drug* OR cannabis OR cocaine 
OR opiate* OR opioid* OR methadone* OR intoxicat* OR abus* OR exposure OR ethnic* OR race 
OR racial OR parity OR multipar* OR primipar* OR nullipar* OR ((social OR socio OR socioeconomic) 
NEAR/3 (status* OR rank OR class* OR background*)) OR poverty OR income OR ((parent* OR matern* 
OR patern* OR mother* OR father*) NEAR/3 (age OR old* OR young* OR “birth weight” OR birthweight 
OR SGA OR small OR LBW OR VLBW OR ELBW)))) AND ((pregnan* OR “child bearing” OR gravid* OR 
primigravid* OR fetus* OR foetus* OR fetal* OR foetal* OR embryo* OR gestation* OR prenatal OR 
perinatal OR offspring* OR newborn* OR mother* OR intrauter* OR trimester))) OR ((maternal* OR 
paternal*))) NOT ((animal* OR rat OR rats OR sheep OR mouse OR mice OR ewe OR cattle OR pig OR 
swine OR rodent* OR rabbit*) NOT (human* OR wom?n OR child* OR newborn*)))
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PubMed publisher
((((cerebell*[tiab] AND (agenes*[tiab] OR atroph*[tiab] OR hypoplas*[tiab])))) OR ((cerebellum[mh] 
OR (cerebell*[tiab] OR Purkinje OR transcerebel*[tiab])) AND (“Growth and Development”[mh] 
OR brain[mh]ab OR “Brain Injuries”[mh] OR (growth*[tiab] OR develop*[tiab] OR matur*[tiab] 
OR malform*[tiab] OR defect*[tiab] OR deficit*[tiab] OR anomal*[tiab] OR damag*[tiab] OR 
formation*[tiab] OR size OR dysmorphogen*[tiab] OR dysgenes*[tiab] OR abnormal*[tiab] OR 
measure*[tiab] OR ((cerebel*[tiab] OR transcerebel*[tiab]) AND (weight OR volume*[tiab] OR 
diameter*[tiab] OR small*[tiab] OR large*[tiab])) OR hypoplas*[tiab] OR hypogen*[tiab])))) AND 
(((risk[mh] OR Overweight[mh] OR “body weight”[mh] OR “Nutritional Physiological Phenomena”[mh] 
OR “Nutrition Disorders”[mh] OR smoking[mh] OR “Smoking Cessation”[mh] OR nicotine[mh] OR 
“life style”[mh] OR “folic acid”[mh] OR “folic acid deficiency”[mh] OR alcohols[mh] OR “Alcoholic 
Beverages”[mh] OR “Behavior, Addictive”[mh] OR “Substance-Related Disorders”[mh] OR 
“Alcoholism”[mh] OR “Abnormalities, Drug-Induced”[mh] OR “Drug-Related Side Effects and Adverse 
Reactions”[mh] OR “adverse effects”[sh] OR “Maternal Exposure”[mh] OR “Analgesics, Opioid”[mh] 
OR methadone[mh] OR “Ethnic Groups”[mh] OR parity[mh] OR “Social Class”[mh] OR (risk*[tiab] OR 
nutrition*[tiab] OR malnutrit*[tiab] OR malnourish*[tiab] OR underfe*[tiab] OR undernourish*[tiab] 
OR undernutrit*[tiab] OR macronutrient*[tiab] OR micronutrient*[tiab] OR nutrient*[tiab] OR 
supplement*[tiab] OR additive*[tiab] OR deficien*[tiab] OR behav*[tiab] OR obes*[tiab] OR 
overweight*[tiab] OR adipos*[tiab] OR (weight NOT “birth weight”) OR cigarette*[tiab] OR smok*[tiab] 
OR nicotin*[tiab] OR lifestyle OR “life style” OR “folic acid” OR folate OR alcohol*[tiab] OR ethanol OR 
addict*[tiab] OR abuse OR substance*[tiab] OR drug*[tiab] OR cannabis OR cocaine OR opiate*[tiab] OR 
opioid*[tiab] OR methadone*[tiab] OR intoxicat*[tiab] OR abus*[tiab] OR exposure OR ethnic*[tiab] OR 
race OR racial OR parity OR multipar*[tiab] OR primipar*[tiab] OR nullipar*[tiab] OR ((social OR socio 
OR socioeconomic) AND (status*[tiab] OR rank OR class*[tiab] OR background*[tiab])) OR poverty OR 
income OR ((parent*[tiab] OR matern*[tiab] OR patern*[tiab] OR mother*[tiab] OR father*[tiab]) AND 
(age OR old*[tiab] OR young*[tiab] OR “birth weight” OR birthweight OR SGA OR small OR LBW OR 
VLBW OR ELBW)))) AND (pregnancy[mh] OR “Pregnant Women”[mh] OR “Pregnancy Trimesters”[mh] 
OR “Gestational Age”[mh] OR “Embryonic Development”[mh] OR fetus[mh] OR (pregnan*[tiab] OR 
“child bearing” OR gravid*[tiab] OR primigravid*[tiab] OR fetus*[tiab] OR foetus*[tiab] OR fetal*[tiab] 
OR foetal*[tiab] OR embryo*[tiab] OR gestation*[tiab] OR prenatal OR perinatal))) OR (“maternal 
behavior”[mh] OR “Maternal Exposure”[mh] OR “paternal Exposure”[mh] OR “Maternal Nutritional 
Physiological Phenomena”[mh] OR (maternal OR paternal))) NOT (animals[mh] NOT humans[mh]) 
AND publisher[sb] 
Google Scholar 
intitle: Cerebellum|Cerebellar (growth|development|malformation|defect|anomaly) (risk|obesity| 
nutrition| malnutrition|deficiency|macronutrient|smoking|lifestyle|alcohol|drugs|ethnicity|”social 
status”|”parental age”) pregnancy|pregnant human|humans
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CHAPTER 3 – APPENDIX B
Quality score Systematic review on cerebellar growth and environmental factors 
This quality score can be used to assess the quality of studies included in systematic reviews and meta-
analyses and is applicable to both interventional and observational studies, excluding case reports. 
The score was designed based on previously published scoring systems (Carter et al, 2010 and the 
Quality Assessment Tool for Quantitative Studies). The quality score is composed of 5 items, and each 
item is allocated 0, 1 or 2 points. This allows a total score between 0 and 10 points, 10 representing 
the highest quality. 
1. Study design
 0  for studies with cross-sectional data collection.
 1  for studies with longitudinal data collection (both retrospective and prospective).
 2 for intervention studies.
2. Study size
 Imaging studies 
 0 small population for analysis (n<200)
 1 intermediate population for analysis (n= 200 to 1000).
 2 large population for analysis (n >1000).
 Histological studies 
 0 small population for analysis (n<20).
 1 intermediate population for analysis (n= 20 to 100).
 2 large population for analysis (n >100).
3. Exposure
 Observational studies
 0  if the study reported no or unclear exposure in terms of quality or quantity.
 1  if the study used categorical measurements of the exposures.
 2 if the study used quantitative measurements for the exposures.
4. Outcome
 Imaging studies
 0  when using no, unclear or no appropriate method for measuring or describing the cerebellum. 
  Or when description is without a clear clinical definition.
 1  when using a method for describing or measuring the cerebellum without information on 
  validation, reliability or reproducibility. 
 2  when using a standardized and validated cerebellar measurement (volume, diameter, etc.) or 
  protocolled description of ultrasound anomaly.
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 Histological
 0  if the study used no appropriate, unclear outcome measurement or if not reported.
 1  if the study used descriptive observations.
 2 if the study used quantitative observations/measurements of histological findings. 
5. Adjustments
 0 if findings are not adjusted.
 1 if findings are controlled for:
 – Gestational age
 – Occurrence of congenital malformations
 2 if an intervention study is adequately randomized or if findings are additionally controlled for GA, 
  and at least two of the following covariates†: 
 – Maternal body characteristics (age, BMI, ethnicity, socio-economic status)
 – Obstetrical characteristics ( Gravidity, parity, PE/HELLP, IUGR, stage of delivery)
 – Medical characteristics (Medication, disease, subfertility)
 – Fetal characteristics ( Fetal growth, EFW, gender)
 – Other behavioral factors (Drugs, smoking, alcohol, exercise, etc)
† Either adjusted for in the statistical analyses; stratified for in the analyses; or not applicable (e.g. a 
study in nulliparous women only does not require controlling for parity)
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ABBREVIATIONS
2D-US Two-dimensional ultrasound
3D-US Three-dimensional ultrasound
AC Abdominal circumference
BMI Body mass index
BPD Biparietal diameter
BW Birth weight
CC Corpus callosum
CCF  Corpus callosum – fastigium 
CHD  Congenital heart defect
CI Confidence interval 
CPR Cerebro-placental ratio
CRL Crown-rump length
CUS  Cranial ultrasound
EFW Estimated fetal weight
FA Folic acid
FGR Fetal growth restriction
FL  Femur length
GA Gestational age
HC Head circumference
HV Head volume
ICSI Intracytoplasmic sperm injection
ICC  Intraclass correlation coefficient
IQR Interquartile range 
IVF In vitro fertilisation
LCD Left cerebellar diameter
LMP  Last menstrual period
MCA  Middle cerebral artery
MRI Magnetic resonance imaging
NICU Neonatal intensive care unit 
OFD Occipital frontal diameter
PMA Post menstrual age
POF Parieto-occipital fissure
SD Standard deviation
SD(S) Standard deviation (score)
SGA Small for gestational age
RCD  Right cerebellar diameter
UA Umbilical artery
TCD  Transcerebellar diameter
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22nd floor together. I have learnt so much from you! One day we will both be Gynae and PhD. Agree? 
Sanne en Igna, voor mij waren jullie de nieuwelingen, maar al snel bewezen jullie een fantastische 
aanvulling voor het team te zijn. Zet ‘m op. Jan! Oh Jan. We hebben zo gelachen. Bedankt! Door jou 
waren de laatste loodjes niet zo zwaar. Fieke, ik ben trots dat jij in mijn voetsporen treedt. Dames 
van de Prenatale: Charlotte, Paulien, Nina en Averil, bedankt voor jullie hulp en gezelligheid tussen 
de spreekuren door. En natuurlijk ook nog lieve Hein, Evelyne, Babs, Ingrid, Jacky, Meertien, Minke, 
Leonie, Myrte, Zoe en iedereen die ik nog vergeten ben, heel erg bedankt voor de geweldige tijd 
samen. Ik heb genoten van de lunches, etentjes, researchochtenden en congressen naar Uppsala, 
Kaapstad, Barcelona, Montreal en Rome.
En dan mijn lieve paranimfen. Lieve Jorine, wij hebben gelachen en wij hebben gehuild. Ook al 
moesten wij in het begin een beetje aan elkaar wennen, er was een ‘DREAM-team’ geboren. Je drive 
en arbeidsethos zijn inspirerend. Jij bent een kanjer. Ik ben blij dat jij straks naast mij staat. Lieve 
Eline, sinds wij elkaar troffen in het Albert Schweitzer ziekenhuis bleven onze wegen elkaar kruisen. 
Wij konden efficiënt met elkaar werken maar ook verzanden in oeverloze gesprekken, fantastisch! Al 
die tijd op de werkvloer heeft gezorgd voor een prachtige vriendschap. Ik vind het zo bijzonder dat 
ondanks alles jouw eindeloze positivisme blijft bestaan. Zoals jij er voor mij bent, zal ik er voor jou zijn. 
Promoveren doe je niet tussen 9 en 5, niet alleen op de polikliniek, de afdeling of de echokamer. Juist 
de uren daarna geven een proefschrift zijn vorm en glans. 
Lieve Kiki, Pam en Miek, zes luisterende oren, drie lachende monden, drie keukens en drie thuizen, 
bij jullie kon ik vertellen. Tijdens de afgelopen jaren beleefden wij samen zoveel mijlpalen; er werden 
huizen gekocht en eigen bedrijven opgericht, er werd promotie gemaakt en een dochter geboren en er 
wordt binnenkort getrouwd. Laten we het samen blijven vieren.
Peppers! Jullie waren het publiek om al mijn preconceptionele adviezen op los te laten. Dit heeft 
tijdens mijn promotietraject zelfs mogen resulteren in twee prachtige dochters waar ik uiteraard de 
volledige credits voor toe-eigen. Tijdens mijn promotietijd heb ik genoten van de eindeloze verhalen 
op de whatsapp en de horizontale vakanties met jullie die altijd precies op het juiste moment leken te 
komen. 
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Lieve Coebergh, jou kan ik toch zeker niet vergeten. Hier en daar een koffietje en een heerlijk 
blaatverhaal hebben mijn promotietraject aangekleed. Jouw ontspannen, positieve houding siert je, je 
vertrouwen in een goede afloop is groots. Ook voor jouw laatste loodjes ben ik in de buurt!
Lieve Kim, bij ons zijn niet altijd woorden, telefoontjes of etentjes nodig. Onze vriendschap blijft altijd.
Lieve Ruud, Lia, Agnes en Bart, het was meteen thuiskomen in jullie warme familie. Bedankt voor jullie 
interesse, steun en aanmoedigingen. De Doctor-titel is een grote eer voor een klein paardenstaartje 
als ik.
Lieve Harold, al ruim tien jaar in de familie en niet meer weg te denken. Samen met jouw ouders, 
broer, zus en natuurlijk de kindjes, heb ik er een hele familie bij! 
Lieve Zussies, jullie hebben mij laten ratelen over begrijpelijke en onbegrijpelijke dingen, zodat ik aan 
het einde van het gesprek weer snapte wat ik jullie wilde vertellen. Ik ben groot (nou ja) geworden door 
jullie. Jullie zijn mijn eindeloze bron voor inspiratie voor wetenschappelijke en onwetenschappelijke 
zaken.
Lieve pap en lieve mam, jullie hebt mij opgevoed en grootgebracht. De structuur en doelgerichtheid 
van mam en de rust en nuchterheid van pap hebben elke dag weer bijgedragen aan een paar 
bouwsteentjes die samen mijn proefschrift vormen. Als ik mezelf zie door jullie ogen zie ik één en al 
trots. En dat hoeft niet eens met zoveel woorden gezegd, dat mag ook door een klopje op het hoofd.
Allerliefste Freek, mijn laatste woorden zijn voor jou. Eindelijk is het klaar! Samen beleefden wij onze 
eigen avonturen; ik een promotieonderzoek, jij Magnet.me. Alle avonturen kennen pieken en dalen. Jij 
leerde mij dat ik de pieken als pieken moest zien en dat ik mijlpalen (of mijlpaaltjes) kon vieren. Jij hebt 
het allemaal met mij meegemaakt. Jij deelde mijn lachen en mijn tranen, mijn sarcasme en tirades. Je 
was er 4 jaar lang. Je bent er, altijd. 
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